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1   Introduction 
 
System-wide ‘omics’ studies 
Proteomics, genomics, transcriptomics 
For many decades, researchers have investigated the biology of cells, their diversity and their 
main functional building blocks, the proteins, in focused and small-scale experiments. Increasingly 
comprehensive investigations into the complement of all proteins of a cell type, the proteome, 
enable researchers to better understand their functions in the context of biological networks as a 
whole1,2. Specifically, proteomics as a rapidly evolving discipline deals with identification and 
quantification of thousands of proteins in different cell states, including interactions between 
individual proteins and post-translational modifications, which play a pivotal role in regulating 
protein activity.  
Early system-wide biological studies were focused on the genome of an organism, the complement 
of all genes, directly or indirectly encoding for the primary structure of the proteins. The very first 
genome – that of bacteriophage ФX174 - was decoded in 19773 by electrophoretic sequencing 
methods that were pioneered by Fred Sanger and became very popular during the next decades4,5. 
It took until 1995 to analyze the first genome sequences of small cellular organisms6-8. In 1990, 
the Human Genome Project was established as a joint effort of several laboratories to further 
advance sequencing technology and to obtain a reference sequence of man. It took 11 years for 
presenting a first draft9,10 – a milestone in the era of genomics. The finalized sequence of 3 billion 
nucleotides of the human genome was published in 2007 and the number of its protein-coding 
genes is now estimated to be about 20,00011. 
Expression of protein coding genes requires the synthesis of transcripts. Therefore, the transcriptome 
- as the complement of all messenger RNA molecules in a cell type - is to a first approximation 
the missing link between genome sequence and the proteome. DNA microarrays are a very well 
established technology that is frequently applied for transcript analysis and it allows large-scale 
screens for a variety of applications12,13. However, the hybridization-based strategy is limited to 
the detection of known sequences that are synthesized and deposited on a chip. Quantification of 
transcripts is possible but not very precise14. Today, whole-genome sequencing as well as 
transcript analysis benefit greatly from next-generation sequencing technologies15. The automated 
sequencing-by-synthesis approaches overcome major drawbacks of microarrays and facilitate 
in-depth transcriptome analysis. RNA-Seq technology features high-throughput, improved 
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quantification and low costs per base16. Due to the relatively short sequence reads, however, data 
analysis strategies preferably utilize a reference genome.    
 
Figure 1: System-wide studies of different biopolymers: Genomics, transcriptomics and proteomics;  
cartoons in the lower part depict coding sequences in the genome (left),  
transcripts mapped to coding sequences (middle) and mass spectra of peptides (right). 
Challenges of three complementary disciplines 
‘Omics’ technologies aim at unraveling biopolymer sequences, however, different functionalities 
result in different challenges for these disciplines. For instance, the mammalian genome is 
extremely complex and contains highly repetitive sections that complicate sequencing and 
alignment of fragments. Nonetheless, the genome of each species is a fairly stable unit and 
sequencing a reference genome is a onetime effort. In contrast, the transcriptome and proteome 
regulate biological processes in different cell types that are exposed to different environmental 
conditions and that are therefore constantly changing. The proteome varies considerably between 
mammalian cell types and tissues and the copy numbers of different proteins are spread over 
many orders of magnitude. Similar trends apply to transcriptome analysis and greatly increase the 
challenges of obtaining comprehensive data compared to genomics.  For modern proteomics 
research, the availability of reference genomes is of fundamental importance, because data 
analysis almost always relies on protein databases that are derived from genome sequences17,18. 
Due to rapid technological progress, several thousand genomes of different organisms, from 
microorganisms to mammals, are already available today.  
In contrast to genomics, completeness of transcriptomes and even more so, of proteomes, is 
more difficult to determine and even the number of protein coding genes is usually only an 
estimate. Alternative splicing and protein isoforms may or may not be counted as different 
proteins; therefore the size of the proteome is also a matter of definition19. According to a simple 
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‘one gene–one protein’ rule, the first complete proteome characterizing 4,400 different proteins of 
the model organism yeast was obtained in 2008. Completeness was judged by the number of 
proteins expected from genome-wide tagging experiments20.  
There are numerous large-scale investigations into the mammalian proteome of various cell types, 
tissues or body fluids. However, these studies were usually focused on specific questions rather 
than comprehensiveness. Mass spectrometry-based technology only recently succeeded in 
identifying 10,000 proteins from a human cancer cell line21,22. This appears to be not far from the 
number of functional proteins expected to be expressed in a single cell type based on RNA-Seq 
data23-25. However, using current technology, coverage of protein variants remains relatively low 
and in-depth analysis of proteomes remains a time-consuming and laborious effort. Thus, in 
order to complement whole-genome sequencing, which has become fairly routine in research26, 
and transcriptome analysis that is now performed with fast and relatively inexpensive RNA-Seq 
technology, the established proteomics approaches need to be drastically extended as well as 
streamlined and automated. Successfully complementing the ‘omics’ disciplines is one of the 
ultimate goals of proteomics. This would enhance our understanding of system-wide processes by 
enabling comparative studies among genomics, transcriptomics and proteomics (Article 8). 
Therefore, a main objective of this thesis was to make technological contributions towards the 
further development of proteomics.   
 
 
Mass spectrometric instrumentation 
Gentle ionization methods 
The era of mass spectrometry-based proteomics began with the invention of two gentle ionization 
methods that allow bringing proteins into the gas-phase without destroying them. Electrospray 
ionization (ESI) utilizes a needle to spray small droplets containing the charged sample molecules 
into a strong electric field27. The solvent evaporates during this process and the desolvated ions 
enter the mass spectrometer. The second approach employs a laser that ‘excavates’ and ionizes 
molecules from a solid matrix that is co-crystallized with the sample (matrix-assisted laser 
desorption ionization, MALDI)28. Both approaches are very suitable for ionizing large 
biopolymers; however, in terms of coupling to mass spectrometers they are conceptually 
completely different. Electrospray ionization works at atmospheric pressure and produces ions in 
a continuous manner, as opposed to the pulsed matrix-assisted laser desorption ionization that 
happens in the vacuum of the mass spectrometer. The nature of the ionization method is of great 
importance for the analysis strategy and the type of mass spectrometer that can be used. For 
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example, liquid chromatography can relatively easily be combined with electrospray, whereas for 
matrix-assisted laser desorption ionization a spotter has to off-line collect the sample prior to 
mass spectrometry.   
 
Mass analyzers: general working principles 
The mass spectrometers employed for proteomics research have undergone dramatic 
improvements; however, the general working principle of the mass analyzers such as 
quadrupoles, ion traps, time-of-flight (TOF) and ion cyclotron resonance (ICR) have generally 
remained the same for several decades. A remarkable exception, however, is an entirely novel 
electrostatic analyzer presented in 2000 by Alexander Makarov. This Orbitrap analyzer rapidly 
turned into an indispensable tool for proteomics research (see Box for A brief history of the Orbitrap 
analyzer).  
 
 A Brief History of the Orbitrap Analyzer 
 
The earliest predecessor of the Orbitrap 
mass analyzer was the electrostatic Kingdon trap 
in 1923, consisting of an axial wire surrounded 
by cylindrical electrodes (logarithmic field)29. 
The Kingdon trap is not a mass analyzer itself, 
but was used in combination with a quadrupole, 
TOF or ICR as trapping device in the 1990s30. 
Several modifications such as to the shape of 
the outer electrodes by Knight et al., 1981, 
improved the axial confinement for better 
trapping efficiency (addition of a quadrupole 
field)31. The trap was further developed by 
Makarov et al. introducing the spindle-like shape 
of the inner electrode, which induces an electrostatic field with purely harmonic 
potential in z-direction (quadro-logarithmic field)32. As a consequence, ions circulate 
around the central electrode on stable trajectories while also oscillating along the z-
axis with a frequency that is only dependent on the mass-to-charge ratio. Image 
current detection and Fourier transformation of the transient successfully generated 
mass spectra from the Orbitrap analyzer 33. 
External accumulation and injection of ions as confined packets turned out 
to be key challenges when coupling the Orbitrap analyzer to a continuous ion source. 
First, a linear ion trap was employed for storage and subsequent axial ejection, but 
this was later replaced by a more efficient curved rf-only quadrupole (C-trap)., this 
instrument was first introduced commercially only in 2005 and it has already 
undergone several major iterations since – and it is a main topic of this thesis.  
 
Figure 2: Kingdon trap and  
TOF mass spectrometer30. 
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Depending on their working principles, mass analyzers can be categorized into two major types, 
which are (1) beam-type and (2) trap-based analyzers (Figure 3). Quadrupole and TOF analyzers 
are by their nature continuously scanning devices, whereas the ICR and Orbitrap ion traps, 
analyzers perform sequential processes on captured ion populations to obtain a mass spectrum. 
Certain performance characteristics such as resolution, mass accuracy, sensitivity and in particular 
the duty cycle are different between these mass analyzers with important implications for liquid 
chromatography-based shotgun proteomics analysis.  
 
 
Figure 3: Beam-type and trap-type mass analyzers; adapted from 2,34,35. 
 
One of the oldest types of mass analyzer is the quadrupole, consisting of four precisely parallel 
metal rods. Opposite electrodes are connected and one pair receives a positive, the other pair a 
negative direct current (dc) potential that is superimposed by a time-dependent radio frequency 
(rf) potential. When ions are injected into the quadrupole in the direction of the rods, the 
oscillating electric field in the center of the quadrupole only allows a narrow mass-to-charge 
(m/z) range to pass on a stable trajectory. The remaining ions will impinge on the rods. Thus, a 
quadrupole rather acts as a mass filter than as a conventional mass spectrometer. Ramping the dc 
and rf potentials allows different narrow m/z ranges to pass the quadrupole and thereby 
generates a mass spectrum. The x-y-motion of ions that pass the quadrupole in z-direction, 
dependent on the changing potentials, is described in a second order differential equation, the 
Mathieu equation. Its solution provides two dimensionless parameters a and q that characterize the 
amplitude of the dc and rf current. Plotting of a against q, as shown in Figure 4, provides the so-
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called stability diagram of the quadrupole; the intersecting mass-scan line (a/q constant) defines 
the m/z ratios that pass the quadrupole without interruption.  
 
 
Figure 4: Plots of the dimensionless parameters a and q for different m/z values  
generate the stability diagram. 
The mass resolution is inversely proportional to the width of the cross-section between the stable 
region and the mass-scan line. Quadrupoles can also be used in rf-only mode (a = 0), in which 
case they function as wide band mass filters. As such, quadrupoles are frequently employed as ion 
guides or as intermediate reaction region in triple-quadrupole instruments (Q2) as described at 
the end of this section. In general, quadrupole mass analyzers are compact, but feature rather low 
mass resolution. Improving the quadrupole characteristics with respect to resolution and mass 
range is difficult and most importantly requires substantial efforts in manufacturing. Narrower-
diameter rods of hyperbolic shape together with higher rf frequency and lower acceleration 
potential of the ions all contribute to higher resolution. As the resolution correlates with the 
number of oscillations of the ions in the quadrupole, increasing the length of the rods is also 
beneficial, but restricted by practical limitations.  
 
Time-of-flight instruments are beam-type analyzers that determine the m/z ratio of ions based on 
the different time for passing a field-free drift tube. Ions ideally enter with the same kinetic 
energy, therefore those with smaller m/z ratios travel faster than those with larger ones. This 
dispersion allows detection of the ions in the order of increasing m/z ratios. Resolution of TOF 
instruments is limited by the length of the field-free drift tube and the capability of the detector 
to identify two different masses that arrive rapidly one after the other. Reduction of the spatial 
and kinetic energy spread of the ions can efficiently be achieved by a reflectron, i.e. an 
electrostatic mirror that focuses equal m/z ratios, making high resolution (R > 10,000) available36. 
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Special shapes of the flight-path can further increase the resolution; however, they may 
compromise sensitivity37.  
MALDI sources are very commonly coupled to time-of-flight instruments, because the 
pulsed ion flux is very suitable for this analyzer. Continuous ion sources such as electrospray 
devices can be utilized with orthogonal TOF conformations, featuring an acceleration region to 
push a section of the ion beam into the field-free drift tube38 .    
Ion traps are primarily devices to confine ions and store them over a period of time, but they can 
also be employed as mass spectrometers. They are popular because of their robustness, small 
footprint and because their performance characteristics are sufficient for many applications. 
Moreover, the trapping capability allows special applications, such as fragmentation analysis of 
molecules in multiple stages of mass spectrometry. There are two major designs of ion traps that 
were historically developed in the same order as described here. The 3D ion trap (Paul trap) 
consists of three electrodes, a central doughnut-shaped electrode accompanied by two end-cap 
electrodes with small apertures for inlet and ejection of ions39. Ion traps usually employ electron 
multipliers for detection, which for 3D traps are placed directly behind the exit end-cap. Inside 
the ion trap, a three-dimensional quadrupole field is created by superimposing dc and rf 
potentials similar to those in the quadrupole mass filter. Ions with suitably low energy are 
trapped, because their trajectories inside the ion trap allow enough collisions with the helium 
buffer gas, collisional cooling, to sufficiently reduce their kinetic energy. The mass spectrum is 
obtained in the next step by linear ramping of the rf amplitude, which causes sequential ejection 
of ions with different m/z ratios. This strategy, referred to as mass selective instability mode, was a 
major breakthrough in ion trap technology, since it allowed scanning entire mass ranges instead 
of only isolating single mass-to-charge ratios. It was developed by George Stafford and co-
workers in 1984 40.  
Despite its popularity since the 1990s, in proteomics the 3D linear ion trap faces major 
limitations stemming from its performance characteristics. Very limited ion capacity inside the 
trap restricts the number of ions that are available for different processes such as storage, 
isolation, activation, and obtaining the mass or fragment mass spectrum34. Due to the limited 
physical space inside the trap, exceeding the ion capacity causes so-called space charge effects, i.e. 
repulsion of equally charged particles, which overlay the external field. This has major 
implications on the achievable resolution and mass accuracy. Furthermore any parameter is 
affected that is dependent on the number of ions, or more accurately, charges that can be 
accumulated, e.g. sensitivity and dynamic range. A second restriction of the 3D ion trap is its 
relatively low trapping efficiency. Linear ion traps address many of these limitations41, because 
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they store the ions in two dimensions along the z-axis of a quadrupole and are therefore less 
affected by space charge effects34,42. The design of the quadrupole linear ion trap (2D trap) by Jae 
Schwartz et al. resembles a quadrupole that is split into three sections. The central section of the 
three parts is the largest and is intended to store the ions, whereas the front and back sections can 
be used for ion manipulation and for applying an axial trapping potential. An ejection slit in one 
of the central rods allows ion ejection and detection by an electron multiplier as illustrated in 
Figure 3. In recent versions of the quadrupole linear ion trap, the sensitivity is doubled by adding 
a second ion ejection slit and a second electron multiplier to the opposing rod43. Due to the long 
trapping path of the linear ion trap, the tapping efficiency is higher and similarly it is capable of 
storing much larger ion populations than the 3D trap. Isolation is performed by resonance ion 
ejection, i.e. all ions with mass-to-charge ratios higher and lower than the ion of interest are 
ejected from the trap. In the subsequent steps, collision induced fragmentation can be employed 
to generate a tandem mass spectrum (MS/MS). The lowest mass-to-charge ratio that is stable in 
the ion trap is referred to as low mass cut-off and is directly proportional to the main rf amplitude 
applied. In particular, in tandem mass spectrometry, the low mass cut-off has important 
implications, because it limits the lowest fragment mass that can be retained in the trap.  
In direct comparison with a 3D trap using the same detector, a linear quadrupole ion trap was 
found to have 15-fold higher ion capacity34. However, this benefit comes with the need of 
increased dimensions, e.g. longer rods, which need to be manufactured very precisely. As ions are 
spread out along the rods, different field strength at different positions may cause different time 
points of ejection, reducing the resolution of the ion trap mass analyzer. The performance of 
quadrupole linear ion traps was greatly improved by a dual cell design with two compartments 
separated by an aperture43,44. The compartments are kept at different pressures, the first one at 
higher pressure (approx. 7 x 10-3 mbar) to efficiently trap, isolate and fragment ions. Increased rf 
voltage and an isolation waveform during ion injection increase the sensitivity. The second cell is 
held at lower pressure (approx. 5 x 10-4 mbar) to achieve an improved resolution and higher scan 
rates45.     
 
High resolution mass analyzers and image current detection 
ICR and Orbitrap analyzer are both located at the high-performance end of the range of trap-
type analyzers, but different concepts of trapping the ions are applied: ICR technology uses a 
static electric field for axial trapping and a strong magnetic field to force the ions onto orbital 
trajectories inside the ICR cell46-48. Due to its unique shape, the Orbitrap analyzer enables 
dynamic trapping in an electrostatic field32. Major differences to 3D or linear ion traps are 
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detection of image currents and analysis of the resulting signal by Fourier transformation (FT). 
This contrasts with the counting of ions on multipliers that are sequentially ejected from the ion 
trap to obtain the mass spectrum. Image current detection followed by Fourier transformation 
allows very accurate measurement of all mass-to-charge ratios at the same time; this requires a 
device response in which the measured frequency of motion is only dependent on the mass-to-
charge ratio of the ions (Figure 5).  
 
 
Figure 5: Working principle of ICR and Orbitrap analyzers applying  
image current detection and Fourier transformation. 
 
 
In FT-ICR, ions are axially injected into the ICR cell (electric field E) that is present inside a 
strong magnetic field B so that charged particles experience the Lorenz force FL. Coherence of 
ion motion is achieved by broadband rf excitation; ions absorb energy from the signal and start 
moving as phase-coherent packages on larger orbits that are specific to their mass-to-charge ratio. 
A set of extra electrodes detects the image current and very high resolution spectra are obtained 
by Fourier transformation. Recent instruments usually were equipped with 7 T magnetic fields. 
However, commercial instruments can contain magnets up to 18 T49,50 and for research purposes, 
magnets up to 21 T have been tested51.  
For high resolution Orbitrap measurements, in contrast, the ion injection step is crucial and was a 
major challenge during the development of the analyzer52. A curved rf-only quadrupole, the C-
trap, is employed for external collection of ions prior to injection of defined ion packages into the 
Orbitrap analyzer53. The C-trap is filled with nitrogen gas for collisional cooling of the ions, 
before high voltages push the ions orthogonally out of the device. They are then accelerated to 
high kinetic energy and enter the Orbitrap analyzer through a small aperture. Ions are captured in 
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an increasing electrical field that contracts the radius of the ion cloud, referred to as electrodynamical 
squeezing54, and start circulating around the spindle-shaped central electrode in rings made up of 
ions with specific m/z value. In addition, the orbiting ions oscillate along the central electrode as 
illustrated in Figure 5. The frequency of this motion is controlled by the unique shape of the trap 
that provides an exclusively harmonic potential along the z-direction32. The image current 
induced by the axial oscillations in detector electrodes allows precise determination of the mass-
to-charge ratios, because the frequency is independent on any initial properties of the ions.  
 
Important parameters and instrument characteristics 
In FT-based mass spectrometry, the resolution is directly related to the transient length, i.e. the 
duration of time for which the image current is detected. In practice, however, both ICR and 
Orbitrap technologies face certain limitations that restrict the resolution to some maximum value. 
With FT ICR technology, resolution of several millions is achieved utilizing strong magnets, but 
these are a major drawback of the FT ICR technology. Super-conducting magnets require liquid 
helium, which makes maintenance of these mass spectrometers laborious and expensive. 
Infinitely high resolution can theoretically be obtained with infinite transients, but in practice it is 
limited due to collisions of the analyte with background molecules that cause the transient to 
decay after a certain time when the ion packets become incoherent55. This effect is more 
prominent at higher masses - equivalent to larger diameters and collisional cross sections of the 
molecules - even if the mass-to-charge ratio is the same52. In commercial Orbitrap analyzers, the 
signal becomes indistinguishable from the noise after about 1 s. However, this practical limit is 
well matched to requirements of the chromatography time-scale, i.e. peptides eluting within 
several seconds, which is more important than extremely high resolution48.  
The mass resolving power of an analyzer refers to the relative width of a single peak (m/∆m), 
which is related to the minimum mass difference (m2-m1) to distinguish two peaks of equal height 
with a 50% valley in between them56. High resolution mass-spectrometry usually refers to 
resolution values greater 10,000, however, the resolution varies with the mass-to-charge ratio for 
most instrument types. Due to the linear dependence of ion motion on m/z, the resolution in FT 
ICR decreases as 1/(m/z). For the Orbitrap analyzer the decay for larger mass-to-charge ratios 
varies as 1/(m/z)1/2 because of the harmonic oscillations of ion rings along the z-axis32. 
Therefore, FT ICR resolution can be superior at lower mass-to-charge ratios, whereas this trend 
turns around for high mass-to-charge ratios35,56. Typically, the Orbitrap mass analyzers achieved a 
resolving power of 60,000 at m/z 400 with a 750 ms transient time; this is commonly referred to 
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as a 1s scan43. Strategies to further improve the resolution of the Orbitrap mass analyzer were 
demonstrated by Makarov et al.57 and are developed as part of this thesis (Articles 2 and 3). 
Mass accuracy refers to the deviation between the actual (calculated) and the experimentally 
determined mass of a compound and it is dependent on the resolution of the mass analyzer. 
However, there is no linear correlation between these two parameters and both also depend on 
the peaks abundance, i.e. the signal-to-noise ratio, amongst other parameters. In general, if an 
instrument is correctly calibrated, high resolution (> 10,000) can provide parts per million (ppm) 
mass accuracy56. Internal calibration procedures add a reference mass, e.g. background ions that 
are collected and utilized as lock masses58, to each spectrum for correction. This strategy is superior 
to external calibration before and after an analysis, because it accounts for continuous mass drifts 
and those on shorter time scale. External calibration, in contrast, avoids reduction of the ion 
capacity and thereby of the dynamic range of a trap during the actual scan.  
With regard to the Orbitrap analyzer, the major overall limitation in terms of ion capacity is the 
C-trap59. Overfilling is very problematic, because it induces space charge effects that lead to non-
linear mass errors for different mass-to-charge ratios within the same spectrum. Careful control 
of the number of ions is ensured by automatic gain control (AGC), in which injection times are 
matched to space charge limits in order to avoid systematic errors60. Efficient recalibration of 
shotgun proteomics runs can furthermore elegantly be achieved by post-measurement 
recalibration of the data (Article 5).  
The scan speed of a mass analyzer is dependent on a variety of parameters, but as a rule of 
thumb, it is inversely correlated with resolution. Fourier transformation-based approaches are 
comparatively slow as the high resolution is proportional to the transient duration. 2D and 3D 
ion traps are rather fast scanning devices, with up to 33 000 Th/s44. However, enhanced 
resolution scans require longer scan times and ion trap technology by its nature always needs a 
series of consecutive processes to obtain a mass spectrum. Beam-type analyzers feature the 
highest scan rates, e.g. time-of-flight analyzers in the range of microseconds. But in order to 
collect sufficient signal, often many TOF spectra need to be merged, reducing the effective scan 
speed of the instrument61.  
Finally, the detection principle, Fourier transformation of an image current versus electron 
multipliers, implies differences in sensitivity. Electron multipliers are capable of detecting single 
ions, whereas FT-based detection typically requires a minimum of approximately 20 charges to 
detect a signal clearly distinguishable from the noise53,62. Latest improvements in electronics and 
improved thermal stability, however, make single ion detection in the Orbitrap analyzer feasible, 
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given multiply charged ions and sufficient transient length55, and allow covering a dynamic range 
of up to four orders of magnitude within a single spectrum59.  
 
Hybrid instrumentation 
Many of these novel developments and improvements of mass analyzers have rapidly been 
applied in hybrid technologies, i.e. the merging of two mass analyzers in one platform. Such 
instruments exploit the benefits of each component and provide a greater variety of scan modes. 
The most relevant performance characteristic of hybrid mass spectrometers besides resolution, 
mass accuracy and sensitivity is the duty cycle i.e. the speed of acquisition and the information 
density of the data. Merging of mass analyzers introduces a number of challenges because the 
ions have to travel between the devices and they have to undergo several changes of their 
properties to be optimally transferred, trapped, fragmented or analyzed in the corresponding part 
of the instrument. The major effects on the ions are changes in their kinetic energy during 
transfer from a continuous electrospray ion source to discontinuous trapping devices or further 
to beam-type analyzers. These challenges are increased in tandem mass spectrometry, which adds 
isolation and fragmentation of ions, i.e. changes of m/z, mass range and nature of the ions63.  
Before the era of high resolution mass spectrometers, fragmentation analysis was generally either 
performed in ion traps or in triple quadrupole instruments. The latter feature three consecutive 
quadrupoles for isolation, fragmentation and mass selection of fragments, respectively, but are 
not hybrids. A variety of scan modes are available that makes them versatile and popular 
instruments. For precursor ion scans, the first two quadrupoles are operated in an rf-only mode. 
Fragmentation spectra can be recorded by using the first quadrupole (Q1) for isolation and the 
second (Q2) as a collision chamber for fragmentation and the third quadrupole for mass selective 
transfer of fragment ion peaks, so-called precursor-fragment transitions. Triple quadrupole instruments 
are not generally used in shotgun proteomics but remain popular for targeted proteomics assays. 
Exchange of Q3 against a time-of-flight analyzer constituted the first hybrid mass spectrometer 
that became very popular in proteomics64. In contrast to early TOF instrumentation relying on 
matrix-assisted laser desorption ionization, Q TOF instruments that often feature an orthogonal 
layout between quadrupole and TOF trajectories, can readily be coupled to continuous 
electrospray sources and therefore to chromatography setups65. Furthermore, TOF/TOF 
instrument configurations can be employed for acquisition of fragment ion spectra in 
MALDI66,67.   
Due to its high resolution and duty cycle of tandem mass analysis, coupling of a linear ion trap 
with an FT ICR analyzer created a powerful platform for proteomics research68. This hybrid 
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allows parallel acquisition of very high resolution full scans (MS) and very fast tandem mass 
spectra acquisition (MS/MS) with high sensitivity in the ion trap analyzer. The analogue 
instrument configuration featuring the Orbitrap mass analyzer, the LTQ Orbitrap, was introduced 
only two years later53. 
Collision induced fragmentation in triple quadrupole or Q TOF instruments is relatively efficient 
and does not suffer from the low mass cut-off inherent to ion trap mass spectrometry. As 
different physical regions of the instruments are used for tandem mass spectrometry, the process 
is referred to as tandem in space analysis, as opposed to tandem in time analysis that is performed in 
trap based instruments69. The latter apply lower energy to the trapped ions, which frequently 
results in cleavage only of the weakest bonds of the molecules, which then do not undergo any 
further fragmentation reactions. This often occurs with serine or threonine phosphorylated 
peptides, for instance, and it can lead to poor fragmentation spectra. However, this problem can 
be partially overcome by multistage activation, which provides supplemental fragmentation for 
the main peptide fragments to obtain sequence information70. The second generation linear ion 
trap Orbitrap hybrid mass spectrometer is equipped with a collision cell at the far end of the C-
trap that allows beam-type fragmentation at higher collisional energies than ion traps71. The 
fragment ions can then be analyzed with high resolution and high mass accuracy in the Orbitrap 
analyzer. Higher energy collisional dissociation (HCD) of peptides resembles triple quadrupole 
fragmentation and is as efficient. This HCD-based high-high strategy, referring to high resolution 
for MS and MS/MS spectra, is routinely usable in shotgun proteomics runs and enables several 
novel approaches for data analysis (Articles 4, 6, 7). 
 
 
Concepts of mass spectrometry-based proteomics 
Historical perspective 
The fundamental concept of protein sequencing was pioneered by Fred Sanger in 1955, who 
presented the first complete protein sequence - that of insulin - based on electrophoretic 
methods72-76. Mass spectrometry was only introduced into protein analysis much later and 
numerous further developments were required for mass spectrometry-based proteomics to 
become a mature technology. These included many breakthroughs in the MS instrumentation 
itself but importantly also in the upstream and downstream workflow. Indeed, first investigations 
into the complement of proteins in a cell type were performed by biochemical separation such as 
2D-PAGE1 and frequently used antibody-based detection methods. Mass spectrometry was 
already established for the analysis of small molecules and the ion trap analyzer (Paul trap), for 
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which Wolfgang Paul39 received the Nobel Prize in Physics in 1989, was a major contribution. 
Finally, the development of soft ionization methods made protein analysis feasible. John Fenn 
was awarded a share of the Nobel Prize in Chemistry in 2002 for the invention of electrospray 
ionization (ESI)27. This ionization method  had great impact in the field of proteomics together 
with the novel method matrix-assisted laser desorption ionization (MALDI)28, which was 
established by Franz Hillenkamp and Michael Karas around the same time. A protocol to extract 
proteins from 2D-PAGE77 after separation and fractionation according to the isoelectric point 
and size of proteins, and the introduction of nanoelectrospray with reduced flow rate for the first 
time allowed sequencing of single protein species at high sensitivity78. As electrospray ionization 
of molecules is performed at atmospheric pressure, this technology immediately led to the 
introduction of on-line coupling of liquid chromatography devices to mass spectrometers, 
allowing the on-line separation of complex mixtures just before mass analysis (LC-MS), which 
was a major step towards large-scale analyses2,79. Together with the ion trap, the triple quadrupole 
mass spectrometer (QQQ) and the quadrupole time-of-flight hybrid instrument (Q TOF) were 
already popular in the early days of mass spectrometry-based proteomics. Today, the Orbitrap 
analyzer has proven to be especially suitable for proteomics analyses and was also employed for 
the first complete proteome analysis (Figure 6).  
 
 
Figure 6: Key steps from the first protein sequence towards modern proteomics research. 
Mass spectrometry-based proteomics research can be classified into two major approaches: top-
down versus bottom-up. In the first and very intuitive approach intact proteins are ionized and enter 
the mass spectrometer for determination of their intact and fragment mass-to-charge ratios. The 
success of this strategy is limited by the complexity of protein mixtures, the fact that each protein 
has many forms with different masses and that proteins can be difficult to solubilize and separate 
from each other. Furthermore, electrospray ionization transfers multiple charges to large 
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molecules, which complicates spectra interpretation. For purified proteins the molecular weight is 
a limiting factor depending on the instrument resolving power. However, at least theoretically, 
top-down proteomics strategies offer the potential of complete sequence coverage from tandem 
mass spectra (protein MS/MS) and localization capabilities of post-translational modifications on 
the entire protein sequence.  
 
The shotgun proteomics workflow 
The vast majority of mass spectrometry-based proteomics studies apply the bottom-up approach, 
often referred to as shotgun proteomics. Protein mixtures are analyzed in an indirect way by cleaving 
the long amino acid chains in proteins with specific proteases into shorter peptides. The most 
commonly used enzyme for this purpose is trypsin, due to its high specificity for arginine and 
lysine80. The resulting identified peptides have an average length of about 10 AA and are suitable 
for analysis in positive ion mode, because the basic amino acids are at the C-terminus of each 
peptide. When using electrospray ionization, the majority of tryptic peptides carry two to four net 
positive charges depending on their length. In principle, any other protease can also be selected 
for protein digestion. LysC has many of the advantages of trypsin, including the desired peptide 
length as well as sequence specificity C-terminally of lysine and is therefore also frequently used. 
GluC, AspN or LysN mainly occur in proteomics contexts in order to increase protein sequence 
coverage21 or for special applications, e.g. de novo sequencing based on electron transfer 
dissociation (ETD) derived fragments81. Protein digestion can be performed in solution, but for 
removal of detergents such as SDS, it is often desirable to perform in-gel protocols or to employ 
the filter-aided sample preparation protocol82. The resulting peptide mixtures are extremely 
complex; therefore, liquid-chromatography is almost always applied to separate the peptides. At 
low pH, achieved by adding formic or acidic acid to the samples and solvents, the protonated 
peptides bind to the widely used C18 material of a chromatography column. During elution with 
increasing percentage of organic solvent, peptides detach according to their polarity and are on-
line sprayed into the mass spectrometer. In shotgun proteomics, optimum gradient separation is 
important to increase the depth of mass spectrometric analysis and column dimensions are 
chosen to fit the analytical problem. Very complex mixtures greatly benefit from longer columns 
and smaller bead size. These provide better separation, due to their increased number of 
theoretical plates as a consequence of longer interaction with the stationary material83. Longer 
columns and smaller bead size greatly increase the backpressure of the column, unless the 
flowrate is significantly reduced, which may have the unfortunate consequence of peak-
broadening84. Increasing the temperature and working with higher pressure overcomes these 
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drawbacks. Recently, the standard high pressure liquid chromatography systems (HPLC) with a 
pressure limit of several hundred bar have been complemented by UHPLC systems that allow up 
to 1000 bar. These allow flowrates up to 250 nl/min in 50 cm columns with 1.8 µl beads85. 
Together with the latest generation of Orbitrap-based mass spectrometer, such as the Q Exactive 
(Article 2), these optimized chromatography set-ups have a high potential for in depth single-run 
analysis of complex mixtures avoiding any pre-fractionation steps.  
In routine practice, efficient reduction of the sample complexity is usually carried out off-line by 
gel-based methods, size-exclusion or ion-exchange chromatography. Figure 7 illustrates how 
these optional steps can be performed at the protein or at the peptide level. A very 
straightforward strategy employed in our laboratory first applies StageTips86 for strong anion-
exchange chromatography and uses different pH buffers for step-wise elution of peptides onto 
C18 StageTips
87. We also employ OFFGEL technology to provide 12-14 peptide fractions based 
on isoelectric focusing88. These fractions are consecutively analyzed by LC-MS. Alternatively, 2D-
chromatography approaches, e.g. multidimensional protein identification technology (MudPIT), 
facilitate automated fractionation in a two column setup79. The peptide mixture is loaded onto a 
strong cation-exchange column (SCX) and eluted in discrete portions using a stepped salt 
gradient. Each fraction is collected on a reverse-phase column (RP); the peptides are retained, 
while the salt buffers divert to waste, and afterwards each fraction is eluted by an organic solvent 
gradient directly into the mass spectrometer.  
Peptide elution is monitored in the full scans covering an m/z range of 300 – 1650 Th and 
additional information about the peptides is collected in tandem mass spectra. Therefore, the top 
N – usually 5 to 20 – most abundant precursor ions in each full scan are selected in an automated 
manner by the instrument software. They are separately accumulated, fragmented and analyzed. A 
dynamic exclusion list ensures that each precursor is selected only once during typical peptide 
elution times. Due to its largely unbiased nature, this data-dependent top N strategy is applied for 
discovery proteomics studies investigating various aspects of cell biology2. In contrast, hypothesis-driven 
approaches target pre-selected peptides using inclusion lists or multi reaction monitoring (MRM) 
assays and aim to detect and quantify proteins of prior interest. This strategy verifies the presence 
of even very low abundant candidates and can be less time consuming than shotgun proteomics89.  
 
Peptides fragment in a very specific way and cleavage of the peptide backbone is usually most 
dominant. The amino acid sequence is determined from the tandem mass spectra in conjunction 
with the accurate precursor mass by an automated database search. Software tools are then 
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applied to re-assemble proteins from the identified peptides; for details see section Structure and 
analysis of shotgun proteomics data. 
 
 Figure 7: Typical shotgun proteomics workflow. 
 
Quantitative proteomics 
Observing as many different proteins as possible in a single cell type or tissue is a first qualitative 
step to obtain insight into the biological system under study. Many questions, however, need to 
be addressed by quantitative comparisons between different cell states, e.g. healthy versus disease, 
or by evaluating the influence of systematic perturbations on the proteome, because this can 
directly reflect biological function. As mass spectrometry by its nature is not quantitative, 
different isotope labeling strategies have been developed for pursuing quantitative proteomics 
studies41,90,91 (Figure 8). Replacing isotopes introduces a difference in the mass of a compound, 
while minimally affecting chemical properties or biology. For example SILAC (Stable Isotope 
Labeling of Amino acids in Cell culture), which is a metabolic labeling strategy, uses amino acids 
with specific heavy atoms that are incorporated into proteins and therefore allows labeling of the 
entire proteome of cultured cells92. The SILAC approach has been extended to whole animals, for 
instance with mice that are fed with a special diet93. In a spike-in format94 SILAC can even be 
used to quantify human tissues95. Chemical labeling is a broadly applicable strategy, because it can be 
used for proteins independent of their origin. Heavy or light isotope tags are covalently bound to 
peptides - most commonly dimethyl groups96,97, TMT98 or iTRAQ99. The tags in the latter 
methods are designed to lead to the exact same precursor mass for the conditions to be 
compared, thus they are indistinguishable in an MS spectrum. Fragmentation of the labeled 
peptides, however, reveals different reporter ions in the low mass region of the tandem mass 
spectrum. These strategies allow relative quantification of two or more conditions in a single LC-
MS run. The multiplexing capability of chemical labeling is often higher than that of metabolic 
labeling approaches; however, the MS/MS-based quantification of reporter ions suffers from 
contaminating precursor ions that may distort the ratios of the peaks and degrade accuracy. 
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Recent strategies try to overcome this drawback, but add complexity to the experiment100,101. In 
contrast, the abundance information contained in full scans not only allows precise quantification 
using several scans, but can also be used in label-free approaches that are completely software-
based and increasingly accurately provide ratios of up- or down-regulated proteins when 
comparing between two or more different LC-MS runs. Label-free quantification requires very 
high reproducibility and minimal retention time shifts, and it is particularly successful for very 
high ratios102. 
 
 
Figure 8: Quantitative proteomics strategies; light and dark blue indicate the presence  
of light and heavy isotopes in the samples and mass spectra, respectively.   
Finally, the analysis of qualitative and quantitative large-scale proteomics datasets represents a 
challenge in itself, because the amount of data is far beyond what human experts can manually 
cope with. Modern studies can contain hundreds of thousands of mass spectra and several 
gigabytes of data. The discipline of computational proteomics evolved to handle the data in statistically 
proper ways and to extract the maximum amount of information 
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Structure and analysis of shotgun proteomics data 
Information content in the LC-MS map 
Shotgun proteomics data feature three dimensions at the MS level: (1) the mass range and (2) the 
signal intensity inherent to the mass spectra, and (3) the retention time axis reflecting the order of 
the peptides eluting from the chromatographic column. The three dimensional elution profiles of 
the peptide features can be modeled from consecutive full scans. In high resolution mass 
spectrometry, the isotope patterns are resolved and represented in the LC-MS map. Figure 9 
illustrates the extremely high complexity of proteomics data acquired from a complete 
mammalian cell lysate separated over a two hour gradient.  
 
 
Figure 9: LC-MS map of a mammalian cell lysate and zoom in 2D;  
selected isotope clusters are depicted as 3D elution profiles.  
 
As high resolution mass analysis allows distinction between the isotope peaks of a cluster, the 
monoisotopic mass of each peptide can be determined with high accuracy. The MaxQuant 
software is tailored to such high resolution data and its post-processing algorithms achieve mass 
accuracies below 100 parts per billion (ppb) for most peaks103. A Gaussian curve is fitted to the 
three central data points of each MS peaks and an intensity-weighted mass deviation is calculated 
for the assembled three-dimensional peak profiles of all features detected in the LC-MS map. 
Non-linear mass recalibration based on peptide charge pairs allows calculating an individual mass 
accuracy for each peptide precursor taking the abundance of the peak and the number of 
measurements into consideration104. This very high mass accuracy is a potent filter option for 
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database search as it significantly reduces the search space of possible peptide precursors. Along 
the same lines, confident assignment of the isotope clusters functions as noise filter for the data. 
One of the primary motivations for creating the MaxQuant software environment was SILAC-
based quantification; recently this was extended by sophisticated label-free quantification 
algorithms102. 
 
Peptide fragmentation spectra 
A second layer of information about the peptides, which is not displayed in the LC-MS map, are 
the fragmentation spectra that are acquired either in parallel or alternately with the full scans. 
Depending on the capabilities of the instrument, up to 20 tandem mass spectra are acquired in 
each duty cycle, i.e. between two consecutive full scans, usually in a data-dependent fashion 
(Figure 10).  
 
 
 
Figure 10: Schematic of a data-dependent MS and MS/MS cycle (top10); peptide candidates targeted in the 
MS/MS scans (1-10) are selected based on their peak intensity in the previous full scan (left). The depicted examples 
show that the first fragment ion spectrum (1) remained unidentified, whereas (2) and (3) could be assigned a peptide 
sequence during data analysis.  
 
For a tandem mass spectrum, the precursor ion of interest is isolated in a selection window of a 
few Th and typically accumulated for several tens of milliseconds, until a desired number of ions 
is collected. Fragmentation of the precursor ions is subsequently carried out in the appropriate 
section of the mass spectrometer. MS/MS spectra used to be recorded at nominal resolution in 
the ion trap part of hybrid Orbitrap analyzers, but recently it has become feasible to acquire both 
full scans and fragment ion scans at high resolution43,105.  
The composition of tandem mass spectra is dependent on the peptide fragmentation chemistry 
induced by different dissociation principles. Collisions of protonated peptides with neutral gas 
atoms in CID and HCD result in predominant cleavage of amid bonds in the peptide backbone. 
Thus, they generate sequence ladders of b- and y-type ions from the N- and C-terminus, 
respectively. Complementary fragmentation methods, termed electron capture dissociation or 
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electron transfer dissociation, induce peptide fragmentation by a single electron or an electron 
transferred from negatively charged fluoranthene molecules, respectively106,107. The peptide radical 
ions generated in this way fragment into c- and z•-type ions by cleavage of the N-Cα bonds. In 
each case, the regular backbone ions provide information on the amino acid sequence. Tandem 
mass spectra also feature a great number of additional peaks that are derived from various other 
fragmentation pathways, but these are not generally used in automated peptide identification 
(Articles 4, 6 and 7). 
 
Data analysis strategies 
Software tools usually follow one of two major approaches for peptide identification in large-
scale datasets18. One is solely based on the data in the tandem mass spectrum and is referred to as 
de novo sequencing. It frequently utilizes graph-based approaches108,109. Fragment ion peaks 
represent the nodes of the graph, while the edges are the mass differences between two peaks. 
The amino acid sequence is determined by finding the longest and most likely path through the 
graph. De novo sequencing has the advantage of being completely independent of any previous 
knowledge such as protein or gene sequences stored in databases. This allows, in principle, to 
identify novel proteins and genes or to work with unsequenced organisms. High resolution 
tandem mass spectra are particularly advantageous for de novo sequencing approaches, because the 
high mass accuracy allows distinguishing amino acids with the same nominal mass such as Q 
from K and amino acid pairs with very similar mass. However, very high spectrum quality and 
sufficiently long runs of successive fragment ions are required.  
Routine shotgun proteomics studies aim to generate as many peptide identifications as possible. 
Therefore database supported identification strategies are more suitable, because these tolerate 
lower data quality. Tandem mass spectra are matched against theoretical spectra created from 
protein sequences of the organism being studied. Protein databases usually refer to the sequence 
of the decoded reference genome; however, there are various approaches to incorporate protein 
variant data from other sources such as transcriptome data generated by RNA-seq approaches 
(Article 8). Depending on the experimental conditions, several parameters in a peptide database 
search are defined by the user. These include enzyme specificity, fixed and variable modifications 
and the mass tolerance, which depends on the MS system that was used. The peptide search 
engine then compares a list of peptide sequences to the spectrum and assigns peptide spectral 
matches with a score reflecting the confidence of identification. The commercial search engine 
Mascot110 as well as the recently released Andromeda search engine (Article 4) apply probability-
based scoring models. This means that the score is calculated based on the probability that 
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matches between observed and calculated peaks in the tandem mass spectrum occurred 
randomly. The peptide identification score can be extended by an expectation value providing a 
statistical confidence measure and taking the accurate precursor mass into consideration. The 
latter is often sufficient to independently determine the molecular composition of short peptide 
fragments104. 
The number of incorrect peptide spectrum matches in the entire dataset is controlled by 
restricting the false discovery rate (FDR) among all identified sequences. According to the target 
decoy approach, the database is extended by reversed sequences and the resulting number of 
matches that correspond to such reverse hit directly yields the FDR111. In general, 1% false 
positives identifications are accepted at the peptide level; however, the protein FDR needs to be 
restricted in a similar manner to provide the same level of confidence in protein hits. When 
reassembling the proteins from the identified peptides, correct identifications mostly feature 
several unique peptides, whereas incorrect proteins identifications are often identified by just a 
single peptide sequence. In shotgun proteomics, overlapping or similar protein sequences, e.g. 
isoforms, are only distinguishable if differentiating peptides were identified; otherwise compatible 
protein sequences are combined into protein groups.  
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2   Challenges and Limitations in Shotgun Proteomics: A Baseline Study 
 
 
Article 1             More than 100,000 detectable peptide species elute in single shotgun 
proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS 
 
Annette Michalski, Jürgen Cox, Matthias Mann   
J Proteome Res, 2011, 10(4),1785. 
 
 
Prologue 
With the advent of high resolution hybrid mass spectrometers in shotgun proteomics research, 
the accurate precursor mass derived from MS spectra complements the tandem mass 
spectrometric information for peptide identification. The most common strategy is data-
dependent selection of the N most abundant precursor ions from the previous full scan. 
Advantages of this strategy are that (1) the most abundant peptide features are fragmented, which 
guarantees the highest available quality of tandem mass spectra and that (2) the duty cycle of the 
mass spectrometer is as high as possible. Conversely, the approach is limited by the sequencing 
speed of the instrument and - for low abundant ions - by the sensitivity of the mass analyzer, 
which is related to the brightness of the ion source and transmission of the ion beam.   
In 2009, when this thesis was started, a novel linear ion trap Orbitrap mass spectrometer with 5-
10 fold improved sensitivity, the LTQ Orbitrap Velos, was introduced43. For the first time, very 
high resolution and high mass accuracy full scans and tandem mass spectra could be routinely 
acquired in large-scale datasets. Higher energy collisional fragmentation (HCD) rapidly enabled a 
novel standard for shotgun proteomics experiments, even for the analysis of phosphorylated 
peptides112,113. In our experience, the identification rate in peptide mixtures resulting from 
mammalian cell lysates is usually higher than 50%, which is facilitated by high MS and MS/MS 
spectra quality. This translates to 10,000 unique peptide sequences and 1,800 proteins during 90 
minutes gradient time. This was significantly higher than the identification rates obtained with 
low resolution ion trap measurements.  
Motivated by the overwhelming complexity present in the LC-MS map of standard shotgun 
proteomics analyses, we were interested in estimating the capabilities and the potential of the 
latest mass spectrometric instrumentation with respect to mammalian cell lysate. Therefore, we 
carefully investigated and quantified the peptide features, represented by isotope clusters in the 
LC-MS map, over the entire elution time. This analysis revealed that more than 100,000 features, 
likely representing peptides, are detectable in the full scans. Obviously, this number is dependent 
24 
 
on the full scan resolution as well as on the cycle time, i.e. the number of full scans available to 
detect the isotope clusters in the first place. Experiments with higher resolution and increased 
scan speed revealed that the number of features can even be significantly higher than our rather 
conservative estimate of 100,000. The accessibility of these peptide features would appear to only 
be limited by the sequencing speed of the mass spectrometer. However, high sequencing speed is 
only beneficial if the targeted precursor ions are sufficiently abundant and the instrument is 
sufficiently sensitive to collect the requested number of ions for the fragment spectrum in an 
appropriate time interval. Interestingly, our study revealed that complex peptide mixtures contain 
many candidates that fulfill these criteria and could therefore potentially have been identified, if 
sequencing speed had been fast enough to target them.  
We also analyzed the detrimental influence of co-eluting precursor ions in the same isolation 
window on the identifiability of the tandem mass spectra. This effect is particularly severe for low 
abundance peptides. Strikingly the median precursor intensity fraction (PIF), a key measure to 
estimate the identifiability, was only 0.14 for all detected HeLa peptides. Incorporating a 
fractionation step only achieved slight improvements. Due to decreasing transmission efficiency 
and overlapping of isotope clusters, reduction of the size of the isolation window before peptide 
fragmentation is not an appropriate solution, either. Thus, insufficient purity of precursor 
isolation sets a principal limitation to data-dependent analysis of complex mixtures. At the same 
time, our article reveals that the potential of the shotgun proteomics strategy is not yet fully 
exploited and challenges manufacturers to further improve instrument capabilities.  
In the long run, findings such as ours may encourage mass spectrometrists to develop novel 
strategies for data acquisition. Independently, first steps have been taken towards data-
independent approaches and scanning of broader mass ranges, which deliberately generate very 
complex fragmentation spectra114,115. This, however, provides huge challenges to informatics 
analysis tools and so far, these attempts still suffer from limited dynamic range and insufficient 
sensitivity.  
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’ INTRODUCTION
In bottom-up, MS-based proteomics, protein mixtures are
digested to peptides with proteases.1,2 Most typically, peptides
are separated with liquid chromatography, online electro-
sprayed3 and analyzed by MS scans. The most abundant signals
in the MS scans are isolated, fragmented and analyzed by an
MS/MS scan. TheMS andMS/MS information is combined and
used to identify the peptides and proteins in sequence databases.
This basic scheme, supplemented with peptide quantification at
the MS or MS/MS level, is successfully used in a wide variety of
biological applications.4-6 A longstanding challenge of the field is
to identify as many peptides as possible in LC-MS/MS runs.
Previously, using low resolution instruments, peptide identi-
fication rates were as low as a few percent of all fragmenta-
tion events.7 High resolution MS, for example in the form of
hybrid instruments such as the linear ion trap Orbitrap,8 com-
bined with advanced computational proteomics algorithms, now
routinely enabled identification of more than half of all MS/MS
spectra.9 The Orbitrap analyzer combines very high resolution
(60 000 at m/z 400) as well as high sensitivity and for complex
mixtures a dynamic range of at least 103. In particular, the high
mass resolution, which is a precondition for distinguishing
coeluting peptides with similar masses, contributes to the success
of shotgun proteomics. Highly confident assignment of the
charge state allows definite distinction of isotope clusters of
multiply charged peptides from noise peaks. In routine biological
applications, when coupled to reversed phase chromatography,
this allows the identification of several thousand peptides and
proteins with gradients of a few hours.10
Even more identifications, and even complete proteomes, can
be obtained by more sophisticated sample preparation such as
prefractionation or by prolonged gradients.11 However, it would
be attractive to increase the information that can be drawn from
single LC-MS/MS runs, because this implies less sample
consumption and measuring time. A recent technological im-
provement in the Orbitrap platform has been the introduction of
the LTQ Orbitrap Velos, which provides sufficient speed and
sensitivity for analyzing fragment ions with high resolution and
ppm mass accuracy in a standard “top10” method.12 However,
despite ppm or subppm level accuracy in the MS and MS/MS
scans, the precursor isolation in the linear ion tap still requires a
window of a few Th to ensure sufficient sensitivity. This low
resolution precursor isolation is inherent in the technology of ion
trap and quadrupole devices. In combination with the very high
sample complexity typical of proteomics, it inevitably leads to the
cofragmentation of precursor ions that happen to be present in
the same isolation window. Figure 1 illustrates the density of
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ABSTRACT: Shotgun proteomics entails the identification of as many peptides
as possible from complex mixtures. Here we investigate how many peptides are
detectable by high resolution MS in standard LC runs of cell lysate and how
many of them are accessible to data-dependent MS/MS. Isotope clusters were
determined byMaxQuant and stringently filtered for charge states and retention
times typical of peptides. This resulted in more than 100 000 likely peptide
features, of which only about 16% had been targeted for MS/MS. Three
instrumental attributes determine the proportion of additional peptides that
can be identified: sequencing speed, sensitivity, and precursor ion isolation. In
our data, an MS/MS scan rate of 25/s would be necessary to target all peptide
features, but this drops to less than 17/s for reasonably abundant peptides.
Sensitivity is a greater challenge, with many peptide features requiring long MS/
MS injection times (>250 ms). The greatest limitation, however, is the generally
low proportion of the target peptide ion intensity in the MS/MS selection
window (the “precursor ion fraction” or PIF). Median PIF is only 0.14, making
the peptides difficult to identify by standardMS/MSmethods. Our results aid in
developing strategies to further increase coverage in shotgun proteomics.
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peptides eluting in a typical LC-MS/MS run as well as an
example of a cofragmentation event in an LC-MSmap and in an
MS view. Co-fragmentation of peptides raises several challenges.
In quantification methods that are based on low mass reporter
ions, both peptides contribute to the quantified intensities. These
spectra should be discarded, or their acquisition avoided in the
first place.13 More generally, cofragmented, mixture or “chimera
spectra” may reduce peptide identification rates14 but they also
present the opportunity to identify more than one peptide from
an MS/MS spectrum. Several algorithms for second peptide
identification have been published with this goal in mind,
generally with low resolution MS/MS data.15-18
As shown above, researches have so far mainly concentrated
on improving identification rates of targeted peptides. However,
given the fact that most MS/MS spectra can now be identified, it
would be interesting to investigate the peptides that are present
in LC-MS runs but that are not targeted for MS/MS. To our
knowledge, there is no in-depth study of the extent and the
attributes of this population. In particular, it is not clear if these
peptides are in principle accessible to shotgun proteomics. Here
we determine how many peptide species are detectable with
state-of-the-art LC-MS and LC-MS/MS using the feature
detection algorithms of MaxQuant combined with a SILAC
analysis. This establishes a conservative estimate of the number
of peptides present in standard MS analysis of complex cellular
lysates. We then examine the mass spectrometric sequencing
speed and sensitivity necessary to target the peptide population
not currently fragmented. We also investigate the target peptide
ion intensity in theMS/MS selection window, which we term the
“precursor ion fraction” or PIF, as a function of the standard
parameters employed in LC-MS/MS. Most detectable peptides
have a very low PIF and we discuss implications of this finding for
further development towards comprehensive proteomics analysis.
’EXPERIMENTAL PROCEDURES
SILAC Labeling
HeLa S3 cervix carcinoma cells were grown in RPMI 1640
medium supplemented with bovine serum and Penicillin/Strep-
tomycin (1:1000). One out of two populations of HeLa S3 cervix
carcinoma cells were grown in RPMI 1640 medium supplemen-
ted with dialyzed bovine serum and two isotopic variants of lysine
(13C6,
15N2-L-Lys) and arginine (
13C6,
15N4-L-Arg). The cell
populations were harvested by spinning for 5 min at 400 g.
The cells were washed with phosphate-buffered saline and mixed
(heavy-to-light 3:1). Lysis was carried out by douncing (30-40
strokes) in 5 volumes of Hepes KOH (10 mM), pH 7.9, MgCl2
(1.5 mM) and KCl (10 mM) in a homogenizer on ice. The
nuclear and cellular constituents were separated by centrifuga-
tion for 15 min at 3900 rpm, before the crude cytoplasmic
supernatant was ultracentrifuged for 1 h at 60 000 g. Dilution
with glycerol (10% final concentration) and NaCl (150 mM final
concentration) yielded the cytoplasmic extract that was snap-
frozen in liquid nitrogen.
Protein Digestion
Total HeLa cell lysate (unlabeled and SILAC-labeled) or E.coli
lysate were treated with a urea (6 M) and thiourea (2M) solution.
The proteins were incubated with Dithiotreitol (DTT) (1 mM)
for 30min and iodoacetamide (IAA) (55mM) for 20min at room
temperature. Lys-C (1 μg/50 μg protein) (Wako) was added and
the mixture was incubated for 3 h at room temperature. After 1:4
dilution with water, trypsin (1 μg/50 μg protein) (Promega) was
added and the sample was incubated for 12 h at room temperature.
The digestion was stopped by addition of formic acid (3%).
Prefractionation of HeLa lysate was carried out by 1D-SDS-
PAGE (4-12% Novex mini-gel) (Invitrogen) in three separate
lanes. Colloidal Coomassie (Invitrogen) was used for staining of
the proteins before each lane was cut into 8 slices. All gel slices
were subjected to reduction of the proteins with DTT and
subsequently alkylated with IAA. In-gel digestion with trypsin
was carried out at 37 C for 12 h followed by extraction of the
tryptic peptides with 3% TFA in 30% ACN. Organic solvent was
removed and the peptide mixture was concentrated and desalted
on reversed phase C18 StageTips.
19 The peptides were eluted
twice shortly before high resolution LC-MS/MS analysis with
20 μL buffer B (80% ACN in 0.5% acetic acid) into a 96 sample
well plate (Abgene). Organic solvents were removed in a
SpeedVac concentrator and the final concentration was adjusted
with buffer A* (2% ACN in 0.1% TFA).
LC-MS/MS Analysis
The peptide mixture was separated by a nanoflow HPLC
(Proxeon Biosystems, now Thermo Fisher Scientific) and
coupled online to an LTQ Orbitrap Velos mass spectrometer
(Thermo Fisher Scientific) with a nanoelectrospray ion source
(Proxeon Biosystems). Loading of the routinely used amount of
peptides (2 μg) onto a C18-reversed phase column (15 cm long,
Figure 1. Visualization of peptides measured by LC-MS/MS in
complex mixtures. (A) LC-MS map showing a black square for each
detected peptide. (B) Zoom of the red rectangle in (A), with eluting
isotope clusters and a selection window for the MS/MS marked in red.
(C) Precursor selection window in the MS spectrum. (D) Mixture MS/
MS spectrum resulting from fragmentation of the ions in (C).
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75 μm inner diameter) was carried out with a maximal flow rate
of 500 nL/min controlled by IntelliFlow technology. The
chromatography columns were packed in-house with ReproSil-
Pur C18-AQ 3 μm resin (Dr. Maisch) in buffer A (0.5% acetic
acid). Peptides were eluted with a linear gradient of 5-60%
buffer B (80% ACN and 0.5% acetic acid) at a flow rate of 250
nL/min over 60, 90, or 200 min depending on the experiment.
Total LC-MS/MS time was about 40-50 min longer due to
loading and washing. Data were acquired using a data-dependent
“top 10” method, dynamically choosing the most abundant
precursor ions from the survey scan (mass range 300-1650 Th)
in order to isolate them in the LTQ and fragment them by
HCD.20 Dynamic exclusion was defined by a list size of 500
features and exclusion duration of 90 s. Early expiration was
disabled to decrease the resequencing of isotope clusters. The
isolation window for the precursor selection was varied in
different runs between 1, 2, 4, 8, 16, and 32 Th. For the survey
scan a target value of 1 000 000 and a resolution of 30 000 atm/z
400 were set, whereas the target value for the fragment ion
spectra was set to 40 000 ions and the resolution to 7500 at m/z
400. The lower threshold for targeting precursor ions in the MS
scans was 5000 counts.
Data Analysis
The mass spectrometric raw data were analyzed with the
MaxQuant software9 (version 1.1.1.17). A false discovery rate
(FDR) of 0.01 for proteins and peptides and a minimum peptide
length of 6 amino acids were required. The mass accuracy of the
precursor ions was improved by the time-dependent recalibra-
tion algorithm of MaxQuant. The Andromeda search engine21
was used to search the MS/MS spectra against the IPI human
database (containing 87 061 entries) combined with 262 com-
mon contaminants and concatenated with the reversed versions
of all sequences. Enzyme specificity was set to trypsin specificity,
allowing cleavage N-terminal to proline. Further modifications
were cysteine carbamidomethylation (fixed) as well as protein
N-terminal acetylation and methionine oxidation (variable).
MaxQuant was used for scoring of the peptides for identification.
A maximum of two missed cleavages were allowed. Peptide
identification was based on a search with an initial mass deviation
of the precursor ion of up to 7 ppm. The fragment mass tolerance
was set to 20 ppm on them/z scale. Analysis of the data provided
by MaxQuant was performed in the R scripting and statistical
environment22 supplemented by the ggplot2 package.23
The data sets used for analysis have been deposited at
TRANCHE (www.proteomecommons.org).
’RESULTS AND DISCUSSION
Determination of the Number of Detectable Peptides
To obtain a conservative estimate of the number of peptides
detectable with high resolution MS, we prepared lysate from a
mammalian cell line and analyzed it on the LTQ-Orbitrap Velos
platform. We used a standard “high-high” strategy, meaning
that anMS scan in the Orbitrap analyzer at 30,000 resolution was
followed by up to 10 MS/MS events obtained by HCD with
fragment spectrum analysis at 7,500 resolution (see Experimen-
tal Procedures).
We chose a “high-high” strategy over the commonly applied
“high-low” strategy with CID and LTQ detection of fragments
used on Orbitrap XL instruments, even though the “high-low”
strategy in principle would need less precursor ions, making it
more sensitive. MS/MS scan speeds are similar but the “high-
low” strategy allows for parallel operation, giving it an advantage
in total targeted precursors. Nevertheless, in previous investiga-
tions we have found that the “high-high” strategy identifies
more peptides overall,12,24 and we therefore used it in these
investigations. In any case, the results obtained here are mainly
concerned with the number and nature of precursor ions, which
is independent of the MS/MS detection. Those results that
depend on MS/MS acquisition can easily be converted to
instruments with different sensitivity or scan speeds.
We determined peaks in the LC-MS data in the MaxQuant
environment using standard criteria.9 Briefly, MaxQuant ana-
lyzed the 3805 high resolution MS scans in the MS data (RAW
file) and assigned isotope clusters whenever two isotope states
(usually 12C and one 13C) occurred with a mass tolerance of 5
ppm and in at least two consecutive (or next to consecutive) MS
scans. These criteria are reliable noise filters.9 Figure 2A shows a
histogram of the 162 338 isotope clusters resulting from this
analysis as a function of the peptide signal. The distribution is
generally log-normal but there is clearly an additional population
at very low peptide intensities. We suspected that the second
distribution was partly due to nonpeptide compounds. Indeed
when plotting only peaks eluting between the start and the
end of themain population in the Total Ion Current (TIC) graph
(10 and 100 min; Suppl. Figure 1, Supporting Information), the
very low intensity population disappeared (Figure 2B). This
Figure 2. Histogram of intensity of the detected features in an LC-
MS/MS run. (A) Isotope clusters determined by MaxQuant. (B) Same
as (A) but filtered between 5 and 30% organic phase. (C) Same as (B)
but filtered for charge state >1. Gray, all peptides; red, targeted peptides;
green, targeted and identified peptides.
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reduced the number of detected peaks by 30% to 113 618. Since
chemical noise is almost always singly charged, whereas tryptic
peptides are likely to be at least doubly charged, we next filtered
the data by charge state. This is a strongly conservative step,
because we routinely also observe singly charged identified
peptides. The filtering resulted in a final number of 101 726
likely peptide features (Figure 2C). We performed an analysis to
estimate the proportion of peptides with multiple charge states
among all detectable peptides. Peptide features that carry the
same mass ((0.005 Da) and elute in a retention time window of
(7 s, which is equivalent to two full scans before or after the
intensity maximum of the reference peak, are considered to be
the same peptide. According to these criteria we find that 13 550
peptide features (13%) result from multiple charge states. This
number is in the same order of magnitude as the proportion of
multiple charge state identifications that we find among the
identified peptides (17%). The repeated fragmentation of differ-
ent charge states of the same peptide could be reduced by more
sophisticated data dependent acquisition tools. Overall, account-
ing for the fragmentation of different charge states as well as
resequencing of previously targeted peptides would not appre-
ciably change the statistics.
Data-dependent approaches are applied in a majority of
proteomics experiments. Our data clearly show that even state-
of-the-art mass spectrometers such as the LTQ Orbitrap Velos
employed here do not yet come close to targeting the enormous
number of peptides in complex proteomics samples. Out of all
apparent peptide features that are eluting between the start of
peptide elution to the end of the gradient 16 924 (16%) were
targeted for MS/MS, 9797 of which led to identification (success
rate of 58% at 1% FDR). The overall number of MS/MS scans
was 21 906. Similar to the distribution of all (gray) peptides, the
distribution of targeted (red) peptides and identified (green)
peptides are well behaved on a log scale. Interestingly, red and
green peptides have the same intensity distribution, whereas both
are wedged into the high intensity tail of the gray peptide
distribution. This indicates that within the targeted range,
identification success depends little on peptide intensity. The
data dependent acquisition mode ensures that the most abun-
dant peptides are fragmented and since the instrument is working
at maximum fragmentation speed, there is no capacity for
fragmenting the less abundant precursor ions. The low intensity
limit of the gray distribution does not even indicate absence of
further peptides but rather that the dynamic range limit of the
mass analyzer for MS is reached.
We next investigated the physicochemical properties of the
three populations (gray, green, red) to ensure that the detected
peptide-like features indeed represent peptides. A comparison of
their mass, m/z, retention time and charge distributions (Suppl.
Figure 2, Supporting Information) provided strong evidence for
this assumption.
To independently verify that the gray distribution mainly
represents peptides we performed a SILAC experiment by
mixing equal amounts of heavy and light labeled cell populations.
MaxQuant detected SILAC pairs using the isotope criteria
described above in addition to the requirement for pairs of
coeluting isotope clusters with the precise mass difference of the
SILAC label. This allows detecting peptide pairs even if they were
not fragmented and identified, and distinguishes them from
chemical noise with near certainty. Note that due to the more
stringent criteria for SILAC pair detection we found that a
minimum intensity of 105 is needed for SILAC pair detection
and considerably fewer peptide features are expected in this
experiment (Suppl. Figure 3, Supporting Information). While
the overall number of isotope clusters in the SILAC sample
(167 811) is comparable to the number of isotope clusters in
the unlabeled HeLa sample (162 338), we only detected 33 281
SILAC pairs in total (representing 66 562 isotope clusters), at least
one of which was fragmented in 36% of the cases (Suppl. Table 1,
Supporting Information). For 69% of these we unambiguously
identified a peptide sequence in the database (Suppl. Figure 4,
Supporting Information). Examination of the mass, m/z and
retention time distributions of the SILAC population and compar-
ing these to the distributions of the unlabeled peptides described
above (Suppl. Figure 5, Supporting Information), revealed that
there was again excellent agreement for all of these properties,
supporting that the features detected above were indeed peptides.
To ascertain that the above numbers of the unlabeledHeLa cell
lysate were typical, we repeated the analysis with two independent
experiments, which yielded very similar results (Suppl. Table 2,
Supporting Information). Furthermore, we analyzed E. coli cell
lysate, with similar results except that overall numbers were
reduced by about one-third (Suppl. Table 2). This is not
surprising because bacterial proteomes are somewhat less com-
plex than mammalian proteomes (the genome is only about 20%
as large and there is no alternative splicing). The proportions
between detected, targeted and identified peptides were the same
as in the mammalian proteome, suggesting that they reflect
characteristics of complex proteomes in general (Suppl. Table 2).
Together, our results demonstrate that at least 100 000 detect-
able peptide peaks elute under standard LC-MS/MS conditions
and this number is even larger when using faster scan rates.
Although many of these peaks would redundantly identify the
same peptide sequences or peptide sequences of already identified
proteins, our results suggest that a single LC-MS run contains
sufficient peptides to identify a large part of the cellular proteome.
Requirements for MS/MS Sequencing Speed
Having established that at least 100 000 distinct peptide peaks
elute over a standard gradient, we next investigated the MS/MS
sequencing speed that would be necessary to target them. First we
plotted the actual frequency of MS/MS events over the gradient
(Figure 3). From the start of peptide elution to the end of the
gradient, the instrument was sequencing at its maximum rate,
indicating that there were sufficient precursor peaks above thresh-
old value at any elution time.Next, we divided the peptide features
into high abundance (>3  106 cps; the maximum of the iden-
tified peptide distribution), medium abundance (>4  105
cps; down to the lowest identified peptide intensities) and low
abundance (the rest of the gray peptide distribution in Figure 2C).
The peptide features of these three abundance classes are plotted
as a function of retention time in Figure 3. Even among the high
abundance peptides, there are several occasions where more than
three peptides per second elute (dark gray line exceeds the red
line in Figure 3). This is possibly the reason that not all high
abundance peptides were targeted for MS/MS. The medium
abundance peptides, which is the entire population that exceeds
the threshold for MS/MS picking, already requires a sequencing
speed of 17 MS/MS events per second. If all detectable peptides
should be targeted, then a sequencing speed of up to 25 MS/MS
events per second would be necessary (Figure 3). Clearly, further
improvement of the sequencing speed over the 3.3 MS/MS
spectra per second achieved here, would be desirable and is
certainly within reach. When keeping the same threshold for
28
1789 dx.doi.org/10.1021/pr101060v |J. Proteome Res. 2011, 10, 1785–1793
Journal of Proteome Research ARTICLE
picking of peaks, this would have the effect of targeting the entire
median abundance peptide distribution (the red population
would encompass the right half of the peptide population).
However, precursor ion injection times for MS/MS are increas-
ingly limited at high sequencing speed. For this and other reasons
that we investigate below, high MS/MS frequency by itself would
not necessarily lead to a corresponding increase in identified
peptides (green population).
Requirements for Sensitivity in MS/MS
Next we investigated the MS/MS sensitivity necessary for
successful fragmentation of the detectable peptide features. In
figure 4A the intensity at the peak apex versus the ion injection
time necessary to reach the target value of 40 000 ions appears as
a linear relationship in a log-log plot. The ion injection times
can be determined for the high abundance peptide population
defined above and the medium abundant population below
3  106, as well as the border to the low abundance peptide
population at 4  105 (Figure 2C). To cover the medium
abundant peptide features, ion injection times up to 100 ms
are necessary. The low intensity proportion of the gray peptides
would need to be accumulated for 2 s to reach their target value.
Furthermore, in complex samples the targeted peptide is usually
accompanied by other candidates in the isolation window that
reduce the ion injection time needed for the requested target value
(i.e., the PIF is not 1). Figure 4B shows that this effect significantly
reduces the ion injection times in particular for the low abundant
peptides if a fixed overall number of ions are accumulated by the
automatic gain control of the instrument. This is unwelcome
because it reduces the number of desired precursor ions con-
tributing to the MS/MS spectrum. Finally, isolation and fragmen-
tation of the precursor ion does not always happen at the peak apex
during chromatographic elution, thus injection times would tend
to be longer than the ones we calculate.
In conclusion, sensitivity in the MS/MS mode would be
limiting for at least half of the detectable peptide population,
even on an extremely high sensitivity instrument such as the LTQ
Orbitrap Velos.
Required Precursor Intensity Fraction
Co-elution of peptides with similar mass is a general challenge
in shot-gun proteomics, because precursor ion selection is low
resolution and these peptides are often cofragmented. This is
illustrated in Figure 1, where the isolation window spans two
peptide precursors, giving rise to a mixed MS/MS spectrum. To
quantify the effects of this interference, we introduce a parameter
called the “precursor ion fraction” (PIF). The PIF is defined as
the fraction of ion current in the isolation window that is due to
the targeted precursor ion and therefore ranges between 0 and 1.
The PIF is determined for each targeted precursor ion and each
Figure 4. CalculatedMS/MS ion injection time for the desired target value of 40 000 based on the apex intensity of the precursor ions. (A) Relationship
between ion injection time and apex intensity assuming a PIF equal to one. The dashed lines indicate the high, medium and low abundance cases from
Figure 2C. (B) Corrected injection times of the target precursor after considering the actual PIF.
Figure 3. Peptide features eluting as a function of retention time. Gray
scale values for high, medium and low refer to the peptide intensity
regions marked in Figure 2. The red line marks the actual MS/MS
frequency.
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tandem mass spectrum based on the closest full scan, which
could be the previous or the consecutive one. For peptide
features that are not targeted for fragmentation, the PIF is
determined from the full scan closest to the peak apex. As a
consequence, the PIF is per se unrelated to anyMS/MS settings,
such as the peak picking threshold for fragmentation. We first
plotted the dependence of the MS/MS identification rate on
the PIF (Figure 5A). At high PIF, the identification rate was
nearly 60% and it stayed at this high level until a PIF value of 0.5.
As expected the identification rate drops drastically at lower
PIFs. This is in agreement with a recent study that determined
the decrease in identification score after in silicomerging of low
resolution MS/MS spectra of different peptides.14 Those
authors defined the percentage of the intensity of the highest
contaminating peak versus the intensity of the targeted peak
(set at 100%) as “percent chimera intensity” (PCI), and noted
a decrease in identification score at PCI values higher than 20%.
In contrast, the PIF also takes into account any contributions
from multiple peptide precursors or other coeluting species in
the entire isolation window. Note that very few peptides (<150)
with very low PIF (<0.2) were targeted in our experiment, and
these may represent favorable cases for identification. Therefore
the deleterious effect of the low PIF on identification success rate
may be even larger. In any case, our data demonstrates that PIFs
below 0.5 are generally detrimental for identification success in
data driven shotgun proteomics, even for high accuracy MS/
MS data.
The above experiment was performed with an isolation
window of 4 Th. The extent of coelution of additional precursor
ions is strongly influenced by the width of the isolation window
of the targeted precursor ions and we therefore systematically
varied the isolation window and determined the resulting
distribution of PIFs. The median PIF of targeted peptides
decreased from 0.85 at an isolation window of 1 Th to 0.07 at
an isolation window of 32 Da (Figure 5B). At 2 Th or 4 Th, the
median PIF was 0.73 and 0.54, respectively, both above the value
where the identification rates start to decline. The best success
might be expected with a particularly narrow isolation window.
However, we observed that an isolation window of 4 Th resulted
in the highest number MS/MS identifications (Figure 5B). This
is related to the fact that narrow isolation windows in quadrupole
devices generally limit transmission. Furthermore, the isolation
window is not perfectly rectangular but rather has a somewhat
rounded shape, limiting the retention of ions at the outer edges.
Therefore, the typically used values of 2 or 4 Th are optimal in
practice, despite the beneficial influence of narrow selection
windows on the PIF.
It might appear obvious that reducing the sample complexity
would help in increasing the PIF. Indeed, the analysis of HeLa
cell lysate fractionated by one-dimensional gel electrophoresis
into eight gel slices improved the median PIF, but this effect was
only minor (Suppl. Figure 4A, Supporting Information). This is
likely due to the very high complexity of the HeLa cell lysate
itself, which allows more peptides to be detected as the dynamic
range is increased by fractionation. It is possible that the median
PIF would increase substantially upon very extensive fractiona-
tion. However, due to the measurement times involved, such
strategies are not feasible for most proteomics experiments. We
also checked, if the PIF would improve upon more extensive
chromatography based separation of the peptide mixture.
However, we found that the PIF decreases somewhat, when
the length of the gradient was increased from 30 to 90 and then
to 200 min (from 0.65 to 0.55 and to 0.45; Suppl. Figure 4B,
Supporting Information). As the elution widths of the peaks
increased, presumably those low abundant peptide features that
were not detected in a shorter gradient became detectable by
MaxQuant, because their elution profiles were sampled more
often. These low abundance peaks tend to have a low PIF and
therefore they lower the median PIF of the experiment.
Together, these experiments show that neither sample fractio-
nation nor longer gradients improve the median PIFs substan-
tially. We speculate, however, that increased chromatographic
resolution would contribute proportionally to improving the
PIF of the already detected peaks, but would again lead to the
detection of additional, low abundance peaks in the LC-
MS map.
In Figure 6, we have plotted the identified peptides as a
function of m/z scale and retention time in the LC-MS plane.
The graph has the typical shape with smaller peptides, which are
generally more hydrophilic, eluting first and larger peptides
tending to elute later. Thus, only a specific part of the plane is
occupied by eluting peptides. Color coding the peptides accord-
ing to their PIF clearly shows that the center of the distribution
has most peptides with low PIF (red). Peptides with very high
PIF (green) tend to be outside the typical elution envelope. The
part of the LC-MS/MS run that is richest in peptides that can be
Figure 5. Dependence of peptide identification rates on (A) precursor ion fraction (PIF) and (B) isolation window as a box plot summary of runs with
different isolation window widths.
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fragmented and identified is also the one that tends to have the
worst PIFs.
A zoom of a typical peptide-rich region is shown in Figure 6B.
Each fragmented and identified peptide is overlaid with a
potential MS/MS selection window assuming a median elution
length of 40 s and an isolation window of 4 Th. Reflecting the
median PIF of 0.54 for this experiment, there is substantial
overlap of the potential selection windows. Figure 6C repeats the
same plot but for all targeted peptides. The full extent of the PIF
effect is revealed when plotting potential selection windows for
all eluting peptide features in this region, whether targeted for
fragmentation or not. Clearly the vast majority of peptide peaks
are overlapping with one or more potential selection windows,
demonstrating that cofragmentation would be the norm rather
than the exception, if all peptide features were to be target in data
dependent LC-MS/MS. This can also be confirmed on theore-
tical grounds: even if 100 000 peptide features were to elute
equally spaced in the LC-MS map, there would only be room
for 23 625 peptides with a PIF of 1, given a gradient length of 90
min and an m/z range of 300-1000 Th for at least doubly
charged precursors in a 4 Th isolation window.
As shown above for a particular example, considering lower
abundant peptide features decreases the median PIF. To quantify
this relationship for the entire data set, we plotted the PIF as a
function of the maximum abundance of the isotope cluster as
determined by MaxQuant (Figure 7A). Not surprisingly, there is
a wide range of measured PIFs for each peptide intensity.
However, the median PIF follows a clear trend, with PIF close to
1 occurring regularly for very high intensity peptide signals
(>108 cps) whereas they are largely absent for very low abun-
dance peptide signals (<105 cps). Strikingly, themedian PIF of all
peptide features detected is only 0.14 (Figure 7B). This means
that for half of the peptide features, the ion current provided by
the precursor of interest to the MS/MS spectrum would only be
14% or less, resulting in low identification success of these
mixture MS/MS spectra.
’CONCLUSION AND OUTLOOK
The number of identifiable peptides and their reproducibility
between runs have been of great interest in shotgun proteomics.
Here we have instead focused on the total number of detectable
peptides, regardless of whether they were targeted for fragmenta-
tion or not. Using high resolution MS and the MaxQuant
computational environment, we found that more than 100 000
isotope features, likely representing peptides, elute in a standard
LC-MS/MS run. Thus, many more peptides can be detected at
the LC level than are currently targeted and identified by data
dependent LC-MS/MS. We systematically investigated the
factors required to enable their identification. This analysis
showed that a 10-fold higher sequencing speed would allow
targeting all of the currently detectable peptide features.
Figure 6. (A) LC-MS map of the complex peptide mixture colored by the PIF. Zoom of the indicated region for (B) all identified peptides, (C) all
targeted peptides, and (D) all detected peptide precursor features.
Figure 7. (A) PIF as a function of peptide feature intensity. The red line
indicates the median signal intensity bins of all peptide features. (B) Box
plot of (A). The median of all peptide features is 0.14 and is indicated by
the red line.
31
1792 dx.doi.org/10.1021/pr101060v |J. Proteome Res. 2011, 10, 1785–1793
Journal of Proteome Research ARTICLE
Increased ion current by a factor of 10-100 would bring most of
the peptides within the sensitivity range required for successful
MS/MS. Most strikingly, we found that the vast majority of
peptides have close neighbors in the LC-MSmap and that in the
median case only 14% of the peptide current in the isolation
window is due to the precursor ion. Therefore cofragmentation
of peptides would occur for almost all of the more than 100 000
peptide features, if they were targeted for fragmentation. The
theoretically most effective approach for solving this problem
would be high resolution precursor selection. However, this is
not possible given existing technology. Even the reduction of the
selection window to 2 Th results only in an increase of the PIF of
0.29 but at the expense of precursor intensity and identification
success. A practical approach to deal with this effect is a
demultiplexing algorithm (see for example ref 21) in conjunction
with the appropriate overfilling of ions in the precursor isolation
window. All our results are based on the dynamic range of state of
the art instruments. The above trends will be intensified as the
dynamic range and the resolution of mass spectrometers is
enhanced and will further increase the number of detected
precursor ions.
Our findings have interesting implications for the further devel-
opment of shotgun proteomics. For example, an increase in
sequencing speed is welcome and necessary, but not sufficient.
Likewise, ongoing improvements in the sensitivity of instruments
will yield benefits for the foreseeable future, but will not by
themselves make all detectable features identifiable. Instead, our
data suggest that a classical data driven MS and MS/MS strategy
will eventually have limitations because virtually all MS/MS spectra
will bemixture spectra. Therefore, not only advanced inclusion and
exclusion features for peak selection, but also some form of
multiplexing of MS/MS in a high resolution format will likely need
to be a component of future shotgun proteomics strategies.
Alternatively, if the peptide identity can be established in separate
experiments, it may be transferable for many of the peptides that
were not targeted for sequencing. However, this will need strict
reference standards and sophisticated algorithms. Finally, we note
that for many proteomic samples of low complexity, the depth of
coverage achievable today is already sufficient and even for very
complex proteomes, depending on the question asked, it may not
be necessary to identify all detectable peptide features.
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Prologue 
Mass spectrometry is the analytical technique of choice for diverse applications including but not 
limited to proteomics and biological questions. Analyzing a wide variety of starting materials 
requires different technologies and specifications, but also a high degree of flexibility of the 
instruments.  
The Orbitrap analyzer has proven to be a very versatile tool and it is well accepted by researchers 
from many different areas, due to its high performance in conjunction with relatively low 
maintenance efforts. Interestingly, the Orbitrap hardware itself did not undergo any changes since 
it was introduced to the market in 200553, but the associated instrument platforms were modified 
and improved in several iterations. The original format of a hybrid instrument with an up-front 
linear ion trap analyzer (LTQ Orbitrap), was extended by an extra collision cell attached to the C-
trap, enabling higher energy collisional dissociation (HCD)71 in the LTQ Orbitrap XL. 
Furthermore, optional ETD capability was added to the instrument107. The linear ion trap was 
replaced by a dual pressure double linear trap that provides more efficient trapping, 
fragmentation and faster scanning (LTQ Orbitrap Velos)43. An important device permitting 
greatly improved sensitivity was the stacked ring ion guide located behind the inlet, and a shorter 
version of the heated capillary that has a larger diameter in later instrument versions; together this 
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increased the ion current by up to a factor 10. Beyond the hybrids, a very robust and simple 
instrument without mass selection device was developed especially for small molecule 
applications in a benchtop format (Exactive)116. Thus, Orbitrap instrumentation was improved 
considerably and the platforms became more and more powerful over several years - without 
touching the Orbitrap analyzer.  
Proteomics was a major field of application for Orbitrap instrumentation from the beginning and 
a very demanding area as outlined in Article 1. In this thesis, we therefore co-developed and 
evaluated several hardware and software features of two novel Orbitrap instrument types prior to 
their release in 2011. In close collaboration with the research and development team from 
Thermo Scientific, Bremen, our efforts were primarily focused on shotgun proteomics 
measurements, quality control and intuitive usage, as well as the development of novel acquisition 
strategies. The projects were largely carried out on prototype instruments featuring only selected 
tools or preliminary versions of the final user-interface.  
 
The quadrupole Orbitrap combination, Q Exactive, is particularly successful in shotgun 
proteomics applications because of its very high sequencing speed. One cycle in a top 10 method 
with resolution of 50,000 and 12,500 at m/z 400 for MS and MS/MS scans, respectively, takes 
only slightly above one second (Article 2). This is achieved by collecting ions in the C-trap or 
fragmenting them in the HCD cell simultaneously to the previous scan in the Orbitrap. 
Furthermore, an enhanced Fourier transformation algorithm doubles the resolution at a given 
transient length, which can also be used to increase sequencing speed. The shortest transient that 
can be selected is 64 ms (corresponding to the lowest resolution 12,500 at m/400). Theoretically 
this time can fully be used for accumulating ions without impacting the fastest cycle time given by 
this minimum scan time. In practice, the time span is slightly shorter due to some overhead: 
about 50 ms ensure entirely parallel operation. In shotgun proteomics experiments this 
functionality permits another mode of operation that applies a fixed ion injection time. Instead of 
selecting a specific target value that is controlled by predictive AGC, ions for the tandem mass 
spectrum are accumulated for a defined time period. That strategy makes optimal use of 
instrument capabilities and ensures very well defined, regular cycles. Finally, multiplexing scan 
modes at the MS and MS/MS level provide a variety of options to further improve sensitivity or 
sequencing speed of the instrument. In principle, it provides the Q Exactive with the capability to 
implement targeted proteomics approaches based on the ability of the quadrupole to rapidly 
switch between m/z ranges to be isolated. These strategies can be applied in conjunction with the 
data-dependent strategy.  
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In 2011, the latest generation hybrid instrument, the Orbitrap Elite, was introduced. This marked 
the first time that the dimensions of the Orbitrap analyzer were changed in a commercial 
instrument. Importantly, the compact Orbitrap is not only smaller than the previous version, but 
the ratio between the diameters of the outer and the central electrodes was modified. This 
provides a stronger electrostatic field and consequently about a factor two higher resolving power 
at the same transient length. Together with the enhanced Fourier transformation described 
above, resolution is improved by a factor four. The instrument also underwent improvements 
with regard to the ion optics for better robustness. Furthermore, a novel scan mode in the ion 
trap, rapid CID, was introduced. For shotgun applications, it is most beneficial to reduce the 
resolution for the sake of sequencing speed, unless very low abundant samples are analyzed. The 
ultra-high resolution can also be applied advantageously in top-down proteomics as demonstrated 
in Article 3.   
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Mass Spectrometry-based Proteomics Using
Q Exactive, a High-performance Benchtop
Quadrupole Orbitrap Mass Spectrometer*□S
Annette Michalski‡, Eugen Damoc§, Jan-Peter Hauschild§, Oliver Lange§,
Andreas Wieghaus§, Alexander Makarov§, Nagarjuna Nagaraj‡, Juergen Cox‡,
Matthias Mann‡¶, and Stevan Horning§¶
Mass spectrometry-based proteomics has greatly benefit-
ted from enormous advances in high resolution instrumen-
tation in recent years. In particular, the combination of a
linear ion trap with the Orbitrap analyzer has proven to be a
popular instrument configuration. Complementing this hy-
brid trap-trap instrument, as well as the standalone Or-
bitrap analyzer termed Exactive, we here present coupling
of a quadrupole mass filter to an Orbitrap analyzer. This “Q
Exactive” instrument features high ion currents because of
an S-lens, and fast high-energy collision-induced dissocia-
tion peptide fragmentation because of parallel filling and
detection modes. The image current from the detector is
processed by an “enhanced Fourier Transformation” algo-
rithm, doubling mass spectrometric resolution. Together
with almost instantaneous isolation and fragmentation, the
instrument achieves overall cycle times of 1 s for a top10
higher energy collisional dissociation method. More than
2500 proteins can be identified in standard 90-min gradients
of tryptic digests of mammalian cell lysate— a significant
improvement over previous Orbitrap mass spectrometers.
Furthermore, the quadrupole Orbitrap analyzer combina-
tion enables multiplexed operation at the MS and tandem
MS levels. This is demonstrated in a multiplexed single
ion monitoring mode, in which the quadrupole rapidly
switches among different narrow mass ranges that are
analyzed in a single composite MS spectrum. Similarly,
the quadrupole allows fragmentation of different precur-
sor masses in rapid succession, followed by joint analysis
of the higher energy collisional dissociation fragment ions
in the Orbitrap analyzer. High performance in a robust
benchtop format together with the ability to perform com-
plex multiplexed scan modes make the Q Exactive an
exciting new instrument for the proteomics and general
analytical communities. Molecular & Cellular Proteom-
ics 10: 10.1074/mcp.M111.011015, 1–11, 2011.
Mass spectrometry-based proteomics often involves the
analysis of complex mixtures of proteins derived from cell or
tissue lysates or from body fluids, posing tremendous analyt-
ical challenges (1–3). After proteolytic digestion, the resulting
peptide mixtures are separated by liquid chromatography and
online electrosprayed for mass spectrometric (MS) and tan-
dem mass spectrometric (MS/MS) analysis. Because tens of
thousands of peptides elute over a relatively short time and
with ion signals different by many orders of magnitude (4, 5),
mass spectrometers have been pushed to even higher sen-
sitivity, sequencing speed, and resolution (6, 7). In current
shotgun proteomics there are mainly four mass spectrometric
separation principles: quadrupole mass filters, time of flight
(TOF)1 mass analyzers, linear ion traps, and Orbitrap™ ana-
lyzers. These are typically combined in hybrid configurations.
Quadrupole TOF instruments use a quadrupole mass filter to
either transmit the entire mass range produced by the ion
source (for analysis of all ions in MS mode) or to transmit only
a defined mass window around a precursor ion of choice
(MS/MS mode). In the latter case ions are activated in a
collision cell and resulting fragments are analyzed in the TOF
part of the instrument with very high repetition rate. This TOF
part of quadrupole TOF instruments replaces the final qua-
drupole section of triple quadrupole instruments, which are
today mainly used for targeted proteomics (8–10).
The quadrupole TOF instruments achieve peptide separa-
tion “in space”, meaning the ions are separated nearly in-
stantaneously by passing through either the quadrupole
section, in which only a chosen small mass range has stable
trajectories, or by traversing the TOF section. In contrast,
trapping instruments such as linear ion traps separate ions “in
time” by applying external RF-DC fields to a stationary ion
population that allow only a certain ion population to stably
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remain in the trap (see ref (11)) for the concept of separation
and fragmentation in time versus in space).
The Orbitrap mass analyzer was developed about ten years
ago by Makarov. It consists of a small electrostatic device into
which ion packets are injected at high energies to orbit around
a central, spindle-shaped electrode (12–14). The image cur-
rent of the axial motion of the ions is picked up by the detector
and this signal is Fourier transformed (FT) to yield high reso-
lution mass spectra. Commercially, the Orbitrap analyzer was
first introduced in 2005 in a hybrid instrument (15). In pro-
teomics and related fields, this combination of a low resolu-
tion linear ion trap with the high resolution Orbitrap analyzer—
termed “LTQ Orbitrap”—has now become widespread (16,
17). The LTQ Orbitrap instruments represent a multistage trap
combination (Fig. 1). In MS mode the linear trap performs the
function of collecting the ion population, passing them on to
an intermediate C-trap for injection and analysis in the Or-
bitrap analyzer at high resolution. In MS/MS mode the linear
ion trap only retains a chosen mass window, which is acti-
vated by a supplemental RF field leading to fragmentation of
the trapped precursor ions, and records the signal of a mass
dependent scan at low resolution. Note that the high resolu-
tion MS scan can be performed at the same time as the low
resolution MS/MS scans in the linear ion trap. Recently, an
improved linear ion trap Orbitrap analyzer combination
termed “LTQ Orbitrap Velos” has been introduced (18). It
features an S-lens with up to 10-fold improved ion transmis-
sion from the atmosphere, a dual linear ion trap, and a more
efficient Higher energy Collisional Dissociation (HCD) cell in-
terfaced directly to the C-trap (18). HCD fragmentation is
similar to the fragmentation in triple quadrupole or quadrupole
TOF instruments and its products are analyzed with high
mass accuracy in the Orbitrap analyzer (19). Thus, the LTQ
Orbitrap or LTQ Orbitrap Velos instruments offer versatile
fragmentation modes depending on the analytical problem
(20–22).
Taking advantage of the small size of the Orbitrap analyzer
a standalone benchtop instrument termed “Exactive” has
been introduced mainly for small molecule applications. How-
ever, because of the absence of mass selection, its use in
proteomics is limited to non-mass selective fragmentation of
the entire mass range (called “All Ion Fragmentation” (AIF) on
this instrument (23)).
The combination of a quadrupole mass filter with an Or-
bitrap analyzer has not yet been reported. We reasoned that
such a quadrupole trap combination might offer unique and
complementary advantages to the hybrid mass spectrome-
ters described above. In particular, a quadrupole Exactive
instrument or “Q Exactive” would be able to select ions vir-
tually instantaneously because of the fast switching times of
quadrupoles and it would be able to fragment peptides in
HCD mode on a similarly fast time scale. Furthermore, be-
cause of the small size and mature technology used in
current quadrupole mass filters, this analyzer combination
should have a small footprint and be particularly robust.
Finally, the ability to separate “in space” and analyze MS
and MS/MS ranges at high resolution in the Orbitrap ana-
lyzer offers the promise of enabling efficient multiplexed
FIG. 1. Mass spectrometers incorporating an Orbitrap analyzer.
The Exactive is a standalone instrument without mass selection. The
total ion population is collected in the C-trap and injected into the
Orbitrap analyzer (see text and Fig. 2 for details on detector compo-
nents). In the LTQ Orbitrap Velos combination, ions can be selected
“in time” by mass selective scans in the linear ion trap. In CID mode,
the LTQ and Orbitrap operate as separate mass spectrometers. In
HCD mode its function is to isolate a particular precursor, which is
then fragmented in the HCD cell. In contrast, in the Q Exactive mass
selection is “in space” as ions of only a specified m/z range have
stable trajectories and are transferred to the storage or fragmentation
devices before Orbitrap analysis.
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scan modes not currently applied in proteomics research
using trapping instruments.
EXPERIMENTAL PROCEDURES
Construction of a Quadrupole Orbitrap Instrument—The Q Exactive
instrument includes an atmospheric pressure ion source (API), a
stacked-ring ion guide (S-lens) in the source region, a quadrupole
mass filter, a C-trap, an HCD cell, and an Orbitrap mass analyzer as
shown in Fig. 2. Ions are formed at atmospheric pressure (in this work
in a nanoelectrospray ion source), pass through a transfer tube to an
S-lens described in (18) and then via an injection multipole into a bent
flatapole. The bent flatapole has 2-mm gaps between its rods, ori-
ented in such a way that the line of sight from the S-lens is open for
clusters and droplets to fly unimpeded out of the flatapole.
After collisional cooling in the bent flatapole, ions are transmitted
via a lens into a hyperbolic quadrupole (r0  4 mm), capable of
isolating ions down to an isolation width of 0.4 Th at m/z 400. The
quadrupole is followed by its exit lens combined with a split lens used
to gate the incoming ion beam. A short octapole then brings ions into
the C-trap interfaced to an HCD cell with axial field (18). The gas-filled
HCD cell is separated from the C-trap only by a single diaphragm,
allowing easy HCD tuning. Fragmentation of ions in the HCD cell is
achieved by adjusting the offset of the RF rods and the axial field to
provide the required collision energy. As long as this offset remains
negative relative to the C-trap and the HCD exit lenses, all fragments
remain trapped inside the HCD cell, even if the offset of the RF rods
is varied. This allows to introduce multiple precursor ions and to
fragment them at their optimum collision energy without compromis-
ing the storage of preceding injections. The summed ion population
can then be transferred back into the C-trap, ejected into the Orbitrap
analyzer and analyzed in a single Orbitrap detection cycle. This opens
the possibility of fundamentally new, “multiplexing” modes of opera-
tion. In practice, the useful number of ion injections for a single
Orbitrap detection is limited by the sum of the individual inject times
being lower than the time for the Orbitrap scan.
A new challenge posed by interfacing the Orbitrap analyzer to a
quadrupole is the automatic gain control (AGC) of weak ion signals.
This problem was addressed by using an AGC pre-scan for a full MS
spectrum with subsequent prediction of the ion currents for the weak
signals on the basis of their share in total ion current (predictive AGC).
The mass range covered by the instrument is m/z 50–4000, with
the range of mass selection reaching m/z 2500. Acquisition speed
ranges from 12 Hz for resolving power 17,500 at m/z 200 (corre-
sponding to 12,500 at m/z 400) to 1.5 Hz for resolving power 140,000
at m/z 200 (corresponding to 100,000 at m/z 400). Vacuum in the
Orbitrap compartment is typically below 7  1010 mBar, which
makes the analyzer adequate for high resolution analysis of most
analytes, including large peptides and small proteins.
The ability to fill the HCD cell or the C-trap with ions while a
previous Orbitrap detection cycle is still ongoing is another important
innovation that allows to significantly reduce the influence of low ion
currents on acquisition speed and quality of spectra.
Processing of Transients Using Magnitude and Phase Information
(eFT)—Transients detected in the Orbitrap mass analyzer are pro-
cessed using an enhanced version of Fourier Transformation (eFT™)
for conversion of transients into frequency and then m/z. Details of
the technique can be found in (24). Both eFT and conventional FT
make use of complex numbers, which can be represented by mag-
nitude and phase, or by real and imaginary components. As the initial
phase of the ion package appears to be dependent on initial param-
eters of the ions in a very complex way (25), FT spectra have to be
presented in the so-called magnitude mode, which amounts to dis-
regarding the phase information. However, in Orbitrap mass spec-
trometers the built-in excitation-by-injection mechanism (26) provides
an initial phase of ion oscillations that is almost m/z independent. This
synchronization allows converting spectra in such a way that the real
component of data can be utilized, which results in narrower peaks. In
practice, eFT uses a combination of the magnitude and the real
component of the signal to improve mass accuracy and peak shape.
Better accuracy of synchronization is achieved, if detection starts
as early as possible after ion injection. For this reason, modifications
of preamplifier and Orbitrap analyzer were introduced to reduce the
delay between ion injection and start of transient detection from
almost 10 ms to a fraction of a millisecond.
Practical implementation of eFT achieves between 1.8- and 2-fold
increase of resolving power for the same transient (except for rapidly
decaying signals, for example from proteins, where the gain is re-
duced to about 1.4-fold because of “hard sphere” collisions with
background gas). The dual-spectrum online processing is computa-
tionally demanding but still fast enough to be completed in the LC MS
time scale. Thus cycle time is still determined by transient acquisition
and ion injection times and not by processing of the data. The eFT
method is sensitive to precise synchronization of the instrument elec-
tronics and remaining shot-to-shot jitter, so that final mass accuracy
is comparable to that of traditional magnitude mode FT spectra.
Side-lobes in eFT spectra are comparable to those in conventional FT
spectra.
Preparation of HeLa Lysates—HeLa cells were lysed and the pellet
was dissolved in a urea (6 M) and thiourea (2 M) solution. Proteins were
reduced with dithiotreitol (1 mM) for 30 min at room temperature
followed by alkylation with iodoacetamide (55 mM) for 20 min in the
dark. The mixture was incubated with LysC (1 g/50 g protein)
(Wako, Richmond, VA) at room temperature for 3 h before 1:4 dilution
with water. Incubation with trypsin (1 g/50 g protein) (Promega,
Madison, WI) was carried out for 12 h at room temperature. The
digestion was stopped by addition of formic acid (3%). Organic
solvent was removed in a SpeedVac concentrator. The peptide mix-
ture was desalted on reversed phase C18 StageTips (27). Directly
before analysis, peptides were eluted into 8 well autosampler vials
with 60 l buffer B (80% acetonitrile in 0.5% acetic acid). Organic
solvent was removed in a SpeedVac concentrator and the final sam-
ple volume was adjusted with buffer A* (2% acetonitrile in 0.1%
trifluoroacetic acid) to 12 l.
LC MS/MS Analysis for Q Exactive and LTQ Orbitrap Velos—A
nanoflow HPLC instrument (Easy nLC, Proxeon Biosystems, now
Thermo Fisher Scientific) was coupled on-line to a Q Exactive or an
LTQ Orbitrap Velos mass spectrometer (both from Thermo Fisher
Scientific) with a nanoelectrospray ion source (Proxeon). Chromatog-
raphy columns were packed in-house with ReproSil-Pur C18-AQ 3 m
resin (Dr. Maisch GmbH) in buffer A (0.5% acetic acid). The peptide
mixture (5 g) was loaded onto a C18-reversed phase column (15 cm
long, 75 m inner diameter) and separated with a linear gradient of
5–60% buffer B (80% acetonitrile and 0.5% acetic acid) at a flow rate
of 250 nL/min controlled by IntelliFlow technology over 90 min. Be-
cause of loading and washing steps, the total time for an LC MS/MS
run was about 40–50 min longer.
MS data was acquired using a data-dependent top10 method
dynamically choosing the most abundant precursor ions from the
survey scan (300–1650 Th) for HCD fragmentation. Target values on
Q Exactive were similar to those typically used on an LTQ Orbitrap
Velos. Determination of the target value is based on predictive Auto-
matic Gain Control (pAGC) in both instruments. However, the LTQ
Orbitrap Velos is equipped with electron multipliers, which allows
scaling of the number of ions in a direct manner. In contrast, scaling
of the number of ions is more indirect on the Q Exactive accounting
for the difference in target values for the same S/N. Dynamic exclu-
sion duration was 60 s with early expiration disabled on the LTQ
Orbitrap Velos. Isolation of precursors was performed with a 4-Th
Q Exactive, a Benchtop Quadrupole Orbitrap Mass Analyzer
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window and MS/MS scans were acquired with a starting mass of 100
Th. Survey scans were acquired at a resolution of 70,000 at m/z 200
on the Q Exactive and 30,000 at m/z 400 on the LTQ Orbitrap Velos
(see Results and Discussion and Table I for conversion of resolution
values to different m/z values). Resolution for HCD spectra was set to
17,500 at m/z 200 on the Q Exactive and 7500 at m/z 400 on the LTQ
Orbitrap Velos. Normalized collision energy was 30 eV for the Q
Exactive and 35 eV for the LTQ Orbitrap Velos—they are not identical
because of different scaling functions in the instrument software. The
underfill ratio, which specifies the minimum percentage of the target
value likely to be reached at maximum fill time, was defined as 0.1%
on the Q Exactive. For the LTQ Orbitrap Velos the lower threshold for
targeting a precursor ion in the MS scans was 5,000 counts. Both
instruments were run with peptide recognition mode enabled, but
exclusion of singly charged and unassigned precursor ions was only
enabled on the LTQ Orbitrap Velos. This was because of the higher
sequencing speed of the Q Exactive and a slightly different precursor
selection algorithm for the data-dependent scans. However, in prac-
tice there was not much difference between the settings with regard
to the number of identified unique peptides and proteins.
To demonstrate multiplexing of selected ion monitoring (SIM)
scans, a method alternating full scans and SIM scans over the entire
gradient was set up on the Q Exactive. The 92 min range in which
peptides eluted was divided into 23 segments of 4 min duration. For
each of these segments, three SIM windows of 2 Th width were
defined, centered around 69 randomly chosen, low abundance pre-
cursor ions observed in these elution time windows in a previous
top10 run. Pre-selection of these low abundance peptides was car-
ried out manually based on the msms.txt file resulting from MaxQuant
analysis. The method for multiplexed SIM scans was specified using
the “Targeted SIM” template in the Q Exactive method editor. Reso-
lution was set to 140,000 at m/z 200 and a target value of 1e6 ions for
both scan types was chosen. The maximum ion injection time was set
to 10 ms for the full scan and to 100 ms for each of the multiplexed
SIMs. The inclusion list was saved in the global list features and in the
data-dependent settings page “inclusion” was set to “on.” Multiplex-
ing of MS/MS spectra was done in exactly the same format as the
standard top10 method, except that “msx” in the method setup of the
data-dependent scans was set to 2 for multiplexing the fragment ions
of two consecutively selected precursors.
Analysis of Proteomic Data—The mass spectrometric raw data
from top10 methods were analyzed with the MaxQuant software
(developmental version 1.1.1.32) (28). The false discovery rate (FDR)
was set to 0.01 for proteins and peptides, which had to have a
minimum length of 6 amino acids. MaxQuant was used to score
peptides for identification based on a search with an initial allowed
mass deviation of the precursor ion of up to 7 ppm. The allowed
fragment mass deviation was 20 ppm. Search of the MS/MS spectra
against the International Protein Index human data base (version 3.68,
87,061 entries) combined with 262 common contaminants was per-
formed using the Andromeda search engine (29). Enzyme specificity
was set as C-terminal to Arg and Lys, also allowing cleavage at
proline bonds and a maximum of two missed cleavages. Carbam-
idomethylation of cysteine was set as fixed modification and N-ter-
minal protein acetylation and methionine oxidation as variable mod-
ifications. MaxQuant applied time-dependent recalibration to the
precursor masses for improved mass accuracy. Further analysis of
the data provided by MaxQuant was performed in the R scripting and
statistical environment (30). The data sets used for analysis are de-
posited at Tranche (www.proteomecommons.org).
RESULTS AND DISCUSSION
Our goal was to construct a high performance quadrupole
Orbitrap mass spectrometer in a compact format. Details of
the hardware are in Experimental Procedures but here we give
a brief overview. We started by building on the Exactive
platform. The Exactive does not have mass selection capa-
bility and was developed mainly for small molecule applica-
tions (31). However, it can be equipped with a higher energy
collisional dissociation cell (HCD) at the far side of the C-trap.
Thus the detection system of the Exactive already allows HCD
fragmentation (19) albeit without mass selection. This mode is
called “AIF” for All Ion Fragmentation on this instrument and
can also be used in proteomics (23). To support mass selec-
tive MS/MS scans in the Q Exactive, the transmission from
electrospray source to vacuum was increased up to 10-fold,
for which we used the S-lens employed in the LTQ Orbitrap
Velos (18). New, rapidly switching electronics systems con-
trolling the instrument were incorporated. Apart from some
inlet ion optics changes the Orbitrap analyzer is the same as
in previous Orbitrap analyzers. The Orbitrap voltage is 5 kV as
it is on the Exactive and therefore higher than the 3.5 kV on
LTQ Orbitrap instruments. The Q Exactive also employs a 90°
bent ion path from the source toward the mass analyzer in
common with the Exactive and in contrast to the LTQ Orbitrap
instruments. The defining difference of the Q Exactive com-
pared with the Exactive is the presence of a mass selective
quadrupole analyzer between the ion source and the C-trap
(Fig. 2). This quadrupole is the same as that used in triple
quadrupole Access instruments, however, it features a mod-
ified RF-generator capable of driving selection of wide mass
selection windows.
From a practical point of view, maintenance of the Q Exac-
tive is similar to that of the Exactive. The quadrupole mass
filter has very few tunable parameters and the instrument is
automatically calibrated in a few minutes.
Mass Spectrometric Resolution—In the analysis of complex
mixtures, peptides of similar mass often co-elute and there-
fore resolution is a key parameter of a mass spectrometer in
these applications (7). Shotgun proteomics on the LTQ Or-
bitrap instruments is usually performed with 30,000 or 60,000
resolution at m/z 400. (Note that resolution decreases with the
square root of the m/z value in Orbitrap analyzers.) High
intrinsic resolution of an instrument allows short transients
and hence short cycle times in topN methods—facilitating
deep coverage of the proteome.
Because of the higher voltage of the Q Exactive, resolution
at the same transient length is 20% higher. More importantly,
we here employ eFT of the transients, which boosts resolution
by a factor 1.8 to 2.0 (for further explanation see Experimental
Methods). A similar principle has recently been described by
Marshall and coworkers for FT ICR (32).
In Fig. 3, the resolution of the Q Exactive is demonstrated
for the tetra peptide MRFA. As apparent from the widths of
the isotope peaks and by their spacing, a resolution of more
than 90,000 was achieved at m/z 524. The figure also illus-
trates the effect of turning the eFT algorithm on and off
(although in normal operation of the Q Exactive, eFT is always
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on). With eFT enabled, the instrument clearly resolves the two
isotopes of the same nominal mass that are because of two
13C carbon atoms or the sulfur atom contained in methionine
(13C2 versus
34S).
In the Exactive instrument, resolution is specified at m/z 200
because of its small molecule applications and this conven-
tion is kept in the Q Exactive. We provide a table to aid
comparison between resolution values at m/z 200 and m/z
400 used with the LTQ Orbitrap instruments for the four
possible transient lengths on the Q Exactive (Table I). The
standard 60,000 resolution scan on the LTQ Orbitrap instru-
ments uses a 768 ms transient. On the Q Exactive, a reso-
lution of 100,000 (at m/z 400) is reached with a 512 ms
transient. We use a resolution of 50,000 (at m/z 400), cor-
responding to a 256 ms transient length as a standard in
proteomics experiments. This resolution is only slightly
lower than that normally used on LTQ Orbitrap instruments,
but takes less than half of the time. For MS/MS experiments
we employ a resolution of 17,500 at m/z 200 (12,500 at m/z
400), which is achieved with a transient length of 64 ms.
This value is substantially higher than the 7,500 resolution
(at m/z 400) typical for HCD experiments on the LTQ Or-
bitrap Velos. The higher resolution in MS/MS spectra helps
in assigning fragments of large precursors, however, the 64
ms transient was mainly chosen because even shorter tran-
sients would decrease the signal to noise in the MS/MS
spectra.
Cycle Times for MS and MS/MS Analysis—As the quadru-
pole only serves as a selection device, the Q Exactive cannot
perform MS and MS/MS operations in parallel (Fig. 1). On the
other hand, the Q Exactive—unlike the LTQ Orbitrap Velos—
fills ions in parallel to Orbitrap transient acquisition. Therefore,
we next tested its overall cycle times and compared them to
other Orbitrap instruments.
For the analysis of complex peptide mixtures, topN exper-
iments consisting of a survey scan followed by N MS/MS
scans are typically performed. Depending on the complexity
of the mixture, N is usually between three and 20, and top10
is a widely used standard method. As explained above, a
transient of 256 ms results in a resolution of 50,000 (at m/z
400), which is appropriate for proteomic applications. We
combined this survey scan with ten 64 ms MS/MS scans
(resolution 12,500 at m/z 400). If accumulation of the ions to
the desired target count happened entirely in parallel with
transient detection and if there was no overhead, this method
would take 896 ms. The actually measured time for this se-
quence was 1.06 s, indicating that all overhead times together
amounted only to about 160 ms (Fig. 4). This figure even
included the automatic gain control scan performed before
each full scan (whereas fill times for MS/MS scans are deter-
mined by “predictive AGC”).
Completion of a full top10 method in about 1 s is exceed-
ingly fast and compares favorably with top10 HCD methods
on a Velos instrument. For example, the number of HCD
spectra in such a Velos based method in a recent study was
3.3 MS/MS/s over the entire gradient (4). Even compared with
top10 CID methods on the Velos instrument, which have the
advantage of parallel acquisition, the Q Exactive proved to be
faster in our hands (18). The reasons for the very fast cycle
times are fivefold: (1) eFT allows using short transient times (2)
ion filling is done in parallel with detection (3) overhead times
of electronics components have been minimized (4) precursor
FIG. 2. Construction details of the Q Exactive. This instrument is based on the Exactive platform but incorporates an S-lens, a mass
selective quadrupole, and an HCD collision cell directly interfaced to the C-trap. Note that the drawing is not to scale.
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selection is done “in space” in a few ms and (5) HCD peptide
fragmentation is nearly instantaneous.
Because of the parallel ion accumulation in the Q Exactive,
fill times shorter than the transient length do not affect the
overall cycle time. In our experiments with complex mixtures
(see below), fill times for full scans were in the range of 1 to 10
ms, and for MS/MS scans they were generally between 5 and
50 ms leading to completely parallel acquisition and detection
in almost all cases. The fill times observed here are similar to
those of the LTQ Orbitrap Velos (18), indicating comparable
sensitivity of both instrument types in full scan and HCD
MS/MS mode.
Q Exactive Performance for Proteome Analysis—To char-
acterize the performance of the Q Exactive for shotgun pro-
teomics, we prepared a digest of a mammalian cell line (Ex-
perimental Methods). The peptide mixture was separated by
on-line HPLC in a 90 min gradient by standard methods used
in our laboratories. The entire analysis was done in triplicate
and for comparison it was also performed on an LTQ Orbitrap
Velos. Fig. 5A shows a heat map of the MS signals generated
by peptides eluting from the column over the 90 min. The inset
in the heat map is a zoom of a typical region (Fig. 5B), showing
the complexity of eluting isotope patterns in this peptide
mixture derived from whole cell lysate. As can be seen on the
left hand scale, MS scans occurred every second and conse-
quently eluting peptide peaks were well sampled. The MS
spectrum in Fig. 5C depicts a single MS scan intersecting the
zoomed region and indicates a triply charged precursor that
FIG. 3. Resolution of the Q Exactive using eFT. A, Isotope cluster of the MRFA peptide from a mass scan with a 512 ms transient employing
eFT. B, Zoom into A demonstrating resolution of the 13C2 isotope from the
34S isotope. The red curve is the simulated signal for MRFA. C, The
same isotopes as in B measured with the same transient but without enabling eFT.
TABLE I
Four Q Exactive resolution settings and transient times
Resolution @
m/z  200 Th
Resolution @
m/z  400 Th
Transient length
17,500 12,500 64 ms
35,000 25,000 128 ms
70,000 50,000 256 ms
140,000 100,000 512 ms
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was selected for fragmentation. Note that on the Q Exactive
all fragmentation is performed by HCD and MS/MS spectra
are always acquired with high resolution. This enables unam-
biguous recognition of charge states as illustrated in Fig. 5D
and high fragment mass accuracy.
The data were analyzed in MaxQuant with the integrated
Andromeda search engine (28, 29). Table IIA lists the results of
the database search of the Q Exactive data. The total number
of MS scans was in excess of 5,000 and the total number of
MS/MS scans in excess of 35,000. (Note that top10 sequenc-
ing is only performed when there are sufficient peptide can-
didates in the MS scan that meet selection criteria for frag-
mentation.) The number of isotope patterns detected was
close to 150,000, a very high number considering that the
gradient was not particularly long (4, 5), presumably because
of the short MS and MS/MS cycle time of 1 s. On average
12,563 unique peptides were identified in each run, for a total
of 16,255 peptides in the triplicate analysis. These peptides
mapped to an average of 2,557 proteins per run, and a total of
2,864 proteins of the HeLa proteome with the three 90 min
gradients (supplemental Tables S1–S5).
For comparison, we performed the same analysis on an
LTQ Orbitrap Velos. As expected, significantly more unique
peptides were identified by the Q Exactive in the single LC
runs (12,253 versus 10,207 on average; increase of 23%).
Thus the Q Exactive, despite its compact format, represents
an advance in the analysis of complex peptide mixtures as
typically analyzed in shotgun proteomics. Note, however,
that the above comparison only considers relatively short
analysis of very complex mixtures and compares HCD frag-
mentation on both instruments. A detailed comparison of
the two instrument types would require additional experi-
ments and should also take into account that the Velos
instrument can perform high or low resolution CID, in addi-
tion to HCD. Furthermore, the LTQ Orbitrap Velos, unlike the
Q Exactive, is available with an ETD unit thereby providing a
complementary fragmentation approach.
Multiplexing at the MS and MS/MS Levels—The linear ion
trap Orbitrap analyzer combination is very versatile because
it is comprised of two fully functional mass spectrometers.
This allows isolation and fragmentation in different parts of
the instruments and offers considerable flexibility in com-
bining isolation and fragmentation events. Although many of
these operation modes are not possible on the Q Exactive,
it turns out that this novel combination of a mass filter and
an Orbitrap analyzer also enables unique scan events. The
principle feature making these scan modes possible is the fact
that mass selection occurs “in space” which is extremely fast
(Fig. 1). This should allow almost arbitrarily complex “mixing and
matching” of MS and MS/MS mass ranges followed by high
resolution analysis in the Orbitrap analyzer.
Fig. 6 illustrates two such multiplexed scan modes, one at
the MS level and one at the MS/MS level. In selected ion
monitoring (SIM) scans, a narrow mass range is accumulated
providing increased signal to noise for particular ions of inter-
est. SIM scans are useful in many applications but they are
not often performed on Orbitrap instruments. This is because
(1) the isolation of the SIM mass range in the linear ion trap is
relatively time consuming, (2) there is a space charge limit on
the number of ions that can be cleanly isolated, and (3) the
analysis of even a single SIM scan takes considerable time.
With few exceptions such as the lock mass injection to correct
the mass scale (33), multiple mass range filling of the Orbitrap
has not been implemented. The Q Exactive does not have the
above limitations and, for example, allows selecting several
SIM mass ranges of interest (Fig. 6A). In this mode, the C-trap
is used as a storage device, which is filled with the desired
number of ions from up to ten different SIM windows. These
ions are together injected into the Orbitrap analyzer and
measured in the same way as full mass ranges. Because fill
FIG. 4. Cycle times for a top10
method on the Q Exactive. A, Large
ticks represent the total cycle consisting
of MS and MS/MS scans. Duration for the
MS survey scans is indicated by the green
arrows (resolution 70,000 at m/z 200 or
50,000 at m/z 400) and for the MS/MS
scans by the blue arrows (resolution
17,500 at m/z 200 or 12,500 at m/z 200).
The x axis indicates chromatographic elu-
tion time and the y axis the total spectral
intensity. B, Total cycle time for a top10
method is about 1 s and fragmentation
frequency is more than 12 Hz. The lower
trace indicates parallel ion accumulation
for the following scan. Note that peptide
ion accumulation times for typical LC col-
umn loads are generally shorter than tran-
sient times (as indicated in this example)
and that they therefore do not add to cy-
cle times.
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times are typically much shorter than MS transient times,
multiplexed SIM scans use Orbitrap instrument time much
more efficiently. We demonstrate this concept in Fig. 6B–6D
where a complete HeLa cell lysate was run in a 90 min
gradient. (Note that such a gain does not occur on TOF
instruments because they are not limited by scan times.)
FIG. 5. Proteome analysis with the Q Exactive. A, Heat map of an LC MS/MS run of a peptide mixture resulting from proteolytic digestion
of a HeLa lysate. B, Zoom of a typical part of the heat map. Marks on the left hand side represent the MS survey scans of each MS and MS/MS
cycle and are separated by 1 s. C, Survey spectrum showing 50,000 resolution (at m/z 400) and the isotope pattern of a triply charged precursor
in green; the asterisk indicates a co-eluting precursor ion. D, MS/MS spectrum of the precursor shown in C with 12,500 resolution (at m/z 400)
and zoom of a doubly charged fragment ion.
Q Exactive, a Benchtop Quadrupole Orbitrap Mass Analyzer
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Three peptides known to be of low abundance from a previ-
ous top10 run were selected to define mass ranges (LTGMA-
FRVPTANVSVVDLTCR, DMIILPEMVGSMVGVYNGK, DAA-
TIMQPYFTSNGLVTK). Fig. 6B represents the full range MS
scans. In Fig. 6C and 6D, depicting a zoom into one of the SIM
windows, the peptides are clearly visible with very good signal
to noise. The ion injection time of most full scan was less than
1 ms, whereas ions for each of the SIM scans were accumu-
lated for 100 ms accounting for the drastically improved sig-
nal-to-noise. At this high sensitivity, other peptides emerged
from the background but were clearly resolved from the tar-
geted peptide. These three multiplexed SIM windows were
analyzed together in 140,000 resolution scans (0.5 s), adding
little to the overall cycle time. Switching time to position the
quadrupole at each mass window was 6 ms. Clearly such
multiplexed SIMs could play an important role in targeted
peptide analysis and peptide quantification.
In complex mixture analysis, sequencing speed can be a
limiting factor. In principle, fragmentation of several precur-
sors with simultaneous recording of the fragments can fur-
ther boost the number of analyzable MS/MS events per unit
time. Although in principle possible with a linear ion trap, in
practice the necessary multiple rounds of peptide isolation
and fragmentation preclude such an option on the LTQ
Orbitrap. The Q Exactive, however, can successively isolate
different precursor ions and fragment them in the HCD cell
each at an individual normalized collision energy suitable for
its properties. As each population of precursor ions is only
FIG. 6. Multiplexing at the MS level.
A, The quadrupole mass filter is set to
transmit a specific SIM mass range. Af-
ter accumulation of the desired number
of ions, the quadrupole is rapidly
switched to the next SIM window up to
the total number of SIM windows to be
monitored. The combined SIM ranges
are analyzed together in one high-reso-
lution scan as shown in cartoon form in
the inset. B, Three-dimensional repre-
sentation of a 4-min segment of full
range MS scans from a 90 min LC run of
HeLa peptides. C, Visualization of the
data from triplex scans acquired directly
after each full scan in the same segment.
Signals of the targeted low abundant
peptides are clearly visible in the three
SIM scans in C but virtually absent in
the full scans in B. D, Zoom of one of the
SIM ranges in C show that the SIM range
contains peptides of even lower abun-
dance than the targeted one marked
with the dark blue arrow.
TABLE II
A, Peptide identification from HeLa lysate triplicate analysis on a Q Exactive (90 min gradient)
MS spectra MSMS spectra Identifications % Unique peptides Proteins Isotope clusters
HeLa (1) 5427 35203 37.23 12298 2513 146138
HeLa (2) 5098 35911 38.35 12830 2601 143556
HeLa (3) 5274 35348 38.23 12560 2557 144336
 Triplicates 37.94 16255 2864
B, Peptide identification from HeLa lysate triplicate analysis on an LTQ Orbitrap Velos (90 min gradient)
MS spectra MSMS spectra Identifications % Unique peptides Proteins Isotope clusters
HeLa (1) 2012 19818 55.64 10420 1895 125738
HeLa (2) 2102 19103 56.64 9855 1843 120553
HeLa (3) 2005 19634 56.37 10347 1906 126717
 Triplicates 56.21 14401 2242
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fragmented once during injection into the HCD cell, all frag-
ment ions are stored successively in the HCD cell and then
they undergo joint analysis in the Orbitrap analyzer (see Fig.
7A). To demonstrate this, we specified a top10 method with
multiplex degree of two. Fig. 7B shows a representative
example of a multiplexed MS/MS spectrum analyzed at the
normal MS/MS resolution setting of 12,500 (at m/z 400).
Visual inspection of the spectrum clearly reveals extensive
sequence information from both sequences. Interpretation
of these deliberately multiplexed spectra, as opposed to
cofragmented precursors, is aided by the fact that the same
number of ions can be fragmented for each targeted pre-
cursor. Although it is clear that multiplexed MS/MS scans
are easily possible on the Q Exactive platform, further in-
vestigations will be necessary to determine any resulting
gain in peptide identifications. However, increased se-
quencing speed is not the only application of multiplexed
MS/MS. As an example, the fragmentation of different
charge states of multiply charged proteins could yield inter-
esting structural information.
Conclusions and Outlook—We have described the con-
struction and initial performance evaluation of a new type of
mass spectrometer, the combination of a quadrupole mass
filter with the Orbitrap analyzer. The quadrupole is one of the
most robust and mature mass filters. Its combination with the
relatively recently introduced Orbitrap mass spectrometer al-
lowed realization of a high performance instrument with a
small footprint and straightforward operation. These charac-
teristics make the instrument an interesting addition to the
proteomics toolbox, especially as proteomics is performed
more and more by nonspecialist groups with biological or
biomedical background.
Performance of the Q Exactive for complex peptide mixtures
compares well with current LTQ Orbitrap instruments such as
the LTQ Orbitrap Velos. Although the Q Exactive only offers the
HCD fragmentation mode, we have shown here that HCD
speed and sensitivity are not limiting. In fact, parallel filling of the
ions combined with nearly instantaneous ion selection and frag-
mentation allowed implementation of a top10 method with 1-s
cycle times. In comparison, the MS/MS scan rate of quadrupole
TOF instrumentation could reach nominal speed up to 50
MS/MS per second, but, because of the lower transmission of
TOF, signal to noise in each scan will be severely compromised
unless high sample loads are used. An interesting novel feature
of the Q Exactive is its ability to multiplex MS and MS/MS mass
ranges, almost without limitations, which we have demon-
strated here with two examples: multiplexed SIM mass ranges
and multiplexed MS/MS spectra. In contrast to quadrupole TOF
instrumentation, where scan speed in SIM mode is limited
mainly by the time needed to reach acceptable signal to noise
ratio, multiplexed SIM scans allow decoupling spectral acquisi-
tion speed from the speed of acquiring SIM scans and thus to
utilize the full high transmission to the Orbitrap analyzer. We
anticipate that the Q Exactive will enable additional interesting
multiplexing capabilities in the future.
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Ultra High Resolution Linear Ion Trap Orbitrap
Mass Spectrometer (Orbitrap Elite) Facilitates
Top Down LC MS/MS and Versatile Peptide
Fragmentation Modes*□S
Annette Michalski‡**, Eugen Damoc§**, Oliver Lange§, Eduard Denisov§, Dirk Nolting§,
Mathias Müller§, Rosa Viner¶, Jae Schwartz¶, Philip Remes¶, Michael Belford¶,
Jean-Jacques Dunyach¶, Juergen Cox‡, Stevan Horning§, Matthias Mann‡,
and Alexander Makarov§
Although only a few years old, the combination of a linear
ion trap with an Orbitrap analyzer has become one of the
standard mass spectrometers to characterize proteins
and proteomes. Here we describe a novel version of this
instrument family, the Orbitrap Elite, which is improved in
three main areas. The ion transfer optics has an ion path
that blocks the line of sight to achieve more robust oper-
ation. The tandem MS acquisition speed of the dual cell
linear ion trap now exceeds 12 Hz. Most importantly, the
resolving power of the Orbitrap analyzer has been in-
creased twofold for the same transient length by employ-
ing a compact, high-field Orbitrap analyzer that almost
doubles the observed frequencies. An enhanced Fourier
Transform algorithm—incorporating phase information—
further doubles the resolving power to 240,000 at m/z 400
for a 768 ms transient. For top-down experiments, we
combine a survey scan with a selected ion monitoring
scan of the charge state of the protein to be fragmented
and with several HCD microscans. Despite the 120,000
resolving power for SIM and HCD scans, the total cycle
time is within several seconds and therefore suitable for
liquid chromatography tandem MS. For bottom-up pro-
teomics, we combined survey scans at 240,000 resolving
power with data-dependent collision-induced dissocia-
tion of the 20 most abundant precursors in a total cycle
time of 2.5 s—increasing protein identifications in com-
plex mixtures by about 30%. The speed of the Orbitrap
Elite furthermore allows scan modes in which comple-
mentary dissociation mechanisms are routinely obtained
of all fragmented peptides. Molecular & Cellular Pro-
teomics 11: 10.1074/mcp.O111.013698, 1–11, 2012.
In many mass spectrometric applications, the resolving
power of the instrument is of pivotal importance. Ultimate
resolution has so far been obtained by Fourier Transform
Mass Spectrometry (1) and in a recent example, Marshall and
co-workers detected more than 26,000 components in a sin-
gle spectrum of a crude oil mixture (2). In ion cyclotron reso-
nance (ICR)1 Fourier transform mass spectrometry, resolution
is determined by the length of the transient and by the
strength of the magnetic field. Increasingly larger magnets
have allowed resolution in excess of one million for small
molecules. The relatively recently introduced OrbitrapTM ana-
lyzer utilizes a different physical principle to obtain high res-
olution (3–6). The signal is recorded from the image current
produced by ion packets which oscillate around and along the
spindle-shaped inner electrode of the trap: the higher the
electric field, the larger the number of oscillations per unit time
and the higher the resolving power. To increase field strength,
several design options can be pursued, including increasing
the radius of the inner electrode of the device (7). Here we
describe an Orbitrap analyzer that achieves higher resolving
power through reduced trap dimensions. Resolution is further
increased by making use of the phase information during
Fourier Transformation (8–11). This ultra high resolution Or-
bitrap analyzer was combined with other instrumental im-
provements to construct a novel linear ion trap Orbitrap hybrid
mass spectrometer termed the Orbitrap Elite.
We describe principles of this instrument and characterize
its operation for both intact protein analysis and for bottom up
peptide mixture analysis. Top down protein analysis has pre-
viously mainly been performed with Fourier transform (FT) ICR
instruments because of their very high resolving power (12–From the ‡Department of Proteomics and Signal Transduction,
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14). One of the challenges in using top down approaches in
proteomics has been to obtain cycle times commensurate
with liquid chromatography tandem MS (LC MS/MS) time
scales (15). The linear ion trap Orbitrap has also been em-
ployed for top down proteomics (16–19). Here we take ad-
vantage of the ultra high resolution of the Orbitrap Elite to
enable fast LC MS/MS compatible top-down scan methods.
In bottom-up proteomics typically very complex peptide
mixtures are analyzed (20–22). Online LC MS runs contain
evidence for tens of thousands of peptides (23, 24) and this
places a premium on the resolution of the survey (MS) scans.
A popular shotgun proteomics method on the linear ion trap
Orbitrap (LTQ Orbitrap or LTQ Orbitrap Velos) is a “1 s” survey
scan with 60,000 resolution at m/z 400 (768 ms transient), and
ion trap collision-induced dissociation (CID) scans of the ten
or twenty most abundant ions (“high resolution” “low resolu-
tion” or “high–low” top10 method). Here we explore topN
methods with much higher resolution survey scans as well as
an increased number of fragmentation events per cycle en-
abled by “rapid CID” scans. A “high–high” strategy (high
resolution MS as well as MS/MS (25)) has been routinely made
possible on Orbitrap instruments by higher energy collisional
dissociation (HCD) with the advent of the LTQ-Orbitrap Velos
(26). We show that this strategy benefits from the shorter
transients and higher resolving power possible on the Or-
bitrap Elite.
It has been demonstrated that a combination of two frag-
mentation methods can greatly augment sequence related
information in peptide MS/MS (27–29) and we explore this
dual approach with CID and HCD fragmentation of the same
precursor ions.
EXPERIMENTAL PROCEDURES
The Orbitrap Elite is a further development of the LTQ Orbitrap
Velos (26). This hybrid instrument combines a Velos PRO dual cell
differential pressure linear ion trap mass spectrometer with a high
field Orbitrap mass analyzer (Fig. 1A). The Velos PRO builds on the
LTQ Velos (30) and its extensions include (1) a new generation of ion
optics consisting of a 45° rotated bent quadrupole Q0, a neutral beam
blocker, and an octopole ion transfer device, (2) faster ion trap mass
analysis scan speed of 66,000 amu/s, and (3) a higher dynamic range
detection system for improved quantitation performance, and (4) the
addition of beam-type collisional dissociation capabilities for the
stand-alone ion trap system.
New Generation Ion Optics—The S-lens consists of a set of stain-
less steel apertures to which an RF voltage is applied, alternate lenses
having opposite (180°) phase. This device is used in a high pressure
regime (low millibar) to efficiently focus the ion beam emerging from
a transfer tube through a final exit lens (31). Droplets and solvent
clusters exiting the transfer tube are kept from passing into the
downstream ion optics by a curved quadrupole ion guide. The ion
guide has been rotated 45° with respect to the orientation in the LTQ
Velos so that noncharged droplets and solvent clusters can pass
through the gap between the quadrupole rods, rather than impinge on
the rod surface itself. This significantly reduces the potential for
contamination of the quadrupole ion guide. The new geometry allows
for a stainless steel rod to be positioned in the region of curvature of
the quadrupole ion guide where it serves as a neutral beam blocker.
The combination of the 45° rotated quadrupole ion guide and the
neutral beam blocker reduces the rate of contamination and improves
the longevity of the ion optics system. A short octopole, Q00 (r0 5.56
mm, rod diameter 2 mm, length 28.58 mm operated at 3 MHz, 800
Vpp), located between the exit lens and curved quadrupole, has also
been added and replaces the quadrupole device in this region in the
LTQ Velos. This octopole tends to be more robust to contamination
and it is also used as a dissociation device in the stand-alone Velos
PRO (32).
Faster Scan Speed—The dual cell differential pressure linear ion
trap allows for substantially accelerated scan rates and higher reso-
lution owing to the lower pressure in the mass analyzing cell of the ion
trap (30). The normal scan rate on the LTQ Velos is 33,000 amu/s,
which typically achieves peak widths of 0.34 amu at m/z 1822 and is
sufficient to separate isotopes of triply charged ions. By optimizing
operating conditions such as the resonance ejection amplitude and
the phase relationship between the resonance ejection and trapping
RF signals, a small sacrifice in resolution can give a large improve-
ment in scan rate. In the Velos PRO, the scan rate has been doubled
to 66,000 amu/s while still maintaining better than unit resolution,
achieving an average peak width at half height of 0.47 amu at m/z
1822. With this rapid scan rate up to 12.5 MS/MS scans can be
performed per second (rapid CID or rCID).
Higher Dynamic Range Detection System—Because of the faster
scan rates the ion currents generated when performing mass analysis
are also increased. Therefore, a higher dynamic range detection
system is required. Discrete dynode electron multipliers have been
developed (SGE Analytical Science Pty Ltd, Australia) that replace the
continuous channel electron multipliers in the LTQ Velos. These new
electron multipliers have linear outputs up to 160 A yielding six
orders of magnitude dynamic range. A 24 bit analog-to-digital con-
verter is employed in the electrometer circuitry which matches the
performance of the discrete dynode multipliers. The wider linear
dynamic range of this detection system increases the precision and
accuracy for doing quantitative analysis while also offering enhanced
limits of detection.
High-field Orbitrap Analyzer—The Orbitrap mass analyzer generally
consists of an outer barrel-like electrode of maximum radius R2 and
a central spindle-like electrode along the axis of maximum radius R1,
with the outer electrode maintained at the virtual ground of the pre-
amplifier, while the central electrode is at a voltage -Ur (Ur0 for
positive ions) (3). In a standard Orbitrap analyzer, R1  6 mm and
R2  15 mm (5), whereas the high-field analyzer described here is
more compact with R1  5 mm and R2  10 mm (Fig. 1C), i.e. the
outer electrode is scaled down by a factor of 1.5. Similarly to an
analyzer described recently (7), a decrease of the R2/R1 ratio from 2.5
to 2 allows an increase in the frequency in addition to the above
scaling factor, thus bringing the total gain of frequency to 1.8-fold.
This is accompanied by an increase of the injection ion energy of
1.4-fold. Despite the increase in space charge density in the ana-
lyzer by a factor of (1.5)3  3.4, the additional shielding provided by
the relatively thicker central electrode keeps space-charge induced
frequency shifts even slightly below those in the standard analyzer.
As the injection slot was scaled down by the same factor as
the outer electrode to avoid compromising the quality of the field
inside the analyzer, an additional focusing of the incoming ion beam
became necessary. This was achieved by adding a miniature Einzel
lens in the form of a 1-mm plate with a 2 mm ID orifice at a voltage of
up to 1000 V, which was sandwiched between two similar plates at 0
V and separated by gaps of 1 mm. This assembly was mounted on the
same block as the deflector at the entrance to the Orbitrap analyzer.
Scaling down of the outer electrodes appeared also to slightly
reduce their capacitance to ground and to each other, which in turn
allowed the use of lower-capacitance transistors in the image current
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preamplifier. The resulting sensitivity increase of about 30% resulted
in the same signal-to-noise ratio for the same number of ions as in the
standard analyzer even for twice shorter transients.
We found that reduction of the gap between the outer and the central
electrodes requires an almost proportional improvement of machining
accuracy of the electrodes. This was achieved by rigorous refinement of
the existing manufacturing and measurement techniques.
Transient Processing with eFT—FT of a digitized transient is a fast
processing method but it requires relatively long detection times to
achieve high resolving powers. It is thus desirable to further increase
the resolving power for a given acquisition time. We applied a newly
developed enhanced version of the Fourier Transformation (eFT™),
which is also employed in another novel instrument, the Q Exactive
(11). Details of the technique can be found in ref (10). Briefly, both eFT
and conventional FT make use of complex numbers, which can be
represented by magnitude and phase. As the initial phase of the ion
package typically depends on initial parameters of the ions in a very
complicated way (8), FT spectra normally have to be presented in the
so-called magnitude mode, which amounts to disregarding the phase
information. However, in Orbitrap mass spectrometers the built-in
excitation-by-injection mechanism (33) provides an initial phase of ion
oscillations that is almost independent of m/z. This synchronization
allows converting spectra in such a way that they correspond to zero
initial phase for all m/z values (so-called absorption spectra) and
exhibit narrower peaks. In practice, eFT uses a combination of mag-
nitude and absorption spectra along with Hanning apodization, triple
zero-filling, and additional filtering to improve mass accuracy and
peak shape.
Better accuracy of spectra conversion is achieved if detection
starts as early as possible after ion injection. Therefore, the following
modifications of the preamplifier and Orbitrap analyzer were intro-
duced: (1) High-speed diode bridges have replaced mechanical relays
that were previously used for protection of the preamplifier during
pulsing of the Orbitrap central electrode, such that the preamplifier is
always ready for detection, (2) the capacitance between deflector at
the entrance to the Orbitrap analyzer and each of detection elec-
trodes was balanced by modifying the deflector geometry, (3) the
capacitance between each of detection electrodes and ground was
reduced and also balanced by replacing ceramic isolators with quartz
ones as well as by changing the geometry of the Orbitrap holder. (4)
The capacitance between Einzel lens elements at the entrance to the
Orbitrap analyzer and each of these detection electrodes was mini-
mized by implementing this lens as a miniature ceramic printed-circuit
board.
Together, these measures allowed reducing the delay between ion
injection and start of transient detection from almost 10 ms to a
fraction of a millisecond. In addition to improved eFT, this reduction of
delay allows to capture the entire first beat of the transient (see e.g.
(34)) even for large proteins like intact antibodies and therefore sig-
nificantly improves sensitivity of Orbitrap detection for top down
analysis.
The practical implementation of the eFT achieves up to twofold
increase of resolving power for the same transient. For rapidly decay-
ing signals, for example from proteins, this gain is reduced to about
1.4-fold because of background collisions (8). The dual-spectrum
online processing is computationally demanding but still fast enough
to be completed in the LC MS time scale. Thus cycle time is still
determined by transient acquisition and ion injection times and not by
processing of the data. The eFT method is sensitive to precise syn-
chronization of the instrument electronics and remaining shot-to-shot
jitter, so that final mass accuracy is comparable to that of traditional
magnitude mode FT spectra. Side-lobes in eFT spectra are compa-
rable to those in conventional FT spectra.
Sample Preparation—Intact proteins (all from Sigma Aldrich) were
dissolved in buffer A (98% water, 2% acetonitrile (ACN), 0.1% formic
acid) prior to LC MS analysis. For direct infusion experiments, protein
stock solutions were diluted in 50% ACN, 50% water, 0.1% formic
acid.
HeLa cells were lysed in urea (6 M) and thiourea (2 M) solution. The
protein mixture was reduced with dithiotreitol (1 mM) for 30 min at
room temperature and alkylated with iodoacetamide (55 mM) for 20
min. The proteins were first digested with LysC (1 g/50 g protein)
(Wako, Richmond, VA) for 3 h at room temperature. The sample was
diluted (1:4) with water before 12 h incubation with trypsin (1 g/50 g
protein) (Promega, Charbonnières, France) at room temperature. For-
mic acid (3%) was added to the mixture to quench enzyme activity.
The peptide mixture was desalted on reversed phase C18 StageTips
(35) and eluted into 8 well autosampler vials with 60 l buffer B (80%
ACN in 0.5% acetic acid). ACN was removed in a SpeedVac concen-
trator. The sample volume was adjusted with buffer A* (2% ACN in
0.1% TFA) to 12 l.
LC MS/MS Analysis—Intact proteins were separated on a nano-
bore analytical column (75 m ID  10 cm) with an integral fritted
nanospray emitter (PicoFrit®, New Objective, Inc., Woburn, MA) con-
taining 5 m polymeric reversed-phase media (1000 Å pore size)
using an EASY-nLC system (Thermo Scientific), which was oper-
ated at a flow rate of 300 nL/min. A linear gradient of each 20 min
10–50% buffer B and 50–80% buffer B (80% ACN in 0.1% formic
acid) was applied. This setup was extended with a trap column (150
m ID  2 cm) containing identical chromatographic material. MS
data were acquired by a relatively low resolution survey scan (10
microscans, resolution 15,000 at m/z 400), followed by a data
dependent selected ion monitoring (SIM) scan of the most abun-
dant (5 microscans, resolution 120,000 at m/z 400, isolation width
10 Th) and a data dependent HCD scan of the most abundant ion
of the SIM scan (5 microscans, resolution 120,000 at m/z 400,
isolation width 10 Th, normalized collision energy 18%). Dynamic
exclusion duration of 10 s was enabled. A cycle time of 5.8 s was
achieved. A modified method in which the data dependent SIM
scan was replaced by a data dependent HCD scan at a different
normalized collision energy, was used to increase the number of
identified fragment ions.
The peptide mixture from a tryptic HeLa digest was separated with
a linear gradient of 5–60% buffer B (80% ACN and 0.5% acetic acid)
at a flow rate of 300 nL/min on a C18-reversed phase column (75 m
ID  15 cm) packed in-house with ReproSil-Pur C18-AQ 3 m resin
(Dr. Maisch GmbH) in buffer A (0.5% acetic acid). An Easy-nLC
chromatography system (Thermo Scientific) was on-line coupled to
the Orbitrap Elite instrument (Thermo Scientific) via a Nanospray Flex
Ion Source (Thermo Scientific). MS data were acquired in a data-de-
pendent strategy selecting the fragmentation events based on the
precursor abundance in the survey scan (300–1650 Th). The resolu-
tion of the survey scan was varied between 60,000, 120,000, and
240,000 at m/z 400 Th with a target value of 1e6 ions and 1 or 2
microscans. Low resolution CID MS/MS spectra were acquired with a
target value of 5000 ions in normal and rapid CID scan mode. MS/MS
acquisition in the linear ion trap was partially carried out in parallel to
the survey scan in the Orbitrap analyzer by using the preview mode
(first 192 ms of the MS transient). The maximum injection time for
MS/MS was varied between 25 ms and 200 ms. HCD MS/MS spectra
were acquired with a resolution of 15,000 and a target value of
40,000, setting the first mass to 120 Th. Dynamic exclusion was 60 s
and early expiration was disabled. The isolation window for MS/MS
fragmentation was set to 2 Th.
Data Analysis—High-resolution mass spectra of the intact proteins
were deconvoluted using the Xtract software (Thermo Scientific) and
further processed with ProSightPC (36, 37) (Thermo Scientific). The
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analysis of the mass spectrometric RAW data was carried out using
the MaxQuant software environment (developmental version 1.2.0.23)
applying standard settings unless otherwise noted. Peptide scoring
for identification is based on a search with an initial allowed mass
deviation of the precursor ion of up to 7 ppm. To further improve the
precursor mass accuracy a time-dependent recalibration algorithm
was applied. Fragment mass tolerance was 0.5 Da for low resolution
and 20 ppm for high resolution spectra. Enzyme specificity was
defined as C-terminal to Arg and Lys including proline bond cleavage
and a maximum of two missed cleavages. Carbamidomethylation of
cysteine was set as fixed modification and N-terminal protein acety-
lation and methionine oxidation as variable modifications. MS/MS
spectra were searched against the IPI human data base (version 3.68,
87,061 entries) combined with 262 common contaminants by the
Andromeda search engine, with 2nd peptide identification enabled
(38). The FDR for proteins and peptides (which had to have at least 6
amino acids) was set to 0.01. Results provided by MaxQuant were
further analyzed using the R scripting and statistical environment. The
data sets are provided at Tranche (www.proteomecommons.org) us-
ing the following hash: ZtXTc5NwSIxEwDzZKlD3b14XYnUCo7nKb-
WAnIGRZXORy3eoXWSodhh/w7SZBxTAZbqoDPDs8FGkVcBB-
pe8N1fC1M1EAAAAAAAANYw.
RESULTS AND DISCUSSION
Overview of the Orbitrap Elite—Like its predecessors, the
LTQ Orbitrap and LTQ Orbitrap Velos, the instrument is a
combination of two mass analyzers, a linear ion trap and an
Orbitrap mass analyzer (Fig. 1). It offers up to three fragmen-
tation modes, CID or ETD in the dual linear ion trap, or HCD in
its dedicated collision cell. The fragment ions produced by
CID or ETD are normally analyzed in the ion trap at low
resolution and in parallel with the acquisition of the MS tran-
sient. However, they can also be transferred to the C-Trap
and recorded in the Orbitrap analyzer. HCD fragments are
always analyzed in the Orbitrap analzyer.
In the Orbitrap Elite instrument, as discussed in detail in
EXPERIMENTAL PROCEDURES, the interface optics in the
front part of the instrument now incorporates a rotated square
transfer quadrupole with a beam blocker preventing neutral or
low charged material from passing. The dual ion trap was
equipped with new electron multipliers that tolerate up to
10-fold higher ion currents, which improves the dynamic
range of the device. This in turn allowed further speed-up of
the low resolution CID fragmentation mode. This scan mode
was named rCID for rapid CID and it allows acquisition of up
to 12.5 MS/MS spectra per second (EXPERIMENTAL PRO-
CEDURES). The changes in interface optics together with the
improved dual ion trap constitute the Orbitrap Velos Pro in-
strument, whereas the central feature of the Orbitrap Elite
instrument described in this publication is a novel Orbitrap
analyzer with drastically improved resolving power.
A detailed description of the principles and construction of
the novel Orbitrap analyzer is given in EXPERIMENTAL PRO-
CEDURES. Briefly, the major hardware change was a reduc-
tion in the inner diameter of the outer electrode from 30 to 20
mm whereas the size of the spindle-shaped inner electrode
was only reduced from 12 to 10 mm (Fig. 1C). These smaller
dimensions, with an increased ratio of inner to outer electrode
FIG. 1. The Orbitrap Elite mass spectrometer. A, Novel elements compared with the LTQ Orbitrap Velos are highlighted and encompass
the source region, the dual linear ion trap and the Orbitrap analyzer. ETD fragmentation is optional. B, Computer model of the inlet ion optics,
showing the S-lens on the left and the dual ion trap on the right. The bent, square transfer quadrupole allows neutrals to leave the ion optics
and impinge on the depicted beam blocker. C, Comparison of dimensions of the standard (left) to the compact, high-field Orbitrap analyzer
(right).
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diameters, lead to a higher field strength, resulting in almost
doubling of the resolving power at the same scan time. An
improved signal processing algorithm (eFT), which takes
phase information into account (EXPERIMENTAL PROCE-
DURES), provides a further boost by a factor up to 2. To-
gether, the Orbitrap Elite instrument achieves about fourfold
higher resolution at the same transient length. This translates
into 240,000 resolution at m/z 400 with the standard 768 ms
transient—a radical improvement over the 60,000 resolving
power achieved by the predecessor instrument. This very high
resolution per unit time can alternatively be used to shorten
cycle times at the same resolving power. An overview of the
different resolution settings as a function of transient length can
be found in Table I. Even the shortest transient (48 ms), results
in a resolving power of 15,000, twice that of the 96 ms scan
typically used for MS/MS on the Orbitrap Velos. In principle,
even shorter transients would produce sufficient resolution for
MS/MS. However, we decided against such scan modes be-
cause the ratio of useful transient time compared with overhead
times and ion filling times would become unfavorable.
Top Down at an LC Time Scale—High resolution is an
important requirement for resolving the different charge states
of intact proteins investigated in top-down proteomics. We
selected carbonic anhydrase II, a frequently used standard in
top-down proteomics, to investigate the advantages of the
increased resolving power and sequencing speed of the in-
strument. We devised a method that alternates between a
survey scan with 15,000 resolution followed by a high reso-
lution SIM scan of a particular charge state acquired in a data
dependent manner. This same precursor m/z is subsequently
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FIG. 2. Top down method at an LC time scale. Total ion chromatogram of an LC separation of carbonic anhydrase II (29 kDa). Fast survey
scans reveal the charge envelope and are followed by high resolution SIM and HCD scans. Overlapping fragment isotope distributions are
clearly resolved from each other.
TABLE I
Resolution and transient length of Orbitrap hybrid instruments. The
highest resolution on Orbitrap Elite (indicated by an asterisk) can only
be activated when using the developer’s kit
Resolution
Transient
LTQ Orbitrap Orbitrap Elite
– 15,000 48 ms
7500 30,000 96 ms
15,000 60,000 192 ms
30,000 120,000 384 ms
60,000 240,000 768 ms
120,000 480,000* 1536 ms
Ultrahigh Resolution Linear Ion Trap Orbitrap Instrument
Molecular & Cellular Proteomics 11.3 10.1074/mcp.O111.013698–5
55
fragmented by HCD and analyzed at a high resolving power of
120,000 (Fig. 2). We found that the Orbitrap Elite is capable of
isotopically resolving and measuring this 29 kDa protein with
a root mean square mass accuracy below 2 ppm under these
conditions. Averaging times for five to six microscans of the
HCD fragmentation spectra were much shorter than in the
LTQ Orbitrap Velos, without reducing signal-to-noise. Decon-
volution with Xtract of a single, six microscan HCD spectrum,
in which charge state 34 carbonic anhydrase was frag-
mented, revealed 30 b-type and 31 y-type ions (sup-
plemental Fig. S1). For enolase (46.6 kDa), 15 b-type and 20
y-type ions were identified following fragmentation of the 58
precursor charge state by HCD. For both of these model
proteins optimizing the MS/MS parameters such as increas-
ing the collision energy but mainly averaging of up to 24
microscans increased the number of identified fragment ions
to 49 b-type and 48 y-type ions for carbonic anhydrase II and
30 b-type and 42 y-type ions for enolase (supplemen-
tal Fig. S1).
Ultrahigh Orbitrap Resolution for Top Down Experiments—
The implementation of the compact Orbitrap analyzer and eFT
signal processing allows the Orbitrap Elite to reach a compa-
rably high resolution as a 17 Tesla FT ICR instruments at m/z
400 Th and with standard signal processing methods. In
contrast to the inversely linear dependence of FT ICR resolv-
ing power on m/z, however, the Orbitrap resolving power is
inversely proportional to the square root of m/z (1). Therefore,
for subsecond acquisition on an LC-MS time scale its resolv-
ing power at m/z 1000 already corresponds to a 25 Tesla
FT-ICR instrument, and it should be particularly suitable for
top down experiments of larger proteins such as BSA (66.4
kDa) and enolase (46.64 kDa). Using static electrospray con-
ditions we found that charge state 47 of intact yeast enolase
could readily be baseline resolved at a resolution setting of
240,000 corresponding to 768 ms transients (Fig. 3A). To
reach this resolution, a vacuum better than 1010 Torr was
necessary. On the predecessor instrument, partial resolution
of intact yeast enolase could occasionally be observed (Fig.
3B).
Parallel topN CID Method for Bottom Up Proteomics—For
the analysis of complex peptide mixtures, a standard mode of
operation is the acquisition of a survey spectrum in the Or-
bitrap analyzer while the linear ion trap isolates, dissociates,
and scans the fragments. For this “high-low” mode, we eval-
uated the influence of the higher resolution in the survey
spectra and of the faster MS/MS scans. LTQ Orbitrap instru-
ments select precursors for fragmentation on the basis of a
snapshot or preview spectrum—the first 192 ms of the MS
transient—after which time the CID scans are initiated in the
LTQ. However the resolution is increased fourfold, allowing
isotopic resolution for all charge states and the entire m/z
range (300–1650) at higher signal-to-noise. We found that this
increased the quality of precursor ion selection.
To investigate the instrument capability for the analysis of
very complex peptide mixtures such as HeLa cell lysate, we
started with a digested standard of 400 ng that was ana-
lyzed using different methods. Comparison of the normal
CID and rapid CID scan modes revealed that rCID produced
significantly more fragmentation events and therefore this
mode was chosen for all subsequent experiments. The
scheme in Fig. 4A shows the timing sequence of MS and
MS/MS scans at different MS transient lengths. For a 192
ms survey scan, resolution is 60,000 and there is no parallel
operation between MS and MS/MS scans. Due to rCID an
entire top20 method takes 2.7 s, easily compatible with
peptide LC elution profiles. At 384 ms resolution is 120,000
and a few MS/MS scans are performed in parallel with the
survey scan. At the full 768 ms transient (240,000 resolu-
tion), about six CID spectra are performed in parallel, while
total cycle time is still unchanged (Fig. 4A). Therefore, the
longest transients appear to be advantageous because the
increased resolution comes “for free” as it does not cost
extra measurement time.
We make use of the fixed cycle time to explore the benefits
of high resolving power on complex peptide mixture analysis.
Three top20 methods were established as outlined above
using 60,000, 120,000, and 240,000 resolution for the survey
scan (Fig. 4A). When analyzing the HeLa peptide mixture with
these methods, we found that the number of potential peptide
features (isotope clusters) detected by MaxQuant, nearly dou-
bled from 93,000 at 60,000 resolution to 148,000 at 240,000
resolution under otherwise identical conditions (Table II). Fig.
4B shows a zoom into the LC MS map of the 240,000 reso-
FIG. 3. Isotope resolved spectrum of enolase with Orbitrap Elite
and LTQ Orbitrap Velos instruments. Spectra were acquired with
transients of A, 768 ms on the Orbitrap Elite and B, 1536 ms on the
LTQ Orbitrap Velos. In these conditions, the superior resolution of the
Orbitrap Elite instrument (2  higher in 2  shorter transient time)
helps to baseline resolve the 47 charge state of the intact yeast
enolase.
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lution versus the 60,000 resolution run and demonstrates the
rich feature set in complex peptide mixtures with 540 versus
320 isotope clusters, respectively.
ICR Fourier transform mass spectrometry measurements of
small molecules can resolve the fine structure in the isotope
patterns of small molecules (isobaric species with the same
nominal mass) (39), although to our knowledge this has not
yet been reported in proteomics LC MS/MS experiments. We
inspected the methionine and cysteine containing peptides
and found that the 34S isotope and 13C2 peaks (M  0.011
FIG. 4. Parallel CID top20 method and ultra high resolution survey scans. A, High resolution MS scan at three different transient lengths
followed by 20 CID MS/MS scans in the linear ion trap. Note that cycle time is unaffected by the resolution of the full scan. Preview refers to
the portion of the survey scan that is used to select precursor ions for fragmentation. B, LC MS heat map of peptides eluting over a 3 min elution
time interval in a 40 Th range. More detail is visible in the ultra high resolution setting (left panel) compared with the normal resolution setting
(right panel). C, Separation of isobaric species in standard LC MS/MS analysis. The 34S isotope containing peak is clearly resolved from the
13C2 isotope.
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Da) were clearly resolved from each other (Fig. 4C). Thus, the
high resolution immediately indicates the presence of a sulfur
atom in the peptide.
Based on the above observations, we selected a 240,000
resolution survey scan and top20 CID scan as the standard
high-low method. Analysis of the 2h gradient of the 400 ng
HeLa peptide sample identified 11,543 unique peptides and
2268 proteins (supplemental Tables. S1–S4), an increase of
25–30% over the analysis of the same sample on the LTQ
Orbitrap Velos. Although not demonstrated here, quantifica-
tion accuracy was also observed to increase due to the sev-
eral-fold higher resolution.
High Resolution MS/MS Methods—The Orbitrap Elite offers
CID, HCD and optional ETD fragmentation modes. Analysis of
the fragments is either in parallel mode in low resolution in the
linear ion trap (for CID and ETD) or in sequential mode in the
Orbitrap analyzer (for CID, ETD, and HCD). In principle, all
these modes can be mixed and matched according to the
analytical question under investigation. Fig. 5 depicts three
prototypical combinations of scan modes. In a pure HCD
mode, a survey scan is acquired and is followed immediately
by N HCD spectra that are also recorded in the Orbitrap
analyzer. A 384 ms survey scan already provides resolution of
120,000, which is adequate for most applications and which
helps to limit the overall cycle time in this mode. HCD spectra
are acquired at the lowest possible resolution (48 ms tran-
sients; 15,000 resolution at m/z 400). A complete top15 se-
quence takes 3.3 s, about the same time required for a top10
method with half the resolution in MS and in MS/MS mode in
the predecessor instrument. We measured the 400 ng HeLa
cell lysate sample with this method and obtained significantly
improved numbers of peptide identifications compared with
FIG. 5. Combinations of fragmentation modes. A, Sequential mode in which a high resolution survey scan with 120,000 resolution (384 ms)
is followed by 15 HCD scans at 15,000 resolution (48 ms transients). B, Parallel and sequential mode in which an ultra high survey scan with
240,000 resolution is acquired in parallel with 10 rCID spectra in the linear ion trap and in sequence with 10 HCD scans that are analyzed in
the Orbitrap analyzer. The same precursors are analyzed by rCID and HCD. C, Double sequential mode in which a 120,000 resolution survey
scan is followed by 5 high resolution CID and 5 HCD spectra of the same precursors.
TABLE II
Number of isotope clusters depending on survey scan resolution at
equal cycle time
Resolution Cycle time MS scans Isotope clusters
60,000 2.76 1902 93,624
120,000 2.87 1821 124,808
240,000 2.85 1843 148,085
TABLE III
Protein and peptide identification from HeLa duplicate analysis of a top15 HCD method
MS spectra MSMS spectra Identifications 	%
 Unique peptides Proteins Isotope clusters
HCDtop15(1) 1556 23,211 45.77 10,847 2082 116,632
HCDtop15(2) 1538 22,930 45.82 10,633 2064 115,370
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LTQ Orbitrap Velos measurements (Table III). This high-high
HCD mode offers high sequencing speed and high mass
accuracy MS/MS spectra and is therefore well suited to the
analysis of complex mixtures. In comparison to the CID
method described above, it achieves similar numbers of pep-
tide fragmentation events because it is slightly faster than CID
in the linear ion trap but does not have parallel operation.
Target values for fragmentation are somewhat higher in HCD
(40,000 versus 5,000 ions).
The high scan speeds of this instrument also makes more
complex scan modes possible. For instance, the parallel low
resolution scan mode can be followed by high resolution,
sequential HCD Orbitrap analyzer scans (Fig. 5B). To test
this mode, we selected up to 10 precursors for fragmenta-
tion by CID and repeated fragmentation of the same candi-
dates by HCD. As can be seen in the schematic, this mode
makes particularly good use of the hybrid instrument’s ca-
pabilities. The initial parallel operation with CID fragmenta-
tion allows ample time to perform a survey scan with
240,000 resolution without affecting total cycle time. In
principle, it results in two fragmentation spectra for each of
the peptides. The advantages are illustrated in Fig. 6, the
upper panel of which shows the CID spectrum of the pep-
tide LYGPTNFSPIINHYAR, while the lower panel shows the
corresponding HCD spectrum acquired subsequently in the
same cycle. The CID spectrum has the typical mixture of b-
and y-ions, whereas the HCD spectrum contains a nearly
complete series of y-ions but few b-ions. Both spectra
together account for all possible y-ions as well as a large
proportion of all b-ions of this peptide. Importantly, this dual
FIG. 6. Complementary CID  HCD MS/MS spectra. Example spectra using the parallel and sequential fragmentation mode depicted in
Fig. 5B. A, The rCID spectrum features more b-ions than the HCD spectrum. B, HCD spectrum with nearly complete y-ion series. Mass
accuracy in B but not in A is in the ppm range (absolute average deviation of 3.67 ppm. versus 0.06 Th).
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fragmentation information comes at an acceptable cost in
cycle time and sequencing speed. This parallel top10 CID 
HCD method had a total cycle time of 3.0 s, very similar to
the top15 HCD method. When targeting the same precur-
sors, it sacrifices some sequencing speed but gains in
complementary fragmentation information. Thus it may be
particularly interesting in applications where relatively high
sequencing speed is important but where peptide identifi-
cation is challenging, for instance in the analysis of post-
translational modifications at a large scale.
The final method depicted in Fig. 5C is a further step in the
same direction. Here, two fragmentation modes are applied
but all MS/MS scans are performed in the Orbitrap analyzer.
Therefore this mode is completely sequential and does not
use the linear ion trap as a scanning mass spectrometer. A
120,000 resolution survey scan followed by sequential top5
CID  HCD scans takes about 2.6 s. When targeting the same
precursors, it sacrifices sequencing events compared with the
above methods. However, high resolution MS/MS spectra are
obtained by two different fragmentation methods, yielding
maximum information of the primary structure. Therefore the
sequential top5 CID  HCD scan mode would be very attrac-
tive for applications with limited peptide complexity but high
demands on peptide characterization. This could be the case
in traditional, single protein applications, in proteomics when
no complete database is available, or generally when unusual
modifications are expected.
CONCLUSIONS AND OUTLOOK
Here we have described the Orbitrap Elite, a mass spec-
trometer that achieves fourfold improved resolving power by
increasing the electric field strength in the Orbitrap analyzer
and by enhanced Fourier Transformation. The high resolving
power enables ready isotopic resolution of proteins in the
BSA mass range as well as characterization of their fragments
in a chromatographic time scale. In bottom-up proteomics,
the instrument allows high-low topN CID methods featuring
ultra high resolution survey scans and a large number of
parallel MS/MS experiments in the linear ion trap. For in-
stance, we demonstrated the combination of a survey scan of
240,000 resolution with 20 CID scans all within a 2.7 s cycle
time. Remarkably, this high resolution routinely enabled re-
solving isobars of sulfur-containing peptides. We also ex-
plored the acquisition of CID and HCD spectra of the same
precursor ions, with either parallel or sequential analysis of the
fragmentation spectra. Although not shown here, CID and
HCD fragmentation events could also be distributed to differ-
ent peptide classes. Further fragmentation modes, such as
ETD, can also be incorporated. Moreover, the product ions of
one fragmentation method could be dissociated again by the
same or other fragmentation methods—for example, CID
could be followed by HCD and resulting fragments could be
recorded in the Orbitrap analyzer—all at a rapid time scale. All
these methods are possible in principle and it will be interest-
ing to develop them for a wide range of proteomic and other
applications.
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Prologue 
Modern proteomics datasets contain tens of thousands of mass spectra that make manual 
interpretation impractical. It would not only be too time-consuming, but also prone to a bias 
introduced by the person performing the analysis. Identification of peptides, reassembly of 
proteins as well as scoring and filtering of the results are highly dependent on reproducible 
criteria and application of statically valid models.  
The commercial search engine Mascot has evolved into a gold standard for peptide 
identification110. Unfortunately, the underlying algorithms are inaccessible to the proteomics 
community, which prohibits any modification or adaption to specific problems. After using the 
server-based Mascot search engine in conjunction with the MaxQuant software in our laboratory 
for several years, we wished to gain greater flexibility in programming as well as to switch the 
entire data-processing pipeline to desktop computers. A novel search engine, Andromeda, was 
therefore developed and integrated into MaxQuant. It features the ability to work with arbitrarily 
high fragment mass accuracy. Like Mascot, it applies a probabilistic scoring model and achieves 
similar overall performance on large-scale shotgun proteomics datasets. During extensive tests on 
large-scale datasets and in agreement with our Expert System project (Articles 6 and 7), we found 
it beneficial to supplement the ion types used for peptide identification by water and ammonia 
losses of specific amino acids. Integrating more detailed knowledge of peptide fragmentation into 
the scoring algorithm remains a project for the future.  
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In this thesis we evaluated the success of a second peptide algorithm that was implemented in 
order to tackle the problem of co-fragmenting precursor ions revealed in Article 1. We quantified 
the benefit of identifying more than one peptide from each tandem mass spectrum as a function 
of the width of the isolation window; 4 Th were found to give best results (Article 4). Larger 
isolation windows dilute the targeted precursor ion too strongly and smaller windows permit 
fewer extra identification. Finding second peptides was usually possible when there were indeed 
only one or two extra precursor ions in the isolation window. In contrast, our strategy did not 
help if the remaining precursor intensity was spread over many very low abundant peaks.  
 
High quality peptide identifications are often associated with perfectly annotatable tandem mass 
spectra; however, they can also greatly rely on the accurate precursor mass. Due to the very large 
number of peptide sequences obtained from proteins in databases, the experimental mass 
accuracy of the precursor plays a crucial role in reducing the number of candidates. A prerequisite 
for high mass accuracy is resolution of isotopic patterns and ideally of overlaying clusters of 
different precursor ions, possibly even with different charge states. Mass accuracy, however, also 
strongly depends on the calibration of the instrument.  
We therefore investigated two approaches that were applied to high resolution data at different 
stages of the workflow: At first, we investigated the lock mass feature of the LTQ Orbitrap, 
where polydimethylcyclosiloxane that is present in the laboratory air is deliberately added to each 
spectrum for internal calibration58. The second strategy was novel and entirely software based. It 
can be applied to any dataset of complex mixtures and comes at no experimental cost. This 
software lock mass makes use of sample-inherent information: highly confident peptide 
identifications obtained from a first search with larger mass tolerance (20 ppm or more), 
implemented in Andromeda, are utilized to find a non-linear recalibration function that corrects 
mass errors both on the retention time scale and on the m/z axis. The software lock mass proved 
to be at least as successful as the physical lock mass and is therefore now routinely used in our 
and other laboratories (Article 5).  
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’ INTRODUCTION
Mass spectrometry (MS)-based proteomics is becoming a
commonly used technology in a wide variety of biological
disciplines.1-6 In a “shotgun” format, very complex peptide
mixtures are produced by enzymatic digestion of protein mix-
tures, which are analyzed by liquid chromatography followed by
tandem mass spectrometry.7,8 Per LC-MS/MS run, thousands
of MS andMS/MS scans are acquired, often producing gigabytes
of high resolution data per day and per mass spectrometer.
Computational proteomics has become a key research area,
dealing with the challenges of how to most efficiently extract
protein identification and quantification results from the raw
data. Both the proteomics community and the bioinformatics
community have dealt with many areas of this novel field, and
there is already a large literature outlining and reviewing the
general tasks involved,9-17 particular computational aspects of
the field18-22 and integrated data analysis pipelines.23-30
In this context, our group has developed the MaxQuant
environment, a computational proteomics workflow that ad-
dresses the above tasks with a focus on high accuracy and
quantitative data. It includes peak detection in the raw data,
quantification, scoring of peptides and reporting of protein
groups.31 MaxQuant takes advantage of high resolution data
such as those obtained by the linear ion trap-Orbitrap instru-
ments and employs algorithms that determine the mass precision
and accuracy of peptides individually. This leads to greatly
enhanced peptide mass accuracy that can be used as a filter in
database searching.32 MaxQuant was also specifically designed to
achieve the highest possible quantitative accuracy in conjunction
with stable isotope labeling with amino acids in cell culture
(SILAC).33,34 Using high resolution data combined with indivi-
dualized mass accuracies and robust peptide and protein scoring
results in high peptide identification rates of typically 50% and
even higher on SILAC peptide pairs.31 This was an important
foundation for the quantification of the first complete model
proteome, that of budding yeast.35
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ABSTRACT: A key step in mass spectrometry (MS)-based proteomics is
the identification of peptides in sequence databases by their fragmentation
spectra. Here we describe Andromeda, a novel peptide search engine using
a probabilistic scoring model. On proteome data, Andromeda performs as
well as Mascot, a widely used commercial search engine, as judged by
sensitivity and specificity analysis based on target decoy searches.
Furthermore, it can handle data with arbitrarily high fragment mass
accuracy, is able to assign and score complex patterns of post-translational
modifications, such as highly phosphorylated peptides, and accommo-
dates extremely large databases. The algorithms of Andromeda are
provided. Andromeda can function independently or as an integrated
search engine of the widely used MaxQuant computational proteomics
platform and both are freely available at www.maxquant.org. The combi-
nation enables analysis of large data sets in a simple analysis workflow on a
desktop computer. For searching individual spectra Andromeda is also
accessible via a web server. We demonstrate the flexibility of the system by
implementing the capability to identify cofragmented peptides, signifi-
cantly improving the total number of identified peptides.
KEYWORDS: tandem MS, search engine, spectrum scoring, post-translational modifications, mass accuracy, collision induced
dissociation, higher-energy collisional dissociation, Orbitrap
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The MaxQuant environment originally used the Mascot
peptide search engine36 to match tandem mass spectra to
possible peptide sequences. Mascot together with SEQUEST37
are commonly used search tools in proteomics today. However,
there are many others including Protein prospector,38 ProbID,39
X!Tandem;40 OMSSA,41 ProSight42 and Inspect43 (see
Nesvizhskii et al. for a review14). Mascot takes a probability based
approach to match sequences from a database to tandem mass
spectra.36 Because it is a commercial program the exact algo-
rithms it employs are neither known nor available for modifica-
tion. Furthermore, Mascot is implemented in a client-server
configuration, which imposes practical restrictions for some
applications such as real-time searches. We therefore set out to
develop a new search engine that would be free of these
restrictions. We aimed at performance at least on par with
Mascot, which has become a “gold standard” in proteomic
analysis, and robustness for scaling up to extremely large and
complex data sets. In combination with MaxQuant, the new
search engine would then enable analysis of complex data sets on
desktop machines by any proteomics researcher or biologist
wishing to employ proteomics.
Database searching with fragment mass spectra typically fol-
lows one of three approaches:44,45 (i) deriving a partial or full
peptide sequence with associated mass information (first imple-
mented by PeptideSearch46 and graph theory based de novo
methods47), (ii) autocorrelation between the experimental and
a calculated spectrum (first used in SEQUEST) or (iii) calculating
a probability that the observed number of matches between the
calculated andmeasured fragment masses could have occurred by
chance (pioneered in Mascot). We chose the probability based
approach based on the binominal distribution probability and
started from a score that we had originally developed for analyzing
MS3 data for which no search software was available at the time.48
This score has already been used for ranking the peptides in
MaxQuant searches from the beginning and it also determines the
localization probability of modifications in peptides.48
In this paper, we describe the architecture of the Andromeda
search engine and its scoring function. We perform a rigorous
comparison against the Mascot search engine on several large-
scale data sets. The ability of Andromeda to accurately handle
many modifications of the same peptide is demonstrated. Due to
the complexity of peptide mixtures in shotgun proteomics and
the relatively low resolution of precursor isolation, two peptides
are frequently ‘cofragmented’ and there are algorithms that try to
identify them from mixture spectra.49-52 We demonstrate the
flexibility of the Andromeda search engine by implementing a
novel second peptide identification algorithm.
’MATERIALS AND METHODS
Benchmark Data Sets
Raw data from 84 LC-MS runs was taken from Luber et al,53
a label-free proteome study of mouse dendritic cells to a depth of
5780 proteins. Cell subpopulations were obtained by FACS
sorting, proteins were separated by 1D SDS-PAGE and digested
with trypsin. Peptides from the gel pieces were analyzed on a
nanoflow HPLC system connected to a hybrid LTQ-Orbitrap
mass spectrometer (Thermo Fisher Scientific).
As a phosphoproteomics benchmark data set we took the raw
data from 117 LC-MS runs produced in a phosphatase knock-
down analysis.54 Drosophila Schneider SL2 cells were differen-
tially SILAC labeled as pairs with Lys-8/Arg-10 and Lys-0/Arg-0.
Proteins were separated by 1D SDS-PAGE and digested with
trypsin or in solution digested without gel separation. Peptides
were subjected to TiO2 chromatography and strong cation
exchange chromatography and analyzed on a nanoflow HPLC
system connected to a hybrid LTQ-Orbitrap (Thermo Fisher
Scientific). For the analysis, we used only those MS/MS spectra
that were acquired on a recognized SILAC pair. Modifica-
tions due to labeling with Lys-8 and Arg-10 can then be taken
as fixed.
The benefits of second peptide analysis were investigated
using data that was acquired on an LTQ-Orbitrap Velos. Briefly,
HeLa cell lysate was in solution digested with trypsin, the peptide
mixture was separated on a nanoflowHPLC system and analyzed
using a data-dependent “top 10” method. Several runs were
acquired with varying isolation windows. The precursor ions
were isolated in selection windows of 1, 2, 4, 8, 16, and 32 Th
followed by HCD fragmentation and high resolution data
acquisition of the MS/MS spectra in the Orbitrap.
Data Preparation
MaxQuant, version 1.1.1.25, generated peak lists from the
MS/MS spectra for the database searches. For the low-resolution
MS/MS spectra recorded in “centroid” mode the 6 most
abundant peaks per 100 Th mass intervals are kept for searching.
High-resolution profile MS/MS data is deconvoluted (deiso-
toping and transfer of all fragment ions to single charge state)
before extraction of the ten most abundant peaks per 100 Th. All
statistical filters in MaxQuant like peptide and protein false
discovery rates and mass deviation filters were disabled in order
to score all submitted MS/MS spectra. Peptide masses were
recalibrated by MaxQuant prior to both Andromeda and Mascot
searches. For the Mascot search (using Mascot server version
2.2.04), peak lists written out by MaxQuant were converted to
mgf format, the standard Matrix Science data format. Oxidation
of methionine and N-terminal protein acetylation were used
as variable modifications for all searches. A mass tolerance of
6 ppm was used for the peptide mass. To make Mascot and
Andromeda searches comparable, we did not use the individual
peptide mass tolerances in MaxQuant. A tolerance of 0.5 Th was
used for matching fragment peaks produced by CID. The HCD
fragment ion data used in the co-fragmentation study were
searched with a 20 ppm window in Andromeda. A maximum
of two missed cleavages were allowed in all searches. The
“instrument” parameter was set to “ESI-TRAP” in the Mascot
search. Mascot and Andromeda scores were matched to each
other based on raw file name and scan number.
The search was performed against a concatenated target-
decoy database with modified reversing of protein sequences as
described previously.31 Mouse and human data was searched
against the respective IPI databases,55 version 3.68, while the
drosophila data was searched against protein sequences from
flybase56 version 5.24.
Search Engine Configuration
In Andromeda, the user specifies allowed peptide and protein
modifications, enzymes used for protein cleavages and the
protein sequence databases to be searched in the program
AndromedaConfig.exe. Modifications are specified by their ele-
mental composition. Neutral losses and diagnostic ions can be
specified separately for each type of amino acid with the
modification in question. Modifications that are interpreted as
labels by MaxQuant can be defined here, such as SILAC labels.
Searches with semispecific enzymes are supported as well, where
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only one peptide terminus needs to be a cleavage site according
to the given protease digestion rule while the other terminus can
be an arbitrary position in the protein. An unspecific search is also
supported where both of the peptide termini can be arbitrary
positions in a protein. Parse rules for regular expressions as
defined in the Microsoft .NET framework (msdn.microsoft.
com/en-us/library/az24scfc.aspx) are used to define how a
protein identifier is extracted from the header line of a FASTA
database file entry. Some of the most important regular expres-
sions can be found in Table 1.
Input and Output Formats
Input files for peak lists and parameter values as well as output
files for peptide identifications and a tentative protein list are all
human-readable text files. Parameter files have the ending
“.apar” and contain a list of key-value pairs where each pair is
separated by a “=” sign. Expressions used for modifications,
labels, enzymes and databases must have been defined previously
in the AndromedaConfig.exe program. Peak list files have the
extension “.apl” and can consist of arbitrarily many spectra, one
following the other, each spectrum entry being enclosed by
“peaklist start” and “peaklist end” lines. Some key-value pairs
with peaklist-specific parameters are followed by two columns of
numbers containing the m/z and intensity values. The peptide
result files (“.res”) contain up to 15 candidate peptide matches
for each peak list. For each candidate the peptide sequence,
modification state, score, mass, mass deviation and all corre-
sponding protein IDs are given.
Software Availability
MaxQuant with Andromeda as the integrated search engine
can be downloaded from www.maxquant.org. A standalone
version of Andromeda is available at www.andromeda-search.
org. The source code is provided as Supporting Information 1.
Both applications require Microsoft .NET 3.5, which is either
already installed with Microsoft Windows or can be installed as a
free Windows update. The Andromeda web server can be
accessed at www.biochem.mpg.de/mann/tools/ for a limited
number of submissions of MS/MS spectra. Andromeda has been
written in the programming language C#, using the Microsoft
.NET framework version 3.5.
’RESULTS
Andromeda is a search engine based on a probability calcula-
tion for the scoring of peptide-spectrummatches. A version of it
is fully integrated into the MaxQuant quantitative proteomics
platform. Hence, all the data processing from the acquired raw
data to the list of quantified peptides and proteins can be
performed in a single end-to-end workflow (Figure 1a). In
addition to the regular search Andromeda can be used in different
contexts: for example in MaxQuant it is used for determining the
mass-dependent recalibration function based on a preliminary
database search, and for the identification of one or more
cofragmented peptides (see below). We also provide a stand-
alone version of Andromeda that produces scored peptide candi-
dates, given a collection of MS/MS peak lists and a parameter file
(Figure 1b). In this option, many of the statistical processing
algorithms that are part of MaxQuant are not applied to the data
and the reported list of identified proteins is only tentative
without rigorous control of protein false discovery rate (FDR).
The output consists of a raw list of scored peptide candidates per
spectrum together with the protein list. Furthermore, there is a
web server version of Andromeda for the submission of a limited
set of spectra (Figure 1c), www.biochem.mpg.de/mann/tools/.
In addition to the scoring results of the 15 best peptide
candidates, the annotated spectrum can be inspected for the
highest scoring and all other candidate peptide sequences.
Despite these alternative uses, we anticipate that Andromeda
will most commonly be employed as the search engine for
MaxQuant.
Indexing Peptides and Proteins
To efficiently score an MS/MS spectrum it is important to be
able to quickly retrieve all candidate peptides that have a suitable
calculated precursor mass within a given tolerance. First we
generate a list of all peptides obtained by the specified digestion
Table 1. Most Important Regular Expressions Defining How
Protein Identifiers Are Extracted from the Headers of Fasta
File Entries
regular expression description
>(.*) Everything after “>”
>([∧ ]) Up to first space
>IPI:([∧\| .]*) IPI accession
>(gi\|[0-9]*) NCBI accession
>([∧\t]*) Up to first tab character
>.*\|(.*)\| Uniprot identifier
Figure 1. Three Andromeda configurations: (a) integrated in Max-
Quant, (b) standalone search engine, and (c) web server.
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rule from the protein sequences considering all possible combi-
nations of preset variable modifications. At this stage we are only
interested in the peptide masses, therefore only the number but
not the positions of the modifications are important. The list of
all of these peptides is sorted by mass for quick search access,
which only grows slowly with increasing size (proportional to the
log of the number of peptides for a binary search). The number of
peptides with specificmodifications can become very large, either
when searching in an extended protein sequence database or by
specifying many variable modifications. One common setting is
to search the human IPI database including reverse sequences
and common contaminants digested with trypsin and allowing
for up to two missed cleavages. The number of modifications to
consider can also grow rapidly. For example, in a phospho-
proteomic experiment with triple SILAC labeling of lysine and
arginine, one may simultaneously deal with phosphorylation of
serine, threonine and tyrosine, Lys4, Lys8, Arg6, Arg10 and
oxidation of methionine as variable modifications. (This is the
case for those MS/MS spectra where the SILAC state could not
be determined prior to the database search; otherwise the
modification state of Arg and Lys are set by MaxQuant.) For
the human IPI database and including the reversed sequences,
this corresponds to a list of 174 618 protein sequences resulting
in 7 837 653 peptide sequences and 76 937 183 modification-
specific peptides (without taking modification positioning into
account). These numbers can become even larger, for example in
cases where one wants to search against a six-frame translation of
the whole genome.
Figure 2. Memory and disk structure. (a) Protein list has a two-layer index structure. One small index is kept inmemory whose entries point to blocks of
multiple entries in the secondary index that is kept on disk. Each entry of the disk index points to the position of the protein entry in the file containing the
complete information for each protein including the amino acid sequence. The protein lists are sorted alphabetically by the protein names. (b) Peptide
index that resides in memory points to equally sized blocks of peptide entries, which are kept on disk. (c) Similar structure for the list of all combinations
of peptide sequence and variable modifications. Index and disk entries are sorted by the peptide mass to allow for quick retrieval of all peptide candidates
within a given mass interval.
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We therefore wished to be able to handle protein sequence
information without limitation on the sizes of calculated protein
and peptide lists. Our goal was to work within the memory limits
of 32-bit operating systems, which is around 1.6 GB from within
the Microsoft .NET framework. The data structures for the
search engine have to have an even smaller memory footprint
since other data might be required to be in memory at the same
time. Obviously the full modification-specific peptide list is too
large to keep in memory and it has to reside on the hard disk (or
solid state disk for improved performance). This is also true for
the peptide and protein lists because unlimited scalability is
desired. Only an index for each of the files is kept in memory,
which contains positions of the records relative to the beginning
of the file. These memory indices can already exceed the memory
limitations for very large numbers of peptides. Therefore the
index points to beginnings of blocks of elements in the file with a
suitably chosen block size such that the lengths of the indices in
memory never exceed a fixed size. In Figure 2, the structure of
these lists and the relationships between memory and files
residing on the hard disk are shown for proteins, peptides and
modification-specific peptides. The records always contain in-
dices to the respective items in the hierarchy above, assuring easy
navigation from a candidate peptide to all the proteins that it
occurs in. The modification-specific peptide list is the one that is
directly accessed in database searches. It is sorted by mass, which
allows quick retrieval of peptides within the given mass window.
Protein and peptide list are instead sorted alphabetically by
protein name and peptide sequence, respectively.
Scoring Model
The probabilistic score employed in Andromeda is derived
from the p-score that was introduced for the identification ofMS3
spectra.48 Given a peptide sequence together with a configura-
tion of fixed and variable modifications for that peptide, first the
theoretical fragment ions are calculated (Figure 3). For CID and
HCD the list of theoretical fragment ion masses always contains
the singly charged b- and y-ions. If the precursor charge is greater
than one, the doubly charged b- and y-ions are added. In case of
low resolution ion trap MS/MS spectra the charge state of
fragments usually cannot be determined. The calculated doubly
charged m/z values are then added explicitly if it is desired to
match more highly charged fragments. For high-resolution MS/
MS the charge state can be assigned to a fragment if more than
one isotopic peak is detected. For these cases we remove peaks of
fragments with charge higher than 1 from the spectrum and
reintroduce them into the spectrum as singly charged fragment
ions. If there are several charge states for a fragment their
intensities are added, taking account of the fact that signal is
proportional to charge in the Orbitrap analyzer. We noticed that
even for high-resolution MS/MS data, where charge state
Figure 3. Schematic of the peptide scoring algorithm. The upper left branch shows the calculation of the theoretical fragment ionmasses while the right
branch indicates the processing of the experimental MS/MS spectra. In particular, all ion types that are used for the scoring can be found in the table on
the left. The final score involves an optimization of the number of highest intensity peaks that are taken into account per 100Dam/z interval and over the
inclusion of modification-specific neutral losses.
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detection is possible in general, it is beneficial to consider doubly
charged b- and y-ions as well. This is because for lower mass
fragments sometimes only the monoisotopic peak is detectable
precluding charge state determination and hence also the trans-
formation to charge state one. For example assuming that the
elemental composition of fragments follows the averagine
model57 the ratio between the 13C and monoisotopic peak
intensities for a fragment of 400 Da is 4.6:1. For less abundant
fragments this can obviously lead to nondetection of the 13C peak
while the monoisotopic peak is above the noise level.
Calculated peaks corresponding to water and ammonia losses
are only offered for matching as singly charged ions in those cases
where the main b- and y-ion fragment is present and contains the
amine-, amide- or hydroxyl-containing amino acid side-chains
that tend to lead to the respective side chain loss. Modification-
specific losses are configurable in the program AndromedaCon-
fig, which is included in the MaxQuant distribution. The above-
mentioned modification-specific neutral losses, as well as ions
that are diagnostic for the presence of a particular modification of
an amino acid type can be freely configured there. For example,
the loss of phosphate from a phosphorylated serine or threonine
is much more likely than from a tyrosine, which instead produces
a highly specific immonium ion at mass 216.0426 (see, e.g., Steen
et al.44). If Andromeda is used within MaxQuant, the report for
each modification site includes presence or absence of a diag-
nostic peak in theMS/MS spectrum. The score is calculated once
including configurable neutral losses and once excluding them
and the maximum of the two scores is chosen. (Note that all
scoring procedures are carried out identically for sequences from
the reverse database, so they do not introduce a bias.)
The first step in the actual calculation of the score is to count
the number of matches k between the n theoretical fragment
masses and the peaks in the spectrum. The higher k is compared
to n, the lower the chance that this happened by chance.48
Because there are many signals in MS/MS spectra, including
many low intense noise signals, the number of peaks in a defined
mass interval—here 100 Th, which is the typical distance
between consecutive members of fragment series (average mass
of amino acids)—are limited to a maximum number. The
parameter q is defined as the number of allowed peaks in the
mass interval and it is needed to calculate the probability of a
single random match. If the difference between calculated and
measured masses is less than a predefined value, a match is
counted. This can be done with an absolute mass tolerance
window specified in Th or a relative mass window specified in
ppm. While the former is appropriate for ion trap spectra, the
latter is more suitable for high-resolution FT-ICR or Orbitrap
spectra.
The Andromeda score is calculated as -10 times the loga-
rithm of the probability of matching at least k out of the n
theoretical masses by chance as shown in Figure 3. This is slightly
different from Olsen et al.,48 where the probability of matching
exactly k out of n theoretical masses is determined. The formula
used here is more similar to a definition of a p value for the null
hypothesis that there is no similarity between the theoretical
mass list and list of the spectrum masses. In particular, the score
has the desirable property to vanish for k = 0. The calculation of
the probability is only approximate since the probability for a
single random match is taken to be q/100, which is exact if there
was only one possible match per nominal mass. For high
resolution MS/MS data the true random match probability is
considerably less than this and the true score would be higher but
more complicated to calculate. However, this simplification is
conservative as it decreases the calculated score and is justified by
the excellent performance of the search algorithm on high-
accuracy MS/MS data.
The intensities of the peaks in the MS/MS spectra are
indirectly taken into account by calculating the score for all
values for q (number of peaks per 100 Th) up to the specified
maximum. The best of these scores for varying q is selected.
Therefore two spectrum-sequence comparisons with the same
values for n and k can result in different scores depending on the
intensities of the matched peaks. Generally, the score is higher if
the matches are among the more intense peaks because the
optimal value of q will be lower (see formula in Figure 3).
However, we have found it crucial that this intensity weight-
ing is not done on the overall intensity scale over the whole
spectrum, but that it is restricted to local mass regions (e.g.,
the 100 Th mass range intervals.). This compensates for
underlying global peak density distributions which typically
favor small fragment masses.
The inclusion of additional information like peptide length,
number of modifications or of missed cleavages can aid the
specificity of peptide assignments to spectra. Ideally this is done
in a data-dependent manner in which different weights for
different classes of peptides can be derived from the data by
machine learning in a Bayesian framework. We wished to include
such a weighting of peptide classes into the score while retaining
a basic search engine score that is deterministic and only depends
on the spectrum being scored rather than the ensemble of all
other spectra. To capture the dependence of the score on peptide
mass and on the number of modifications we introduced a fixed
additive component to the Andromeda score, which depends on
the number of modifications and is a linear function of the mass.
The specific values are determined in a manner that adjusts the
distributions of reverse hits from a target-decoy search so that
they become equal. The net effect of this procedure is to
minimize the FDR for a given cutoff value, because it does not
depend on peptide mass and modification state any longer. We
used a large data set of MS/MS spectra and incorporated the
specific weights into the scoring function. A data-dependent
Bayesian scoring can still be applied to the output of the
Andromeda search engine. For instance, MaxQuant additionally
performs a peptide length dependent Bayesian analysis in a data
dependent manner.31
Comparison to the Mascot Search Engine
Mascot36 is a widely used standard for database searching and
most other search engines have been compared to Mascot.
Therefore we investigated how Andromeda compares to Mascot
in terms of scoring of peptide-spectrum matches. As the exact
details of the Mascot scoring system are not known, we com-
pared the performance of Andromeda vs Mascot empirically on
very large sets of proteomic data.
In Figure 4a, we plot the Mascot score against the Andromeda
score for a data set of 732 287 MS/MS spectra derived from a
label-free mouse proteome measurement as described in Materi-
als and Methods. For each MS/MS spectrum the highest scoring
peptide is taken which is not necessarily the same for the Mascot
and the Andromeda scoring. In Figure 4b, the fraction of cases for
which the top-scoring Andromeda and Mascot peptide se-
quences coincide is displayed as a histogram depending on the
Andromeda score. As can be seen, above an Andromeda score
of 100 the top-scoring peptides coincide in almost all cases.
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Of the recorded MS/MS spectra, 89.1% correspond to unmodi-
fied peptides and most of the identified modified peptides have
an oxidized methionine. The point density is indicated by the
color code in Figure 4a which encodes the percentage of points
that are included a region of a specific color. For example, the
yellow line in Figure 4a encloses 95% of all data points. This
visualization allows the visual detection of outliers (like a two-
dimensional data plot), while at the same time retaining informa-
tion about the density of points that would normally only be
visible in a 3D data plot. It is immediately apparent from the
figure that the scores correlate well overall. There are no distinct
populations of peptides that are only identified by one of the
search engines. A linear regression results in the equation M =
0.311 * A - 32.231, where M is the Mascot score and A the
Andromeda score, with an R2 value of 0.708. This indicates that
Andromeda scores are generally about 3-fold larger than Mascot
scores. However, this does not indicate a 3-fold larger confidence.
The statistical power is better determined by calculating coverage
and false discovery rates as a function of score threshold as is
done below. A rough conversion between Andromeda and
Mascot scores can be performed by a division by three or
application of the regression line. Note that there are only very
few and dispersed outliers on either side; of the order of tens of
spectra out of the total of more than 700 000. Furthermore, there
are virtually no high-scoring outliers near either axis, indicating
an absence of spectra that were ranked highly with one method
but scored close to zero with the other. This demonstrates that
no populations of peptides would be lost entirely by employing
one score or the other.
Next we compare the performance of the Andromeda and
Mascot search engines as a function of False Discovery Rates
estimated as the number of hits from the reverse database divided
by the number of forward hits at any given minimum score. The
sensitivity of the database search is defined as the number of
accepted forward hits relative to the total number of forward hits
at the same score. Mascot and Andromeda have very similar
characteristics over the whole range of FDRs, in particular
including the often used 1% FDR rate (Figure 4b). This shows
that the two scores are very close in discriminatory power.
Scoring of Phosphopeptides
Figure 5a shows the same type of plot as in Figure 4a but for a
data set that is enriched for phosphopeptides. Of the recorded
586 883 MS/MS spectra in Figure 5a, 27.4% have one or more
phosphorylations. Outliers are visible in the region of high
Andromeda and low Mascot score and most of them correspond
to peptides with three to five phosphorylation events. Figure 5b
displays the MS/MS spectrum of a peptide with five phospho-
rylation sites that has a Mascot score of 5.2 and an Andromeda
score of 199.3. The y-series coverage is almost complete with
most fragments occurring with a neutral loss of a phosphate
molecule. An FDR coverage curve for the phosphopeptide data
set is depicted in Figure 5c. The performances of Mascot and
Andromeda are similar over the entire range with an advantage
for Andromeda in the high specificity region. At the typical
operation point of 1% FDR results are very close. We speculate
that the better scoring in the region of higher specificity may be
due to a better matching of spectra of phosphopeptides in
Andromeda due to more comprehensive combinatorics of
positioning of phospho-groups on the available serine, threonine
and tyrosine sites in the peptide sequences, including a more
complete offering of neutral losses. During the Andromeda
search we offer up to 1000 positionings of variable modifications
within any given peptide which is exhaustive for most situations.
Figure 4. (a) Andromeda vsMascot score for a data set of 732 287MS/
MS spectra derived from a label-free mouse proteome measurement.53
The score for the top-scoring peptide for each MS/MS spectrum is
shown which is not necessarily the same peptide sequence for the
Mascot and the Andromeda identification. The color code indicates the
percentage of points that are included a region of a specific color. (b)
Histogram of the percentage of cases in which the top-scoring Andro-
meda and Mascot peptide sequences are equal as a function of
Andromeda score. For the comparison leucine and isoleucine were
treated as the same amino acid. (c) False discovery rate as a function of
coverage for the same data set calculated based on the reverse hits from
the target-decoy search.
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In MaxQuant, the top-scoring peptide is furthermore rescored
with essentially exhaustive positioning of modifications. We
merely restrict the combinatorics to 100 000 possibilities to
exclude the rare instances where single peptides cause long
calculation times due to “combinatorial explosion”. In Supple-
mentary Figure 1 (Supporting Information), the same data as in
Figure 5a is shown six times—each time highlighting another
population of top-scoring peptides with a fixed number of
phosphorylations. Peptides with higher phosphorylations tend
to have many data points in the high Andromeda score but low-
to-moderate Mascot score region further indicating that Andro-
meda performs better on highly phosphorylated peptides.
Identification of Second Peptides
Even in high-resolution MS, the selection of the precursor ion
for fragmentation is always performed with low resolution
(typically a few Th) to ensure adequate sensitivity for MS/MS.
In complex mixtures, this results in frequent cofragmentation of
coeluting peptides with similar masses. These ‘chimerical’ MS/
MS spectra52 can be detrimental for identification of the peptide
of interest, especially if the cofragmented peptide is of compar-
able intensity. Co-fragmentation generally reduces the number of
peptides identified in database searches and poses special pro-
blems for reporter fragment based quantification methods be-
cause both peptides contribute to the measured ratios.
However, this situation can be turned to an advantage if both
peptides can be identified. In particular, this presents the
opportunity to identify peptides that have not been targeted
for MS/MS and to obtain two or more peptide identifications
from a single MS/MS spectrum. Although this problem has been
addressed before,49-52 to our knowledge it has not been adopted
in mainstream search engines yet. Here we describe a second
peptide identification algorithm that we have integrated into the
Andromeda/MaxQuant workflow.
To illustrate the principles of our algorithm, Figure 6a shows
an LC-MS map, where 3D peaks are indicated as lines marking
the peak boundaries. The blue isotope pattern has been selected
for fragmentation at the position of the cross on the
Figure 5. (a) Andromeda vs Mascot score for 586,883 MS/MS spectra from the phospho-proteome data by Hilger et al.54 (b) Annotated MS/MS
spectrum of the peptide SHpSLSpSMIpSNApSSpTMR.Mascot and Andromeda produce the same top-scoring peptide sequence with aMascot score of
5.2 and an Andromeda score of 199.3. (c) False discovery rate as a function of coverage for the same data set calculated in the same way as in Figure 4c.
72
1802 dx.doi.org/10.1021/pr101065j |J. Proteome Res. 2011, 10, 1794–1805
Journal of Proteome Research ARTICLE
monoisotopic peak of that peptide. The red rectangle indicates
the region from which ions have been isolated for fragmentation.
Clearly the peptide corresponding to the green isotope pattern
that has not been selected for sequencing intersects with the
isolation rectangle. Therefore its fragments should be present in
the MS/MS spectrum as well. The actual fragment spectrum is
shown in Figure 6b where the fragments originating from the
targeted and identified peptide (blue isotope pattern) are
indicated in blue. This process is repeated for the entire LC-
MS/MS run. For every 3DMS isotope pattern that has not been
selected for sequencing the algorithm checks whether it inter-
sects with the isolation window of anyMS/MS spectrum. If this is
the case then the fragments in this MS/MS spectrum that have
already been assigned to a peptide sequence during the main
Andromeda search are subtracted. The remaining fragments are
submitted to a new database search with the precursor mass from
the peptide that was not targeted for MS/MS. The collection of
these “subtracted” peak lists is submitted to Andromeda in the
same way as in a conventional search. However, the results of this
second peptide search are further processed with their own
peptide length based posterior error probability and precursor
mass filtering. Since these spectra are on average of lower quality
than the original MS/MS spectra we have found it to be crucial
that they have their own data-dependent statistical model for
peptide identification. The resulting peptides are then accepted
up to a 1% FDR and integrated into the usual protein identifica-
tion and quantification workflow.
The HCD data set used for testing (see Materials and
Methods) was acquired with a total isolation width of 4 Th for
every MS/MS spectrum. The identification rate for the set of
second peptide spectra is much lower compared to the normal
MS/MS identification rate of 50%. Nevertheless, since the
number of the second peptide spectra is quite high compared
to normal MS/MS spectra considering cofragmentation still
leads to a considerable increase in peptide identifications. In
our example, the number of identified peptide features increased
by 10.7% by the inclusion of second peptide identifications.
The gain in the number of identified peptides depends on the
isolation width for the acquisition ofMS/MS spectra. For instance,
at an isolation width of 2 Th we observe that the increase
Figure 6. Second peptide identification. (a) LC-MS map of the sequenced (blue) and cofragmented (green) peptide described in the main text. The
blue peptide has been selected for fragmentation at the position of the cross. The red rectangle indicates the isolation window. (b) MS/MS spectrum
leading to the identification of both peptides. Fragments of the two peptides are indicated in blue and green, respectively. The blue peptide is identified in
the conventional database search while the green peptide has been identified as “second peptide”.
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in identified peptides through second peptide identifications is
only 5.7%. The relative gain is larger at increased isolation
width because the average number of additional peptides
within the window increases. However, the chance to identify
the main peptide decreases due to the mixing of the spectrum
with fragments from other peptides. The dependence of the
number of peptide identifications for conventional and second
peptides is shown in Supplementary Figure 2 (Supporting
Information).
’DISCUSSION AND OUTLOOK
Here we have described Andromeda, a novel search engine
for matching MS/MS spectra to peptide sequences in a database.
Andromeda can either be used in a stand-alone mode or—more
typically—as part of the MaxQuant environment. Apart from an
optimal scoring model our intention was to develop a very robust
architecture with unlimited scalability. We have demonstrated
this on large scale data sets with hundreds of thousands of
spectra. Andromeda has been “stress tested” in ongoing studies
and has been the default search engine in our laboratory for some
time. A practical advantage of the MaxQuant/Andromeda com-
bination is that it runs locally on the user’s computer. This
eliminates client-server set up and communication issues. The
computational proteomics pipeline starting from raw data files to
reported protein groups and their quantitative ratios now appears
unified to the user. Despite the local search architecture, proces-
sing speeds are generally not different from the previous Max-
Quant/Mascot environment in which Mascot was run on an
external server. Furthermore, we have added a separate module
called Perseus (www.maxquant.org), which performs bioinfor-
matic analysis of the output of the MaxQuant/Andromeda
workflow. Perseus is already available and in use58 and completes
the pipeline for computational proteomics analysis but will be
described in a future publication (Cox et al., in preparation).
The scoring function at the heart of Andromeda is built on a
simple binominal distribution probability formula (Figure 3),
which we have previously used in scoring MS3 spectra and
localizing PTMs.59 Andromeda divides the MS/MS spectrum
intomass ranges of 100 Th. In each of these ranges the number of
experimental peaks offered for matching is dynamically tested in
an intensity prioritized manner.
False discovery rates for the same initial probability score can
still depend on the number of modifications and on the mass of
the peptide. This is accounted for in Andromeda by an additive
component to the score. Comparison to Mascot on very large
data sets reveals very few outliers—in particular almost no
peptides are exclusively identified by one of the two search
engines. Furthermore, the coverage of identified peptides at any
given FDR is likewise similar, including at the generally used
operating point of 1% expected false positives. We did notice
improved identification of heavily modified peptides in Andro-
meda compared to Mascot, which we attribute to the more
exhaustive combinatorial analysis of placing PTMs on all possible
amino acids. As the Mascot search engine has become one of the
standards in proteomics, equivalent performance fulfills the goal
that we had set for the development of Andromeda and likely
implies favorable comparison to other search engines as well.
Apart from describing the score we have also made the actual
code used in Andromeda available for inspection with this
publication (Supporting Information 1).
A key advantage of Andromeda is its extensibility. For
example, proteomics with high accuracy MS and MS/MS data
(high-high mode60), is becoming increasingly common. An-
dromeda, in contrast to Mascot, allows arbitrarily accurate MS/
MS requirements specified in ppm. Similarly, Mascot precludes
identification of SILAC pairs if the same amino acid can bear a
fixed and a variable modification. This causes a substantial loss of
quantification information, for example in the analysis of lysine
acetylated peptides61 because all MS/MS spectra of lysine-
acetylated peptides that were sequenced on the heavy SILAC
partner will not be identified by Mascot. All these quantitative
ratios are retrieved in the MaxQuant/Andromeda workflow.
More generally, additional scoring modes can be added to
Andromeda. We demonstrated this by implementing a second
peptide identification algorithm into theMaxQuant/Andromeda
workflow. For each isotope cluster that is detected in the LC-
MS data but that was not targeted for fragmentation the
algorithms checks if the precursor isotope pattern intersects
the selection window of any MS/MS event. If so, fragment ions
belonging to the identified peptide are subtracted and the search
is repeated with the cofragmented peptide in a statistically
rigorous way. As demonstrated here, this leads to an appreciable
increase in peptide and protein identifications in complex
mixtures. As another example, special algorithms are necessary
for peptide identification in data independent MS/MS where the
whole mass range is fragmented.62,63 Using the MaxQuant/
Andromeda infrastructure our group recently developed an
implementation of this principle on the Exactive instru-
ment, which consists only of an Orbitrap analyzer with HCD
capability.64
In conclusion, we have developed, described and tested a
robust and scalable search engine that in combination with
MaxQuant represents a powerful and unified analysis pipeline
for quantitative proteomics, which is freely available to the
community.
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Abstract
Mass accuracy is a key parameter in proteomic experiments, improving specificity, and success
rates of peptide identification. Advances in instrumentation now make it possible to routinely
obtain high resolution data in proteomic experiments. To compensate for drifts in instrument
calibration, a compound of known mass is often employed. This ‘lock mass’ provides an internal
mass standard in every spectrum. Here we take advantage of the complexity of typical peptide
mixtures in proteomics to eliminate the requirement for a physical lock mass. We find that mass
scale drift is primarily a function of the m/z and the elution time dimensions. Using a subset of
high confidence peptide identifications from a first pass database search, which effectively
substitute for the lock mass, we set up a global mathematical minimization problem. We perform
a simultaneous fit in two dimensions using a function whose parameterization is automatically
adjusted to the complexity of the analyzed peptide mixture. Mass deviation of the high
confidence peptides from their calculated values is then minimized globally as a function of both
m/z value and elution time. The resulting recalibration function performs equal or better than
adding a lock mass from laboratory air to LTQ-Orbitrap spectra. This ‘software lock mass’
drastically improves mass accuracy compared with mass measurement without lock mass (up to
10-fold), with none of the experimental cost of a physical lock mass, and it integrated into the
freely available MaxQuant analysis pipeline (www.maxquant.org).
Key words: Mass accuracy, MaxQuant, Proteomics, Database search, Orbitrap, Peptide mass
measurement, Lock mass
Introduction
Mass spectrometry (MS)-based proteomics [1–3] greatlybenefits from high resolution and high mass accuracy
measurements [4]. For example, resolving co-eluting pep-
tides of similar mass is a prerequisite for their accurate
quantification, and high accuracy measurement of peptide
masses greatly aid in their identification by providing
stringent filters on possible candidates. Several definitions
of mass accuracy are commonly used, and this important
parameter is often only assessed anecdotally [5]. In
proteomics, the operationally important definition is the best
mass estimate from the MS measurement together with a
statistical confidence interval. This interval can then be used
as the basis for setting a permissible mass deviation window
for peptide identification in databases. Such confidence
intervals can be assigned to each peptide separately. They
are obtained from the measured values from consecutive
scans and isotope states, weighted by the signal for each data
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point. We have previously described principles of extracting
these mass values from large scale data sets and imple-
mented the corresponding algorithms in the MaxQuant
computational proteomics analysis pipeline [4, 6]. As a
result of applying these computational algorithms, these
peptide mass accuracies are frequently improved to the sub-
ppm range. This makes the precursor mass value an
important search parameter and allows a corresponding drop
in the required quality of the MS/MS spectra while still
maintaining a 1% false discovery rate for peptide
identifications.
A precondition for the above analysis was the
elimination of the systematic mass drift by using a lock
mass [7, 8]. A lock mass is a defined compound of
known composition that is added to the MS analysis.
Some instruments feature a separate electrospray source,
which is used to spray the reference compound [9, 10].
Alternatively, the reference compound could be mixed
into the analyte directly, but this has disadvantages
because the compound may interfere with analysis of
low abundance samples or it may not be detectable in
high abundance samples. In electrospray, charged droplets
are formed in laboratory air and analyte ions are desorbed
from them. However, these charged droplets can also
absorb and ionize background chemicals that are always
present in laboratory air [11, 12]. On the LTQ-Orbitrap
family of instruments these ions, specifically polycyclo-
dimethylsiloxanes, can be separately isolated in the linear
ion trap and injected into the C-trap, which is an
intermediate storage trap [13]. In the C-trap the lock
mass ions are mixed with the MS or MS/MS ions to be
analyzed and co-injected into the Orbitrap analyzer. The
ion is recognized by the data system in real time and the
mass scale is automatically adjusted. While this procedure
is sufficiently fast to be routinely applicable in proteomic
experiments, there is some time requirement for isolating
the lock mass ions, adding to overall MS and MS/MS
cycle times. In addition, it can often be desirable to
suppress background ions in laboratory air (i.e., by the
ABIRD device: www.esisourcesolutions.com). This has
the side effect that the lock mass is no longer available.
For these reasons, an alternative to the lock mass would
be beneficial.
In proteomics experiments, typically hundreds or
thousands of peptides are identified in every LC-MS/MS
run. Many of these peptides have very information-rich
MS/MS spectra, and they can be unambiguously identi-
fied even with large mass tolerances. We have previously
made use of this fact by implementing a two-pass search,
where the top identified peptides serve as mass references
for calibration [14]. However, this recalibration was done
globally for the entire LC-MS run, was only applicable to
time of flight data and did not attempt to reach sub-ppm
mass accuracy. For Orbitrap data, the simple mass scale
adjustments [14] would not be applicable. In this paper
we set out to develop algorithms to replace the physical
lock mass with a software algorithm that performs at least
as well in global recalibration of Orbitrap data.
Methods
Protein Digestion
Total HeLa cell lysate was treated with a urea (6 M) and
thiourea (2 M) solution followed by reduction with
dithiothreitol (DTT) (1 mM) for 30 min and alkylation with
iodoacetamide (IAA) (55 mM) for 20 min at room temper-
ature. The proteins were digested with Lys-C (1 μg/50 μg
protein) (Wako, Neuss, Germany) for 3 h at room temper-
ature. The mixture was diluted with water (1:4) before
incubation with trypsin (1 μg/50 μg protein) (Promega,
Mannheim, Germany) for 12 h at room temperature. The
digestion was stopped by addition of formic acid (3%) and
the samples stored on StageTips [15].
LC-MS/MS Analysis
The peptide mixture was loaded onto a C18-reversed phase
column (15 cm long, 75 μm i.d.) that was packed in-house with
ReproSil-Pur C18-AQ 3 μm resin (Dr. Maisch) in buffer A
(0.5% acetic acid). The peptide mixture was separated with a
linear gradient of 5%–60% buffer B (80% ACN and 0.5% acetic
acid) at a flow rate of 250 nL/min on a nanoflowHPLC (Proxeon
Easy HPLC; Thermo Fisher Scientific). On-line coupling of the
HPLC system to an LTQ Orbitrap XL mass spectrometer
(Thermo Fisher Scientific, Bremen, Germany) was achieved
using a nanoelectrospray ion source (Proxeon Biosystems, now
Thermo Fisher Scientific). Data were acquired in a data-
dependent ‘top5’ format, selecting the most abundant precursor
ions from the survey scan (mass range 300–1650 Th) in order to
isolate them in the linear ion trap and fragment them byCIDwith
a normalized collision energy of 35 eV. Survey scans were
acquired with a resolution of 60,000 atm/z 400 and with a target
value of 106 in the Orbitrap analyzer. The MS/MS scans were
acquired with unit mass resolution in the LTQ using 3000 as
target value. Dynamic exclusion was defined by a list size of 500
features and exclusion duration of 90 s. Early expiration was set
to expiration count 3 and S/N threshold 3. The lower threshold
for targeting a precursor ion in the MS scans was 1000 counts.
Three technical replicates were acquired without using the lock
mass option in Xcalibur. In three separate technical replicates
protonated polycyclodimethylsiloxane (PCM-6) with exact m/z
445.1200 Th was selected as lock mass for the measurement
[13].
Data was analyzed by MaxQuant [4] using the Andromeda
search engine [16]. The IPI human data base was used for
peptide identification in the IPI human data base (containing
87,061 entries) combined with 262 common contaminants and
concatenated with the reversed versions of all sequences.
Enzyme specificity was set to trypsin, allowing cleavage N-
terminal to proline. Further modifications were cysteine
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carbamidomethylation (fixed) as well as protein N-terminal
acetylation and methionine oxidation (variable).
Computational Methods
Data were analyzed with the MaxQuant framework [4],
which is written in C# in the Microsoft .NET environment.
Algorithmic parts of MaxQuant are available as source code
and the entire program can be freely downloaded as well
from www.maxquant.org. Detailed instructions for installa-
tion and support programs are also available [17].
Results and Discussion
Time and m/z Dependence of the Mass Error
We start by illustrating global features of the mass error
distributions in liquid chromatography-tandem mass spec-
trometry runs. We performed 2 h LC-MS/MS runs of a HeLa
lysate acquired on an LTQ Orbitrap without enabling the
lock mass feature. Peptides were identified with a suitably
large tolerance for the peptide mass, sufficient to include
possible deviations due to instrumental drift (20 ppm in this
case). We then calculated the mass error for each peptide.
Figure 1 shows the results of these measurements for the
elution profiles (MS-level isotope patterns) of four peptides.
Indeed, all four peptides in Figure 1 are shifted by
approximately 5 to 6 ppm because of the lack of calibration
and because the lock mass feature was not applied. These
mass deviations are far in excess of the sub-ppm accuracy
that the instrument is capable of [4]. It would now be
interesting to determine if the masses are off due to a global
shift, due to statistical fluctuations, or if the mass error is a
function of either retention time or mass, or if it depends on
both. The two doubly charged peptides in Figure 1a and b
have approximately the same mass but differ in their
retention times. One finds that the mass errors of the two
peptides differ from each other by more than 1 ppm,
suggesting a time dependence of the mass error. Likewise,
we can compare the two triply charged peptides in Figure 1c
and d, which have similar retention time but differ in mass.
Again, the difference in the mass errors is more than 1 ppm,
indicating an m/z dependence of the mass error.
To investigate time dependence of the mass error in a
systematic manner we plotted the ppm mass error as a
function of retention times in Figure 2a (red data points).
Clearly, there are systematic effects in the mass error
distribution. There is a tendency for the error to be
slightly greater at larger elution times. In addition there is
a wave-like pattern on the timescale of 10 to 20 min.
Figure 2b shows a zoom of the same data into a smaller
retention time interval. This figure reveals that the red
curve has systematic structures on smaller timescales of
about 1 min as well. The blue data points in Figure 2a
and b are mass errors from the corresponding LC-MS/MS
run in which the lock mass feature was enabled. As
expected, the average mass error is now much closer to
zero. However, also here larger deviations on smaller
timescales can be seen. For instance, at t=80 min and t=
m/z = 546.8192 Th
rt  = 80.92 min
Δm = 6.01 ppm 
m/z = 547.2855 Th  
rt =  40.22 min
Δm = 4.97 ppm
m/z = 499.6159 Th  
rt = 80.20 min
Δm = 5.12 ppm 
m/z = 806.3917 Th 
rt = 80.34 min 
Δm = 6.24 ppm 
(a) (b)
(c) (d)
m/zm/z
m/z
m/z
rt
rt
rt
rt
Figure 1. Three-dimensional views of three MS isotope patterns corresponding to peptides. Peptides (a) and (b) have similar
mass but different retention times. Their mass errors differ by more than one ppm. Peptides (c) and (d) have similar retention
time but differ in m/z. They also require different mass recalibrations
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83.5 min, the mass error rises for short times to 4 ppm.
Inspection of the data files reveals that this is due to loss
of the lock mass in these time intervals.
Figure 3a is a plot of the mass error as a function of m/z
instead of elution time. Again a systematic nonlinear
dependence can clearly be seen. These systematic variations
seem to be only on larger scales of 100 Da without an
indication of systematic effects on lower m/z scales. Histo-
grams of these mass deviations are shown in Figure 3b for
the data with lock mass (blue) and without lock mass (red).
The lock mass helps in keeping the deviations near zero but
does not completely center them there. This is partially due
to the mass dependence of the error, which is not eliminated
by the lock mass. The tail to the right of the distribution is
mainly derived from the time intervals where the lock mass
has not been found. The absolute average mass deviation of
the lock mass data is 0.53 ppm. In the data that were
acquired without lock mass the errors are centered at
~6 ppm. The full width half maximum of both distributions
is similar and, in both cases, around 1 ppm.
The Software Lock Mass Optimization Problem
As we have seen the mass error is a function of (at least) two
variables, time and m/z, and projections onto each of them
display rich structure and clear functional dependencies. It is
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Figure 2. (a) Mass error in ppm for the peptides identified in two LC-MS runs as a function of retention time. Blue points
originate from an LC-MS run in which the lock mass feature has been used while the red points are from an LC-MS run without
lock mass. (b) Same data zoomed in the time window from min 76 to 90 min
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a reasonable assumption that the mass error depends on
these two parameters in an additive way, i.e., the non-
linearities in the mass scale should be independent of elution
time. This assumption makes sense from a physical point of
view. The m/z-dependent error is determined by static
properties of the mass spectrometer that do not vary with
time; for instance, imperfections in the geometry of the
Orbitrap cell. In addition to this static error, a dynamic
component is superimposed that is caused by any kind of
disturbance that happens during the chromatographic time
scale, with temperature shifts being a prominent example.
This means that it should be possible to parameterize the
mass error function as the sum of two terms, f and g, each
depending on only one of the two variables and each being
parameterized by sets of parameters θf and θg:
m ¼ f t; fð Þ þ g m=z; g
 
: ð1Þ
Note that this equation does not assume linearity in any
of the variables or parameters, but only that the contribution
of each variable can be represented as a sum of nonlinear
terms. The explicit form of the parameterization of the
functions f and g are described below.
To determine the functions f and g in the above equation
(equation 1), we generate number triples (Δmj, tj, m/zj) by
performing a first peptide database search with the Andro-
meda search engine [16], which is integrated into the
MaxQuant software package (see Figure 4). For this
purpose, we allow a large tolerance of the peptide mass of
20 ppm. This initial tolerance can be set by the user. While
we have found 20 ppm to be a good value for routine
operation on this instrument class, this number can and
should be increased in cases where the calibration is off by
more than 20 ppm. All peptide identifications that have an
Andromeda score of at least 80 are accepted. The mass error
is then calculated based on the elemental composition of the
identified peptides and the experimentally measured masses.
Note that in MaxQuant the measured peptide mass is derived
from the entire three-dimensional isotope pattern that the
MS/MS spectrum was associated with [4]. MS/MS spectra
not associated with a three-dimensional MS isotope pattern
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Figure 3. (a) Same data as in Figure 2a but plotted as a function of m/z. Red and blue points originate from LC-MS runs
without and with lock mass, respectively. (b) Histograms of the mass errors shown in (a)
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are discarded. The retention time is estimated as the
intensity-weighted time average over the elution profile of
the peptide. The computational task is now to determine the
functions f and g in such a way that their sum best
approximates the calculated mass error. To achieve this,
we minimize the sum of squares of the residual errors
(equation 2).
X
j
mj  f t; f
  g m
z
; g
  2
ð2Þ
For this purpose, the functions f and g have to be
parameterized in a suitable way. We use piecewise linear
functions for f and g. First, the x-positions of these functions
are adapted to the data, and they are then treated as constant
during the minimization. The number of x-positions and
their exact location are chosen such that the number of
degrees of freedom adjusts itself to the complexity of the
data. Roughly speaking, the more data are available the more
complex the parameterizations of the functions can be. The x
positions are chosen such that there are at least 80 data
points per x position in the m/z direction and 50 data points
per x position in the time direction. Furthermore, the x
positions have to be at least 50 Th apart in the m/z direction.
The numbers that are being determined during the optimi-
zation are the y-values at these fixed x positions, typically
several dozens or hundreds of coefficients. The functions f
and g are linearly interpolated between these positions. One
of the y-values has to be fixed to an arbitrary value since the
system otherwise has a zero mode. The numerical solution
of this minimization problem is obtained by the Levenberg-
Marquard method (see, e.g., reference [18] for an introduc-
tion). After the parameters of f and g have been determined,
we can subtract the systematic mass error from the measured
mass of each MS isotope pattern in the LC-MS run.
Subsequently, the actual database search (second pass
search) is performed with individualized peptide mass
tolerances inside the MaxQuant framework as before.
Performance of the Software Lock Mass
Figure 5 depicts the mass error distribution after recalibra-
tion and second pass Andromeda search. Figure 5a and b
show the dependence on m/z while Figure 5c and d show the
First Andromeda search with 20ppm mass tolerance and score threshold 80
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Figure 4. Algorithmic steps of the software lock mass workflow
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time dependence. For the data with and without lock mass
our algorithm has removed all systematic effects from the
data. Figure 6 shows histograms of the mass error after
recalibration. The absolute average mass deviations are
0.29 ppm for the data with lock mass and 0.27 ppm for the
data without lock mass. The corresponding mass standard
deviations are 0.42 and 0.39 ppm, respectively. This
indicates that when using the software lock mass workflow,
the mass accuracy is as good as for data that were acquired
with lock mass. While shown here for a particular example,
we have found this to be true in general. As an example,
Supplemental Figure 1 shows a very challenging LC-MS/
MS run acquired with lock mass feature in which the lock
mass was lost and found again several times. Panel a shows
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Figure 6. Histograms of the mass errors after recalibration
for data acquired with lock mass (blue), and without lock
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the time-dependence of the mass error before recalibration.
The time series of the mass error is bi-stable, flipping back
and forth between zero and 7 ppm. Nevertheless, this very
difficult case is reliably recalibrated by the software lock
mass (Suppl. Figure 1).
Conclusion
Here we have investigated the concept of a software lock
mass, a replacement for its physical version, which is
integrated into the MaxQuant/Andromeda computational
proteomics workflow. We have demonstrated that it per-
forms as least as well as the physical lock mass on typical
complex proteome data. Even data that were acquired with a
lock mass may benefit from the application of our recalibra-
tion workflow, especially in cases where the lock mass
performance was not optimal. In contrast to the hardware
lock mass option, the software lock mass can correct
nonlinearities in the mass scale. Here, we have demonstrated
the method on an Orbitrap instrument. However, we
speculate that other instrument types would also benefit
from the software lock mass approach. For instance, mass
calibration drift typically is an issue of practical importance
for time of flight instruments. Furthermore, while shown
here for MS spectra, the benefits of the software lock mass
also carry over to high-resolution MS/MS spectra.
Importantly, use of the software lock mass is completely
free from an experimental point of view. All it requires is a
peptide mixture of sufficient complexity. In contrast, a
physical lock mass, even if derived from laboratory air,
always has some experimental cost, such as additional
hardware, influence on the spectra, or a slight increase in
cycle time. Since the software lock mass is an unmitigated
benefit, it can be adopted for all proteomics experiments, as
we have done for some time in our laboratory.
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Prologue 
Since the early days of tandem mass spectrometry, fragmentation chemistry has been of great 
interest to researchers as the data can be used to determine structure and composition of the 
substances under investigation. Especially for unknown small molecule species, tandem mass 
spectra often appear to some extent random, despite a number of common fragmentation rules, 
well-described rearrangements or typical neutral losses that are summarized in entire books. In 
contrast, the chemistry involved in peptide fragmentation is much less complex, because the 
regular peptide backbone structure results in quite predictable fragmentation spectra. Usually, the 
peptide bonds are the weakest ones of the molecule and are therefore cleaved first if appropriate 
collision energy is applied. As a result, the fragmentation spectra of peptides feature sequence 
ladders from N- to C-terminus and in the opposite direction. Reading out the amino acid 
sequence is in principle relatively straightforward.  
In practice, however, peptide fragmentation is an extensive area of research by itself, because the 
fragmentation spectra contain many more peaks than just backbone fragments. Furthermore, 
fragmentation pathways are of scientific interest as are the energetic aspects of the fragmentation 
process in the gas phase. For collision-induced fragmentation of protonated peptides, one result 
of such studies was the mobile proton model117. It provides a framework for understanding the 
necessity of a certain number of protons for peptides with a certain number of basic amino acids 
for the generation of interpretable fragmentation spectra.  
Systematic investigations of fragment ions obtained from specifically designed synthetic peptides 
reveal patterns that keep occurring in fragmentation spectra, e.g. the exceptional existence of b1 
86 
 
ions or high abundance of fragment ions that contain an N-terminal proline118,119. Experienced 
mass spectrometrists are familiar with these processes and are able to explain nearly all fragment 
ion peaks of a peptide tandem mass spectrum. Often it is very helpful to try to resolve the entire 
spectrum in this way, because reporter ions or specific neutral losses reveal important 
information that make peptide identification more reliable.  
Despite decades of extensive research, the greatest number of peptide fragmentation spectra has 
probably been obtained very recently in modern large-scale proteomics experiments. Here, 
however, the focus is usually on biological questions and due to the overwhelming number of 
spectra, automated data analysis software and search engines are inevitably applied. Moreover, 
sophisticated software tools such as MaxQuant perform very accurate mass calibration to the data 
and apply statistical concepts to ensure proper data analysis. Conversely, search engines only 
incorporate very basic knowledge of peptide fragmentation for the identification. As a result, 
visual inspection of the results may leave researchers puzzled due to many unannotated peaks.  
The recent success of the high-high strategy in shotgun proteomics now allows explaining the 
origin of fragment ion peaks much more confidently. We were motivated by the excellent quality 
of HCD fragmentation spectra as routinely acquired on the Orbitrap instruments (LTQ Orbitrap 
Velos, Q Exactive and Orbitrap Elite) since 2009, to revisit the extensively studied subject of 
peptide fragmentation chemistry. The aim of this project was to iteratively perform a large-scale 
statistical investigation into the ion types occurring in collision induced fragmentation spectra and 
develop a computer-assisted Expert System to automatically annotate fragment ion spectra with 
information beyond that provided by standard peptide search engines. This Expert System 
features a knowledgebase that contains all fragmentation patterns that we collected and evaluated 
based on our experience. It uses a rule engine to apply this codified experience to identified 
spectra. While novice users primarily benefit from the comprehensive annotation with which they 
can quickly become experts themselves, advanced scientists can modify and extend the rule set 
according to their specific question (Article 7). We then employed this novel software tool for a 
broad inquiry into the nature of fragment ion peaks of tryptic peptides. A detailed comparison of 
the ion types in HCD and high resolution CID reveals a greater variety of fragment ions in HCD. 
Nevertheless, after applying the Expert System the overall percentage of explained or annotated 
MS/MS intensity is very comparable at a median of about 85% for both. This corresponds to a 
35% increase compared to the annotations resulting from standard database identification. We 
further demonstrated the flexibility of the system by adapting the rule set to phosphorylation 
events (Article 6).  
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ABSTRACT: Modern mass spectrometry-based proteomics can produce millions
of peptide fragmentation spectra, which are automatically identified in databases
using sequence-specific b- or y-ions. Proteomics projects have mainly been
performed with low resolution collision-induced dissociation (CID) in ion traps
and beam-type fragmentation on triple quadrupole and QTOF instruments.
Recently, the latter has also become available with Orbitrap instrumentation as
higher energy collisional dissociation (HCD), routinely providing full mass range
fragmentation with high mass accuracy. To systematically study the nature of HCD
spectra, we made use of a large scale data set of tryptic peptides identified with an
FDR of 0.0001, from which we extract a subset of more than 16 000 that have little
or no contribution from cofragmented precursors. We employed a newly
developed computer-assisted “Expert System”, which distills our experience and
literature knowledge about fragmentation pathways. It aims to automatically
annotate the peaks in high mass accuracy fragment spectra while strictly controlling the false discovery rate. Using this Expert
System we determined that sequence specific regular ions covering the entire sequence were present for almost all peptides with
up to 10 amino acids (median 100%). Peptides up to 20 amino acid length contained sufficient fragmentation to cover 80% of
the sequence. Internal fragments are common in HCD spectra but not in high resolution CID spectra (10% vs 1%). The low
mass region contains abundant immonium ions (6% of fragment ion intensity), the characteristic a2, b2 ion pair (72% of spectra),
side chain fragments and reporter ions for peptide modifications such as tyrosine phosphorylation. B- and y-ions account for only
20% of fragment ions by number but 53% by ion intensity. Overall, 84% of the fragment ion intensity was unambiguously
explainable. Thus high mass accuracy HCD and CID data are near comprehensively and automatically interpretable.
KEYWORDS: tandem mass spectrometry, fragmentation mechanisms, shotgun proteomics, ion types, CID, HCD, Expert System,
spectrum annotation
■ INTRODUCTION
Rapid technological development of mass spectrometric
instrumentation in conjunction with advanced bioinformatics
analysis capabilities now allow relatively streamlined and in
depth analysis of proteomic samples.1−3 Modern proteomics
projects routinely generate millions of fragmentation spectra,
making entirely automated software tools a necessity. These
include search engines that match MS/MS spectra to the most
probable peptide sequence in a database, typically relying on
sequence-specific backbone fragments, referred to as “regular
ions” in this article, as well as associated neutral losses.4
However, there are many other fragment ions in tandem mass
spectra, and it has been argued that detailed interpretation of at
least the more abundant peaks should be a requirement for
confident peptide assignment.5 Likewise, detailed understand-
ing of the fragmentation process and discovery of potential new
fragment types requires knowledge of the identity of the
majority of fragmentation peaks.
While there are many different ways to fragment peptides, in
proteomics collision-induced fragmentation has by far been the
most frequently used technique (for a recent tutorial of peptide
fragmentation and spectrum interpretation, see ref 6). While
there are differences in how the ions are activated, the general
ion types are the same and are summarized in Figure 1. The
backbone fragments are designated as a, b, c for N-terminal and
x, y, z for C-terminal types depending on the cleavage position
on the peptide backbone.7−10 A full series of either b- or y-type
ions in principle allows reading out the entire amino acid
sequence from a fragment ion spectrum. In collision-induced
fragmentation techniques, cleavage of the peptide bond is
preferred, but labile post-translational modifications such as
phosphorylation or glycosylation also partially or (rarely)
completely detach. While the chemistry involved in peptide
fragmentation is still not completely understood, the mobile
proton model is currently the most widely accepted framework
to describe the dissociation process.11,12 Moreover, different
fragmentation pathways of protonated peptides have been
extensively investigated and modeled with respect to both
kinetic and thermodynamic aspects.13
In addition to the standard backbone ions, tandem mass
spectra can contain many additional fragment ions.14
Numerous studies of peptide dissociation behavior have been
carried out to investigate the abundance and structure of ion
types such as internal ions, immonium ions or neutral losses
from these (Figure 1).15,16 Some programs such as Protein
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Prospector provide comprehensive lists of produced ion types
for different fragmentation mechanisms and instrument types
and even consider the latter for scoring of tandem mass
spectra.17 Furthermore, special types of ions have been
characterized, for instance, b1 ions of N-terminally acetylated
ions,18 c1 ions in case glutamine is the second amino acid from
the N-terminus,19,20 specific side chain losses such as from
oxidized methionine21 and many more. Finally, novel
fragmentation processes continue to be discussed controver-
sially, such as the extent of scrambling of b-ions due to their
formation of a cyclic peptide structures followed by random
cleavage, which could interfere with determination of the
correct amino acid sequence from the data.22−25
Furthermore, the observed types of fragment ions in a
tandem mass spectrum depend on the instrument type. Triple
quadrupole and quadrupole time-of-flight (TOF) fragmenta-
tion are beam-type dissociation processes,26 where primary
fragments retain kinetic energy and are therefore more likely to
fragment again in the multiple collision conditions typical of
these instruments. In 3D or 2D ion traps the excitation and
activation step is only applied to the selected precursor mass.
Any primary fragmentation product is off-resonance with the
applied radio frequency and therefore usually remains intact.
When collision-induced dissociation is performed in ion traps
(often primarily associated with CID fragmentation), the low
mass fragments are typically not retained, leading to a low mass
cutoff in the tandem mass spectra.27
Higher energy collisional dissociation (HCD), first described
in 2007, made beam type fragmentation available on the
Orbitrap analyzer platforms.28 Recently, HCD fragments have
also been analyzed at low resolution in an ion trap29,30 but are
in general always detected in the Orbitrap analyzer at high
resolution and mass accuracy. Since the introduction of the
LTQ Orbitrap Velos mass spectrometer, which features
improved sensitivity and HCD capability compared to its
predecessors, routine acquisition of tandem mass spectra in the
Orbitrap analyzer has become feasible.31 This approach is
termed “high−high” strategy because both the full scans (MS)
and the fragment ion scans (MS/MS) have high resolution and
high mass accuracy in comparison to previous strategies with
Figure 1. Cleavage sites of the peptide backbone giving rise to N-terminal a-, b- or c-type ions and the corresponding C-terminal x-, y- or z-type ions,
respectively. The most prominent cleavage in CID and HCD fragmentation happens at the peptide bond. The boxes below represent the most
frequent ion types of collision induced fragmentation processes; the color code provides their origin in the peptide sequence.
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acquisition of CID scans (MS/MS) in the ion trap (“high−
low”).32 Note that high−high strategies have been the default in
quadrupole-TOF instruments for many years; however, this did
not necessarily imply high mass accuracy in the MS/MS mode,
primarily due to issues with ion statistics. Because of the
dedicated collision cell, HCD fragment ion spectra cover nearly
the entire mass range and are therefore particularly suitable for
observing the low mass region, which contains an a2/b2 pair,
immonium ions, fragments resulting from the amino acid side
chains as well the reporter ions18 used for quantification in the
TMT or iTRAQ methods.33−35 Importantly, high mass
accuracy of fragment ions helps to unambiguously annotate
the fragment ion peaks. Especially in the low mass region, an
accurate mass measurement may even uniquely determine the
elemental composition of the fragment.
In contrast to ion trap CID data, high resolution HCD has
been relatively little studied. Although HCD ion types are
expected to recapitulate fragmentation rules known from older
CID type instruments, those have not been tested on large-
scale and high accuracy data. Here, we wished to take advantage
of the excellent signal-to-noise, dynamic range and mass
accuracy of HCD spectra on the Orbitrap analyzer to
systematically investigate features of HCD spectra. This was
facilitated by a rule-based “Expert System”, which was
developed in an iterative manner with this study and is
described elsewhere.36 This Expert System synthesizes well-
established knowledge about peptide fragmentation pathways
mechanisms. It is capable of annotating large-scale MS/MS data
sets based on the rules chosen by the researcher. We apply the
Expert System for a comprehensive statistical investigation into
the nature of HCD tandem mass spectra of tryptic peptides.
■ EXPERIMENTAL PROCEDURES
Sample Preparation
Total cell extracts of E. coli, yeast and HeLa cells were separated
by 1D-SDS PAGE (4−12% Novex mini-gel, Invitrogen) in
three separate lanes. Colloidal Coomassie (Invitrogen) was
used for staining of the proteins before each lane was cut into 8
or 10 slices. All gel slices were subjected to reduction of the
proteins with 10 mM DTT in 50 mM ammonium bicarbonate
and subsequently alkylated with 55 mM IAA in 50 mM
ammonium bicarbonate. In-gel digestion with 12.5 ng/μL
trypsin (Promega) in 50 mM ammonium bicarbonate was
carried out at 37 °C for 12 h followed by extraction of the
tryptic peptides with 3% TFA in 30% ACN.37 Peptides were
loaded on C18 StageTips
38 before eluting them with 80% ACN
in 0.5% acetic acid prior to analysis.
HeLa cell lysate was digested according to the filter-aided
sample preparation (FASP) method.39 Briefly, the lysate was
solubilized in SDS-containing buffer and loaded onto Microcon
YM-30 devices (Millipore, Billerica, MA, USA) to remove SDS
and exchange it by urea. The protein mixture was alkylated with
50 mM iodoacetamide before urea was replaced with 20 mM
ammonium bicarbonate. The proteins were digested overnight
at 37 °C with trypsin (Promega) (1 μg of trypsin/100 μg of
protein). Peptides were collected from the filter after
centrifugation. For enrichment of phosphorylated peptides,
the mixture was acidified with trifluoroacetic acid to pH 2.7 and
ACN was added to a final concentration of 30%. Incubation
with TiO2 beads
40 (MZ Analysentechnik, Germany) prepared
in 30 mg/mL solution of dihydrobenzoic acid (Sigma) was
carried out for 30 min, before the beads were washed with 30%
ACN and 3% TFA (twice) followed by two washes with 75%
ACN and 0.3% TFA. The phosphopeptides were eluted with
buffer containing 15% ammonium hydroxide and 40% ACN.
Finally, the eluted phosphopeptides were loaded on C18
StageTips before they were eluted with 60% ACN in 0.5%
acetic acid prior to analysis.
LC−MS/MS Analysis
For the analysis of proteome samples, the peptide mixture was
separated on a C18-reversed phase column (15 cm, 75 μm ID,
packed in-house with ReproSil-Pur C18-AQ 3 μm resin, Dr.
Maisch GmbH). An Easy-nLC (Thermo Scientific, Odense)
with IntelliFlow system was used for sample loading and
operated at a constant flow rate of 250 nL/min during the 110
min linear gradient of 8−60% buffer B (80% ACN and 0.5%
acetic acid). A nanoelectrospray ion source (Thermo Scientific,
Odense) was used for online coupling to the LTQ Orbitrap
Velos mass spectrometer.31 Mass spectra were measured in
positive ion mode applying a data-dependent “top 10” method
for the acquisition of a survey scan followed by MS/MS spectra
of the 10 most abundant precursors. High resolution data was
acquired in the Orbitrap analyzer with a resolution of 30 000
(m/z 400) for MS and 7500 (m/z 400) for MS/MS scans. For
peptide fragmentation higher energy collisional dissociation
(HCD) was used applying a normalized collision energy of 40
eV. The minimal signal threshold required was set to 5000. The
target value in the Orbitrap analysis was 1 × 106 for the MS
scans and 5 × 104 for the MS/MS scans with 2 Th isolation
window and the first mass was set to 80 Th for HCD spectra.
Fragmented precursors were dynamically excluded from
targeting for 90 s. High resolution CID data was acquired on
an Orbitrap Elite (Thermo Scientific) the same parameters;
however, the resolution for MS scans was 120 000 (m/z 400)
and for MS/MS scans 15 000 (m/z 400); the normalized
collision energy was set to 35 eV.
For the phosphoproteome data, the enriched peptide
mixtures were separated on a C18-reversed phase column (20
cm, 75 μm ID, packed in-house with ReproSil-Pur C18-AQ 1.8
μm resin, Dr. Maisch GmbH) applying a 90 min linear gradient
of 5−30% buffer B (80% ACN and 0.1% formic acid) and
analyzed on the Orbitrap Elite instrument41 that was online-
coupled to an Easy-nLC 1000 (Thermo Scientific, Odense).
The MS data was acquired with resolution of 120 000 (m/z
400) and target value of 1 × 106 and MS/MS (HCD
fragmentation) with resolution of 15 000 (m/z 400) and target
value of 5 × 104 in a data-dependent “top 15” method with a
dynamic exclusion of 30 s. The signal threshold was set to 5000
for an isolation window of 2 Th and the first mass of HCD
spectra to 80 Th. The collision energy was set to 35 eV.
Data Analysis
All spectra were processed with MaxQuant42 version 1.2.5.2
using the Andromeda search engine43 to search the MS/MS
spectra with trypsin specificity against the IPI human database
(version 3.68, 87 061 entries) combined with 262 common
contaminants. We allow for up to 2 missed cleavages and N-
terminal acetylation and methionine oxidation were selected as
variable, carbamidomethylation of cysteine was selected as fixed
modification. For MS spectra an initial mass accuracy of 7 ppm
was allowed, and the MS/MS tolerance was set to 20 ppm for
fragment detection in the Orbitrap analyzer for high resolution
CID and HCD. A sliding mass window was applied to filter the
MS/MS spectra for the 10 most abundant peaks in 100 Th. For
identification, the peptide FDR was set to 0.0001. (The protein
Journal of Proteome Research Article
dx.doi.org/10.1021/pr3007045 | J. Proteome Res. 2012, 11, 5479−54915481
89
FDR remained at the standard setting of 0.01, but protein
identifications were not directly used in this paper.) The
shortest peptide length was set to 6 amino acids, and the Max
Quant feature to treat the isobaric amino acids leucine and
isoleucine as indistinguishable for improved statics was
disabled. This setting ensures that either amino acid matches
the fragmentation spectrum as HCD in our setup cannot
distinguish them; however, side chain losses can then be
assigned correctly because the isoleucine/leucine ambiguity is
absent after database search. MaxQuant and Andromeda data
processing provides access to the peptide sequences that were
identified from the MS/MS spectra. Detailed annotation of the
MS/MS spectra was then carried out using the Expert
System.36 Results were further analyzed within the R scripting
and statistical environment.44 Raw mass spectrometric data are
available at Tranche (www.proteomecommons.org) using the
following hash code:
pI2oaLaS i7gPxUWNbesdXCgR17sWvMY6qVkHL
+MtWA0Q5sqn/UxZVSjk3KpFTfrmDYpf3y/Iv6WfaAi6-
HaILdZL0YocAAAAAAAAT7Q==
■ RESULTS AND DISCUSSION
Generation of a High Quality Data Set
To produce a diverse set of fragmentation spectra of tryptic
peptides, we separated proteomes of E. coli, yeast and HeLa
cells by one-dimensional gel electrophoresis, excised eight slices
and in-gel digested them (Experimental Procedures). This
generated a total of 24 complex peptide mixtures, which were
analyzed using a “high−high” strategy on a linear ion trap−
Orbitrap instrument (LTQ Orbitrap Velos) using HCD as the
fragmentation method. For a smaller number of fractions, we
also employed CID fragmentation followed by high resolution
detection of fragments in the Orbitrap analyzer (Experimental
Procedures).
We wished to work with an extremely high quality set of
fragmentation spectra in order to enable us to unambiguously
attribute the observed fragments to the precursors. Therefore,
we set the false discovery rate (FDR) for peptide identification
by MaxQuant using the Andromeda search engine42,43 to
0.0001 rather than the customary 0.01. From our data set, we
obtained more than 100 000 MS/MS spectra that were
identified with this very stringent criterion. We and others
have recently introduced the notion of the precursor intensity
fraction (PIF),45 chimeric or mixture MS/MS spectra,46,47
which refers to the fact that precursor ions are frequently
Figure 2. Peak annotation by the Expert System. (A) Ranking of the six major ion types: intact precursor mass [M+nH]n+, regular ions, immonium
ions (IM), internal fragments, neutral losses and side chain fragments that are considered for peak annotation by the Expert System. (B) Average
intensity coverage of the total intensity of >100 000 MS/MS spectra by standard search engine annotation (Andromeda, red line) and by the Expert
System (black line) vs the precursor intensity fraction “PIF” provides a measure for the purity of precursor isolation. The high quality data set (16
000 spectra) that was selected for statistical investigation is highlighted in gray. (C) Typical MS/MS spectrum with PIF 0.99 annotated by the Expert
System reaching an intensity coverage of 87%. A zoom window displays the high mass accuracy of two fragment ion peaks.
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cofragmented unintentionally in the analysis of complex
peptide mixtures. For our purposes we needed to minimize
the occurrence of coeluting precursor ions in the isolation
window so that they could not “contaminate” the MS/MS
spectra with unassignable peaks. This was achieved by only
retaining spectra with a PIF greater than 0.95. If there was more
than one spectrum for a particular sequence, the one with the
highest PIF was kept. Furthermore, we required the peptide
length to be smaller than 26 amino acids and the charge state to
be 2+, 3+ or 4+. These filters reduced the number of MS/MS
spectra to about 16 000, which were nearly free of any
contaminating peaks and which represented a broad sampling
of typical tryptic peptides.
Computer-Assisted Annotation by the Expert System
We recently developed a computer Expert System,36 which is
now integrated into the Viewer component of the MaxQuant
software environment. Briefly, the Expert System features a
knowledgebase that was supplied with peptide fragmentation
mechanisms described in the literature (see Introduction) and
with knowledge gained from manual evaluation of small and
large-scale HCD data sets. These facts are implemented in a
rule-engine that assigns annotations to the peaks in the MS/MS
spectra. In order to avoid incorrect assignments, the Expert
System follows strict dependencies among its rules. We derived
a rigorous FDR for peak annotation, which made it possible to
derive a minimal yet relative comprehensive set of rules.36
Some MS/MS peaks can have an elemental composition that
corresponds to more than one ion type, and we have developed
a strict ranking of the possible annotations to address this
particular issue (Figure 2A). On the basis of the identified
peptide sequence, regular ions that result from cleavage of
peptide bonds (b- and y-type ions), a-type ions that derive from
the corresponding b-type ion by losing CO and c-type ions that
occur in specific cases,20 are assigned the highest priority for
annotation. The chemical structures of regular ions and
immonium ions are different, and as a consequence, there is
no possible overlap between them. Therefore the order of
assignment is of no consequence, and they are treated with the
same priority. The second step covers annotations of neutral
losses and internal fragment ions; these types derive from
regular backbone ions. Importantly, neutral losses are specific
to N- or C-termini of fragments or to a single or several amino
acids. These are required to be contained in the peptide
sequence to allow an annotation. Internal fragment ions
originate from regular ions that have undergone a second
cleavage of the peptide backbone. The side chains of the amino
acids tryptophan (W), arginine (R) and lysine (K) are prone to
produce specific fragment ions that can carry a proton because
of the heteroatom in their chemical structure. Their mass is
sufficiently large (>100 Da) that they are recorded in HCD
fragment ion spectra as side chain fragment ions. They are
assigned a low priority because they are independent of any
Figure 3. Sequence information content in HCD and CID spectra (A) Median coverage of amino acids by y-type ions (red), b-type ions (blue) and
both together (black) in the upper panel. The boxplot displays the distribution of the peptide length within the data set (>16 000 spectra). The lower
panel shows the median length of the longest sequence tag based on y-type ions (red), b-type ions (blue) and both together (black). (B) Same as
(A) for a data set of 3290 high resolution CID spectra. The dashed gray line in the upper panel repeats the median amino acid coverage in HCD
from panel (A) for comparison.
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other ion type. Finally, incomplete fragmentation results in
protonated precursor ions remaining in the MS/MS spectra,
which are annotated as [M+nH]n+.
The Expert System greatly improves on the number and
intensity coverage of assigned peaks in the fragmentation
spectra calculated by adding the signal for the 10 largest peaks
per sliding 100 Th window. Standard annotation by the
Andromeda search engine results in an intensity coverage of up
to 58% for pure spectra (PIF > 0.95; highlighted in gray in
Figure 2B). Including the additional ion types that are covered
by the Expert System increased the intensity coverage to 84%.
With the Expert System in hand, we next annotated all of the
about 100 000 high scoring fragment spectra in the initial set.
This showed that even for impure MS/MS spectra (PIF less
than 0.5), the intensity coverage of assigned peaks in MS/MS
spectra was still above 50%. A typical MS/MS spectrum with a
high PIF precursor that was comprehensively annotated by the
Expert System is displayed in Figure 2C. Virtually all major
peaks are correctly annotated and fragment intensity coverage
reaches 87%. The figure also illustrates the mass accuracy
typically achieved in our experiment. Even though the lock
mass feature during data acquisition was enabled,48 data
analyzed with Max Quant is routinely independently
recalibrated.49
Sequence Related Information Content of HCD Spectra
The most important information imbedded in tandem mass
spectra relates directly to the amino acid sequence of the
peptide. Cleavage of all peptide bonds, resulting in b- and y-
type ion series, would in principle allow read out of the peptide
sequence from the MS/MS spectrum in two directions starting
from the N- or the C-terminus, respectively. Moreover,
combining the b- and y-ion series highlights complementary
b- and y-type ions pairs that together match the mass of the
unfragmented peptide. Complementary pairs provide strong
constraints for correct peptide identification and can be used in
scoring algorithms even of multiplexed spectra.50
In our large collection of HCD data, we found nearly
universal evidence for such pairs. Typical spectra have the
prominent a2/b2 pair (observed in 72% of the peptide
sequences) followed by at least a few more b-ions. Y-ion series
were very abundant in our spectra, especially in the middle
mass range (450−800 Da). For peptides that were not too long
(<20 amino acids), the low mass b-ion series almost always had
a corresponding, complementary y-ion series of high intensity.
These trends are well-known from triple quadrupole and
quadrupole time-of-flight spectra.
We next evaluated all 16 000 HCD spectra in the collection
(Figure 3A). Remarkably, for peptides up to 12 amino acids the
y-ion series alone provided for at least half of the sequences
complete sequence coverage (median 100%), indicating that
complete sequencing of such peptides even in routinely
acquired large-scale data sets is in principle possible. This
includes the order of the two first amino acids, which is
normally inaccessible because of the missing yn−1 and b1 ions
(see below). With increasing peptide length, the amino acid
coverage slowly drops to a median of 50% at a peptide length of
25 amino acids, which was the upper limit in our collection
(Figure 3A). The b-ion series, in contrast, remains at a constant
level, providing about 30% amino acid coverage independent of
the peptide length. Taking both ion series together yields
median amino acid coverage of 80% percent even for a peptide
length of 20 AA.
Besides the percentage of the sequence that is covered by
backbone fragmentation, another important parameter is the
number of amino acids that can be read out from the MS/MS
spectrum as an uninterrupted part of the sequence, i.e., the
maximum sequence tags length.51 A sequence tag of six amino
acids is generally unique in the human genome even without
added peptide mass information.6,52 In addition to peptide
identification, such stretches are useful for partial de novo
sequencing or homology searching. The lower panel in Figure
3A depicts the median sequence tag lengths based on the two
different ion series of the identified sequence. Peptides up to 10
amino acids contain a complete y-ion based sequence tag, but
above this length, the yn − 1 ion is often of too low intensity to
be recorded. Even small peptides contain short sequence tags of
three amino acids, which are sufficient for peptide identi-
fication. When combined with the y-ion series, the b-ion series
helps to increase the sequence tag length for peptides larger
than 14 amino acids. The largest median sequence tag length is
about 12 amino acids, and it starts to drop from a peptide
length of 16 amino acids.
We next compared the sequence related information content
of HCD with that of high resolution CID spectra both acquired
in the Orbitrap analyzer. A prominent difference is the much
larger contribution of the b-ion series in CID spectra (Figure
3B). This is due to the higher stability of b-ions in ion trap
fragmentation processes. Although lower than the y-ion series,
the b-ion series continued to provide a median of more than
50% sequence coverage up to a peptide length of 19 amino
acids. Nevertheless, the combined contribution from y-ions and
b-ions was slightly higher for HCD than for CID, which partly
reflects the more extensive fragmentation in beam type
instruments and the fact that ion series in CID spectra are
limited by the low mass cutoff that is inherent to ion trap
fragmentation. As a consequence, maximum sequence tag
length was likewise higher in HCD spectra.
We have previously investigated maximum sequence tag
lengths in low resolution CID spectra. In more than 85% of the
identified spectra sequence tags of at least three amino acids
and only in half of the spectra sequence tags of six or more
amino acids were detected.52 Despite the potential for
overcounting due to the lower mass accuracy, these sequence
tags were substantially shorter than tags from either high
resolution HCD or high resolution CID.
Neutral Loss Fragments in HCD
During collision-induced dissociation processes, peptides can
follow numerous fragmentation pathways and consequently
give rise to various ion types beyond those produced by the
typical peptide backbone cleavage. A large class of such ions are
those involving neutral losses from different fragment species.
These occur from nearly all ion types, however, the chemical
structures of the diverse ion types as well as the amino acid side
chains allow specific neutral losses (Figure 2A). In some cases,
these can result either from the peptide terminus or from one
of the side chains of the amino acids, and localization of the
origin is not straightforward. However, such losses can still be
unambiguously assigned to the fragment ion. We carried out a
systematic study considering 45 possible chemical compositions
that could formally occur as neutral losses from amino acid
residues. We then used our large scale data set to determine the
primary neutral losses for all of the fragments in the collection
that contained the amino acid in question. The median absolute
mass accuracy of all neutral losses is 2.7 ppm with 97.5% of the
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peaks within 5 ppm, therefore they can unambiguously be
connected to their precursor fragments. Only first neutral losses
which happened in at least 5% of the cases were considered and
encoded in the Expert System.36 Table 1 summarizes the
observed frequencies of the primary neutral losses that occur in
different combinations in more than 270 000 fragments. While
b-type ions frequently lose a water molecule, the chemical
structure of y-type ions allows both water and ammonia losses.
These are by far the most frequent neutral losses. Furthermore,
acidic amino acids as well as serine and threonine are likely to
lose water. However, it was possible in about 48% of the cases
to assign the neutral loss to either a specific amino acid or the
C-terminus of the fragment, because there was only one
possible origin for the water loss. At least 33% of the spectra
from sequences that contain glutamic acid, serine or threonine
exhibit water losses from those amino acids. This is the case in
only 29% of spectra where the water loss can be confidently
assigned to aspartic acid. The rate of ammonia losses is
comparable to water losses and this also holds true for
confidently assignable losses from glutamine (29%), asparagine
(30%) and arginine (21%). Further frequently observed neutral
losses that are specific to certain amino acids include CH3NO
from glutamine (20%) and from asparagines (29%) or C2H4O
from threonine (26%). While other neutral losses may exist, our
large data set suggests that they are unlikely to occur at
substantial frequencies in HCD spectra.
Internal Fragments
Internal fragments in the MS/MS spectra are characteristic of
beam-type fragmentation because these result from ions
undergoing a second cleavage resulting in a C-terminal
carboxyl-group and an N-terminal oxazolone structure.13,53 In
our large-scale data set, the length of internal fragments varied
between two and more than 10 amino acids, depending on
peptide length. The majority of internal fragments, however,
are shorter than five amino acids. Proline is most often the first
amino acid of an internal fragment since N-terminal cleavage is
very pronounced at this amino acid; this is called the proline
effect.54 However, we found that on the basis of peak presence,
rather than peak intensity, proline initiated internal sequences
were more than four times as common as those of the median
of other amino acids (Supporting Information, Figure S1A).
For cleavage at the C-terminal amino acid of an internal
fragment there is a slight preference for aspartic acid, glutamic
acid, glutamine, tryptophan and histidine (Supporting
Information, Figure S1B). Proline is the least common amino
acid at the C-terminus of internal ions.
Low Mass Region
HCD fragmentation takes place in a dedicated collision cell and
is not subject to the low mass cutoff of ion trap CID spectra,
therefore in principle allowing observation of the entire mass
range. In practice, HCD spectra are normally acquired from m/
z 100, but for a more extensive investigation of the low mass
region we acquired data in our study from m/z 80, which was
the lowest practical m/z without reducing the scan speed of the
instrument. Therefore our data set does not contain immonium
ions with an m/z lower than 80 Th.
Figure 4B displays the frequency of immonium ions in the
MS/MS spectra. The most prominent immonium ions
originate from phenylalanine (F), tryptophan (W) and tyrosine
(Y) and can be observed in at least 84% of all peptide
sequences containing the respective amino acid. This is due to
their chemical structure containing both a heteroatom and an
aromatic system that are prone to stabilize a positive charge and
for the same reason, the immonium ion of histidine (H) is
often present (70%). Carbamidomethylated cysteine (caC),
glutamine (Q) and glutamic acid (E) immonium ions (61, 52,
and 37%, respectively) can also be found relatively abundantly
in the spectra. Aspartic acid (D) and asparagine (N) produce a
significantly lower rate of immonium ions. Interestingly,
immonium ions of isoleucine (I) and leucine (L) are detected
in the MS/MS spectra with different frequencies. Immonium
ions of glycine (G), alanine (A), serine (S), proline (P), valine
(V) and threonine (T) are not observed in our, data as their m/
z is below 80 Th. Arginine (R) and lysine (K) represent special
cases due to their position at the N-termini of tryptic peptides.
A very frequently observed ion is the immonium ion of lysine
with an ammonia loss (IM K − NH3). In fact, this ammonia
loss often occurs even without immonium ion, and this was
therefore implemented as an exception to the strict require-
ment for a detected precursor fragment in the Expert System.
Immonium ions can be used to support the peptide sequence
assignment. In special cases, such as phosphotyrosine (pY),
immonium ions can be used as reporter ions to verify the
existence and the nature a phosphorylation site (see
below).55,56
Another fragment ion type in the low mass region are
fragment ions that result from cleavage of amino acid side
chains in which the molecular structure can stabilize a proton.
This is the case for some of the amino acids that contain a
nitrogen atom, such as arginine, lysine and tryptophan. The
chemical compositions of the side chain fragments and their
frequency of occurrence are displayed in Figure 5C. Note that
these side chain fragments are different from the v-, w- and d-
type ions from high energy CID dissociation carried out on
TOF/TOF instruments.57,58 In addition to the general ion
types, certain amino acid side chains follow different
Table 1. Neutral Losses Considered by the Expert System
and Fraction of Spectra That Contain the Loss from the
Corresponding Amino Acida
NH3 45% (N-term) 30% (N) 29% (Q) 21% (R)
H2O 48% (C-term) 37% (S) 44% (T) 21% (D) 33% (E)
CO 84%
(internal)b
CO2 5% (D)
CH2N2 8% (R)
CH3NO 29% (N) 20% (Q)
CH4O 5% (S)
CH4SO 89% (Mox)
C2H4 5% (I)
C2H5NO 9% (N) 6% (Q)
C2H4O 26% (T)
C2H4O2 6% (D) 6% (E)
C3H6 6% (L)
C3H9N3 6% (R)
C3H6SO 6% (Mox)
C3H8SO 12% (Mox)
C4H8 5% (L)
C8H7N 6% (W)
C9H9N 12% (W)
aOnly examples allowing unambiguous localization of the origin of the
neutral loss were considered. bThis ion is formally equivalent to an a-
type internal fragment.
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fragmentation pathways resulting in unusual ion types.
Lehmann and co-workers observed c1 ions resulting from the
N-terminal amino acid of the peptide, if the second amino acid
is glutamine (Q).19,20,59 Along these lines, we investigated
asparagine and carbamidomethylated cysteine and found the
same behavior for these two candidates. Furthermore, b1 ions
are usually not observed because of their chemical instability.
However, we did observe b1 ions from acetylation of
methionine, serine or alanine at the protein N-terminus. This
is thought to be due to stabilization of this fragment by the
acetyl group.18,60 Besides the qualitative information contained
in the variety of ion types of natural peptides, the low mass
region in HCD fragmentation also gives access to the reporter
ions for the TMT61 and iTRAQ33 quantification methods.34,35
The reporter ions of TMT and iTRAQ are at m/z 126.1277,
127.1248, 128.1344, 129.1315, 130.1411, 131.1382 and m/z
114.1112, 115.1146, 116.1116, 117.1150, respectively. Inves-
tigation of our large-scale and high accuracy data set revealed
no interfering ions of the same m/z. Therefore problems in
quantification by these methods are confined to cofragmenta-
tion of other labeled peptides rather than other ion types that
have the same mass as these reporter ions.
Global Composition of Tryptic HCD Spectra
The different ion types covered by the Expert System, such as
regular ions, neutral losses, internal fragments, immonium ions,
side chain fragments and the intact peptide mass [M+nH]n+ by
their nature occur in MS/MS spectra with different frequencies
(Figure 5A). However, for high confidence of peptide
identification it is predominantly the highly abundant MS/
MS peaks that are of interest. Figure 5B displays the
contribution of each of the ion types to the overall intensity
coverage: Regular ions (a, b, c and y) account for 54% of total
MS/MS spectra intensity and peaks that result from neutral
losses for a further 15%. Immonium ions can originate from
several amino acids, and these signals are added as singly
charged peaks at defined masses in the low mass region.
Together, their mean contribution to the total intensity
coverage is 6%. Unlike immonium ions, internal fragments
are spread over the low to middle mass range of the MS/MS
spectrum because they can be generated by any two cleavages
of the peptide backbone, and hence they are not as obvious in
tandem mass spectra. As described above, in HCD internal
fragment ions are frequently observed. However, their
abundance is lower than that of immonium ions or y-ions,
and together they contribute 10% to the total fragment
intensity. The protonated unfragmented peptide precursor only
has an average intensity coverage less than 1% in our data set.
Side chain fragments account for only 0.1% of total peaks and
an intensity coverage of less than 0.1% and are therefore not
displayed in the pie chart. The fraction of unannotated peaks
accounts for 44% on the basis of the 10 largest peaks per
hundred Th but only for 15% with regard to total intensity
coverage. This provides evidence that remaining peaks are
mainly of low abundance. Note that those, beyond potentially
being noise peaks, could also result from combinations of
multiple neutral losses without precursor fragments or similar,
which were not allowed by the Expert System to maintain a
strict false positive rate. Furthermore, cofragmentation of other
precursors still occurs in our data set to some degree. Together,
our data suggests that nearly all fragment peaks in HCD are
Figure 4. Statistics on the low mass region fragment ions from 16 000 MS/MS spectra. (A) Histogram of the length of all internal fragment ions in
purple; the fraction of internal fragment ions starting with proline is highlighted by light color. (B) Percentage of immonium ion (IM) occurrence if
the amino acid corresponding amino acid was at least once contained in the peptide sequence. Immonium ions of Alanine, Glycine, Proline, Serine
and Threonine were not considered, because their m/z value is lower than 80 Th. (C) Bar plot displaying the five most abundant side chain fragment
ions that are automatically assigned by the Expert System with their total number of occurrences within the data set and their chemical structures.
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explainable on the basis of current understanding of
fragmentation pathways.
We next repeated the same analysis as above for high
resolution CID spectra, which resulted in quite similar findings
for the number of peaks. As expected, the number of
immonium ions and internal fragments was drastically reduced
since ion trap fragmentation is not capable of retaining the low
mass region of the tandem mass spectra and their formation
requires double cleavage. Together with the higher preponder-
ance of high mass b-ions, this has the effect of increasing the
fraction of regular ions to 32% as compared to the 20% of HCD
fragmentation. On the basis of intensity coverage, this effect is
less pronounced (72% for CID compared to 54% for HCD).
Interestingly, using the Expert System the fraction of
unannotated peaks by intensity is very similar between CID
(17%) and HCD (15%).
Characteristics of Phosphorylated Peptides
Protein phosphorylation is among the most important and best
studied post-translational modifications and is almost always
located at serine, threonine or tyrosine in mammalian cells.
Because of its chemical nature, the phosphogroup easily
detaches from serine and threonine during collision induced
fragmentation processes resulting in very characteristic and
abundant neutral loss peaks such as HPO3 and H3PO4.
Furthermore, as already mentioned above, phosphotyrosine
leads to a unique and characteristic immonium ion with m/z
216.0426.
We investigated large scale phosphorylation data with the
Expert System, incorporating rules for the above-mentioned
phosphospecific fragment ions. We found that the occurrence
of both neutral losses from phosphorylated serine is about four
times as high (65% for HPO3 and 49% for H3PO4) as from
threonine (18 and 12%, respectively). Table 2 summarizes the
frequencies of these neutral losses. Their absolute number
reveals an average of three H3PO4 losses and two HPO3 losses
per spectrum.
Finally, we investigated the frequency of xn ions pinpointing
the localization of a serine or threonine phosphor site in the
peptide sequence very recently described by Kelstrup et al.62
Our data set consisting of 1157 spectra of phosphorylated
peptide sequences contains this characteristic xn ion in 279 of
the fragmentation patterns (24%).
Figure 5. Intensity distribution of different ion types. (A) Average proportions of the six major ion types in HCD spectra by peak count based on a
sliding mass window filtering for the 10 most abundant peaks per 100 Da; >16 000 tandem mass spectra. (B) Same as (A) but referring to the
intensity coverage of the MS/MS spectrum. (C and D) Same as (A) and (B) for >3200 high resolution CID tandem mass spectra for comparison to
the HCD ion type distribution.
Table 2. Fraction of 1157 Spectra of Modified Sequences
(Phospho STY) Containing Neutral Losses, Reporter Ions
from Phosphorylated Serine (S) and Threonine (T) or the
Characteristic X-Ion at Least Oncea
−HPO3 −H3PO4 pS pT xn (S,T)
S (1094) 65% (713) 49% (540) 29 279
T (585) 18% (103) 12% (68) 3
aThe first column lists the total number of sequences that contain the
amino acid S or T at least once.
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■ CONCLUSION AND OUTLOOK
In 2007, beam-type fragmentation was introduced on Orbitrap
instrumentation. This HCD mode of fragmentation has
become especially popular since some limitations of ion source
brightness and ion extraction from the collision cell were
removed.31 In our group, for instance, both proteome and
PTM-based investigations are routinely done with HCD rather
than low or high resolution CID. This was one reason why it
was important to investigate the ion types that are produced by
HCD. However, even though the general dissociation
mechanisms operative in CID have been studied for
decades,63,64 large data sets with very high quality thresholds
have previously not been studied. This was made possible here
by very stringent filtering of peptide fragment spectra on the
basis of identification score as well as near absence of
cofragmenting peaks. Most importantly, we developed and
made use of an Expert System, which annotated peptide peaks
with high comprehensiveness but low false positive rates.
Our investigation of HCD yielded a broad and quantitative
overview of the ion types produced. It turns out that HCD
spectra are somewhat more complex than CID spectra but that
the peaks are assignable to the same degree. The low mass
region is particularly straightforward to interpret given the very
high resolution of the Orbitrap analyzer in this region, coupled
to the high mass accuracy, which generally allows determination
of the chemical composition of these fragments. The
information content of HCD spectra is mostly related to very
extensive series of y-ions, supplemented by relatively short
series of low mass b-ions. This is in contrast to ion trap CID
spectra, in which the high mass b-ions are also very prominent.
Nevertheless, the coverage of peptide sequence overall and in
particular with continuous ion series is somewhat higher in
HCD than it is in CID. Remarkably, for tryptic peptides up to
15 amino acids, the fragment contents is almost complete,
meaning that there is sufficient information in principle for de
novo sequencing or at least very long sequence tags.
Our quantification of the overall contribution of different ion
types to the entire MS/MS spectrum revealed that only a
relatively small proportion remains unassigned by the rules that
we have implemented into the Expert System. This proportion
would further shrink if noise and remaining cofragmentation
was further reduced and if the rules of the Expert System were
relaxed. This means that the ion types produced in HCD and
by extension by CID are already very well understood. New
Figure 6. Annotated spectrum of phosphorylated peptide fragmented with HCD. (A) The phosphorylated peptide phSLENETLNK was identified
and annotated by the Andromeda search engine assigning regular ions and single neutral losses. (B) The Expert System was modified for
phosphorylated peptides to enable comprehensive annotation: Several additional neutral losses, internal fragments and immonium ions increase the
intensity coverage to 82%.
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fragmentation pathways of standard peptides could of course be
discovered in the future, but it is unlikely that such ions would
contribute very much to the overall ion intensity. For modified
peptides, our Expert System and quantification of fragmenta-
tion frequencies could help to discover potential new fragment
types. In this connection, we have already demonstrated
straightforward extension of our approach to phosphorylated
peptides. In conclusion, we have here reported the most
extensive investigation into HCD of peptides and hope that the
results will be useful for both small and large scale investigation
of the proteome.
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Expert System for Computer-assisted
Annotation of MS/MS Spectra*□S
Nadin Neuhauser‡¶, Annette Michalski‡¶, Jürgen Cox‡, and Matthias Mann‡§
An important step in mass spectrometry (MS)-based pro-
teomics is the identification of peptides by their fragment
spectra. Regardless of the identification score achieved,
almost all tandem-MS (MS/MS) spectra contain remaining
peaks that are not assigned by the search engine. These
peaks may be explainable by human experts but the scale
of modern proteomics experiments makes this impracti-
cal. In computer science, Expert Systems are a mature
technology to implement a list of rules generated by in-
terviews with practitioners. We here develop such an Ex-
pert System, making use of literature knowledge as well
as a large body of high mass accuracy and pure fragmen-
tation spectra. Interestingly, we find that even with high
mass accuracy data, rule sets can quickly become too
complex, leading to over-annotation. Therefore we estab-
lish a rigorous false discovery rate, calculated by random
insertion of peaks from a large collection of other MS/MS
spectra, and use it to develop an optimized knowledge
base. This rule set correctly annotates almost all peaks of
medium or high abundance. For high resolution HCD data,
median intensity coverage of fragment peaks in MS/MS
spectra increases from 58% by search engine annotation
alone to 86%. The resulting annotation performance sur-
passes a human expert, especially on complex spectra
such as those of larger phosphorylated peptides. Our
system is also applicable to high resolution collision-in-
duced dissociation data. It is available both as a part of
MaxQuant and via a webserver that only requires an
MS/MS spectrum and the corresponding peptides se-
quence, and which outputs publication quality, annotated
MS/MS spectra (www.biochem.mpg.de/mann/tools/). It
provides expert knowledge to beginners in the field of
MS-based proteomics and helps advanced users to focus
on unusual and possibly novel types of fragment
ions. Molecular & Cellular Proteomics 11: 10.1074/mcp.
M112.020271, 1500–1509, 2012.
In MS-based proteomics, peptides are matched to peptide
sequences in databases using search engines (1–3). Statisti-
cal criteria are established for accepted versus rejected pep-
tide spectra matches based on the search engine score, and
usually a 99% certainty is required for reported peptides. The
search engines typically only take sequence specific back-
bone fragmentation into account (i.e. a, b, and y ions)
and some of their neutral losses. However, tandem mass
spectra—especially of larger peptides—can be quite com-
plex and contain a number of medium or even high abun-
dance peptide fragments that are not annotated by the search
engine result. This can result in uncertainty for the user—
especially if only relatively few peaks are annotated—be-
cause it may reflect an incorrect identification. However, the
most common cause of unlabeled peaks is that another pep-
tide was present in the precursor selection window and was
cofragmented. This has variously been termed “chimeric
spectra” (4–6), or the problem of low precursor ion fraction
(PIF)1 (7). Such spectra may still be identifiable with high
confidence. The Andromeda search engine in MaxQuant, for
instance, attempts to identify a second peptide in such cases
(8, 9). However, even “pure” spectra (those with a high PIF)
often still contain many unassigned peaks. These can be
caused by different fragment types, such as internal ions,
single or combined neutral losses as well as immonium and
other ion types in the low mass region. A mass spectrometric
expert can assign many or all of these peaks, based on expert
knowledge of fragmentation and manual calculation of frag-
ment masses, resulting in a higher degree of confidence for
the identification. However, there are more and more practi-
tioners of proteomics without in depth training or experience
in annotating MS/MS spectra and such annotation would in
any case be prohibitive for hundreds of thousands of spectra.
Furthermore, even human experts may wrongly annotate a
given peak—especially with low mass accuracy tandem mass
spectra—or fail to consider every possibility that could have
resulted in this fragment mass.
Given the desirability of annotating fragment peaks to the
highest degree possible, we turned to “Expert Systems,” a
well-established technology in computer science. Expert Sys-
tems achieved prominence in the 1970s and 1980s and were
meant to solve complex problems by reasoning about knowl-
From the ‡Department of Proteomics and Signal Transduction,
Max-Planck Institute of Biochemistry, Am Klopferspitz 18, D-82152
Martinsried, Germany
Received May 5, 2012, and in revised form, July 19, 2012
Author’s Choice—Final version full access.
Published, MCP Papers in Press, August 10, 2012, DOI
10.1074/mcp.M112.020271
1 The abbreviations used are: PIF, Precursor Intensity Fraction;
FDR, False Discovery Rate; MS/MS, Tandem mass spectrometry;
HCD, Higher Energy Collisional Dissociation; PEP, Posterior Error
Probability; PDF, Portable Document Format; IM, immonium ion; SC,
side chain fragment ion; Th, Thomson.
Technological Innovation and Resources
Author’s Choice © 2012 by The American Society for Biochemistry and Molecular Biology, Inc.
This paper is available on line at http://www.mcponline.org
1500 Molecular & Cellular Proteomics 11.11
101
edge (10, 11). Interestingly, one of the first examples was
developed by Nobel Prize winner Joshua Lederberg more
than 40 years ago, and dealt with the interpretation of mass
spectrometric data. The program’s name was Heuristic
DENTRAL (12), and it was capable of interpreting the mass
spectra of aliphatic ethers and their fragments. The hypothe-
ses produced by the program described molecular structures
that are plausible explanations of the data. To infer these
explanations from the data, the program incorporated a the-
ory of chemical stability that provided limiting constraints as
well as heuristic rules.
In general, the aim of an Expert System is to encode knowl-
edge extracted from professionals in the field in question. This
then powers a rule-based system that can be applied broadly
and in an automated manner. A rule-based Expert System
represents the information obtained from human specialists in
the form of IF-THEN rules. These are used to perform oper-
ations on input data to reach appropriate conclusion. A ge-
neric Expert System is essentially a computer program that
provides a framework for performing a large number of infer-
ences in a predictable way, using forward or backward
chains, backtracking, and other mechanisms (13). Therefore,
in contrast to statistics based learning, the “expert program”
does not know what it knows through the raw volume of facts
in the computer’s memory. Instead, like a human expert, it
relies on a reasoning-like process of applying an empirically
derived set of rules to the data.
Here we implemented an Expert System for the interpreta-
tion for high mass accuracy tandem mass spectrometry data
of peptides. It was developed in an iterative manner together
with human experts on peptide fragmentation, using the pub-
lished literature on fragmentation pathways as well as large
data sets of higher-energy collisional dissociation (HCD) (14)
and collision-induced dissociation (CID) based peptide iden-
tifications. Our goal was to achieve an annotation perform-
ance similar or better than experienced mass spectrometrists
(15), thus making comprehensively annotated peptide spectra
available in large scale proteomics.
EXPERIMENTAL PROCEDURES
The benchmark data set is from Michalski et al.2 Briefly, E. coli,
yeast and HeLa proteomes were separated on 1D gel electrophoresis
and in gel digested (16). Resulting peptides were analyzed by liquid
chromatography (LC) MS/MS on a linear ion trap - Orbitrap instrument
(LTQ Velos (17) or ELITE (18), Thermo Fisher Scientific). Peptides were
fragmented by HCD (14) or by CID, but in either case fragments were
transferred to the Orbitrap analyzer to obtain high resolution tandem
mass spectra (7500 at m/z 400). We scanned tandem mass spectra
already from m/z 80 to capture immonium ions as completely as
possible. Data analysis was performed by MaxQuant using the An-
dromeda search engine (8, 9). Maximum initial mass deviation for
precursor peaks was 6 ppm and maximum deviation for fragment ions
for both the search engine and for the Expert System was 20 ppm.
MaxQuant preprocessed the spectra to be annotated by the Expert
System in the same way as it does for the Andromeda search engine:
Peaks were filtered to the 10 most abundant ones in a sliding 100 m/z
window, de-isotoped and shifted to charge one where possible. From
this data, sequence-spectra pairs were selected that had a certainty
of identification of 99.99% PIF values (7) larger than 95% and that
were sequence unique (more than 16,000 peptides).
The Expert System was written in the programming language C#,
using the Microsoft .NET framework version 3.5 and the Workflow.
Activities library, which contains a rule engine to implement an Expert
System (Microsoft Corporation, Redmond, WA).
MaxQuant contains the Expert System as an integrated option in its
Viewer—the component that allows visualization of raw and anno-
tated MS data. MaxQuant can freely be downloaded from www.
maxquant.org. It requires Microsoft .NET 3.5, which is either already
installed with Microsoft Windows or can be installed as a free Win-
dows update. In our group we have implemented the Expert System
both on a Windows cluster and in a desktop version. Additionally, we
provide an Expert System web server, which can be accessed at
2 Michalski, A., Neuhauser, N., Cox, J., and Mann, M., unpublished
data.
FIG. 1. Basic concept of the Expert System. A, An Expert System is constructed by interviewing an expert in the domain (here peptide
fragmentation and the accumulated literature) and devising a set of rules with associated priority and dependence on each other. The
knowledge base contains the rules whereas the rule engine is generic and applies the rules to the data. B, Data are automatically processed
following the steps depicted.
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www.biochem.mpg.de/mann/tools/. Although MaxQuant allows the
Expert System annotation of arbitrary numbers of MS/MS spectra, the
webserver is currently limited to the submission of one MS/MS spec-
trum at a time. After upload of a list of peaks with m/z value and their
intensities—together with the corresponding peptide sequence—the
spectrum with all annotations is displayed. This can then be exported
in different graphical formats.
RESULTS AND DISCUSSION
Construction of the Expert System—Human experts per-
form a generic set of tasks when solving problems such as the
interpretation of an MS/MS spectrum. These rules have to be
codified in the Expert System, mainly in the form of a series of
IF-THEN rules. Fig. 1 shows the major steps involved in build-
ing and using the Expert System. It is important to acquire all
relevant rules to interpret MS/MS spectra as comprehensively
as possible. However, to avoid over-annotation leading to
false positives (see below), the number of rules and their
interactions should not become too large. This balance was
struck by evaluating the performance of different set of rules
on large data sets in conjunction with human experts.
Rules were encoded in a table-like structure, where they
could be activated, deactivated or modified. To create the
knowledge base, the extent of interactions of the rules also
had to be determined—for instance, which combination of
neutral losses to allow. After iterative construction of the
knowledge base, the rule engine then applied the encoded
knowledge to MS/MS spectra and displayed the result to the
user (Fig. 1A). The processing steps that are performed on the
raw MS and MS/MS spectra are shown in Fig. 1B (see also
EXPERIMENTAL PROCEDURES). Note that the workflow is
entirely automated and that user interaction is possible but
not required. Arbitrary numbers of annotated spectra of pep-
tides of interest can be produced as interactive screen images
or high resolution, printable PDF files. The Expert System is
very fast, and 16,000 spectra can be annotated in less than
four hours on a desktop system.
The IF-THEN constraints of our Expert System can be di-
vided into four major parts (Fig. 2). At first the Expert System
calculates any specific backbone fragments (a, b, and y-ion
series), the charged precursor ion, the immonium ions as well
as side chain fragments in the low-mass region and places
them into a queue. In the second part of the workflow every
element in this queue is filtered with respect to the actual
MS/MS spectrum. Even if there is a peak corresponding to a
calculated item in the queue, it may still be filtered out
(symbolized by missing annotations after the filter in Fig. 2).
For instance, a b1 ion is only allowed in very restricted
circumstances.
In the third step, neutral losses and internal fragments for
the filtered values are calculated and added to the queue.
They are then subjected to the same filtering rules as in step
2. Step 3 is iterative, as several subsequent neutral losses
may be allowed.
In the fourth and last step each potential annotation is given
a priority. If there is more than one possible annotation, the
one with the highest priority is chosen (i.e. the one that trig-
gered the rules with higher priority). However, in this case the
Expert System provides a pop-up (or “tool-tip”) containing the
other possibility when hovering the mouse over the peak.
(This can still happen if the FDR is properly controlled and is
then typically caused by two different chemical designations
for the same ion; or by different ions with the same chemical
composition, such as small internal fragments with different
sequence but the same amino acids).
Determining a False Discovery Rate for Peak Annotation—
Use of a very high threshold for peptide identification
(99.99%) ensured that virtually none of the peptides in our
collection should be misidentified. However, when building
FIG. 2. Work flow of the Expert System. ➀ From the database
sequence of the peptide identified by the search engine, a list of
possible fragment ions is created. ➁ Peaks from the measured spec-
trum are compared with the possible fragments and preliminarily
annotated if they pass the rules of the Expert System. ➂ Neutral
losses and internal fragments are generated from the candidate,
annotated peaks and exposed to the Expert System rules. ➃ Potential
conflicts are resolved via the priority of the annotations and peaks are
labeled. Note that possible internal fragment ‘CA’ is crossed out
because the b2 ion has the higher priority.
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FIG. 3. Calculation of false discovery rate for peak annotations. A, The upper panels represent a large number of identified MS/MS
spectra from which annotated peaks are drawn to form a large peak collection of possible fragment masses. From each identified spectrum
in the data set, 10 random fragments are inserted and the number of annotations by the Expert System is counted. This process is repeated
500 times for each peptide. B, Median FDR as determined in A as a function of peptide length distinguished by the mass difference of fragment
ion and theoretical mass. The FDR for peak annotation rises with peptide length and is strongly dependent on the mass difference. Box plot
at the bottom shows that 50% of the peptides were between 12 and 18 amino acids long. The box plots on the right summarize the range of
FDR values regardless of peptide length. C, Graph of the median FDR as a function of peptide length but separated by intensity classes of the
false annotated fragment peaks. Most false positives come from the low abundant peaks (blue) rather than the medium (green) or high
abundance fragment peaks (yellow). D, Same plot as above but differentiated by the fragment ion type of the false positives. Getting lower
number of false positives from regular fragment annotations (blue), compared with internal fragment (green) and neutral loss annotations
(yellow).
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the Expert System, we noticed that it was still possible to
over-interpret the MS/MS spectra. This was initially surprising
to us because our large scale data set had good signal to
noise and peaks was only candidates for annotation when
their calculated mass was less than 20 ppm from the ob-
served mass. The over-interpretation became apparent through
conflicting annotations for the same peak, and was typically
caused by a combination of rules, such as several neutral losses
from major sequence specific backbone or internal ions. Be-
cause conflicting or wrong annotations would undermine the
entire rational for the Expert System, we devised a scheme to
stringently control the false discovery rate for peak annotation.
The false discovery rate (FDR) is meant to represent the
percent probability that a fragment peak is annotated by
FIG. 4. Example spectra before and after Expert System annotation. A, Based on the search engine result, 34% of the fragments by peak
intensities and 24% by peak number are explained, whereas the Expert System almost completely annotates the spectrum (for further
explanation see main text). Posterior Error Probability (PEP) a statistical expectation value for peptide identification in Andromeda. Apart from
the large fraction of a-, b-, and y-ions (pale blue/dark blue/red) and ions with neutral losses (orange), one can find internal fragment ions (purple)
and in the low mass region one immonium ion of Isoleucine (green) and a side chain loss from arginine (turquoise). B, Expert System annotation
of a phosphorylated peptide. Apart from the internal ions, several phosphorylation-related fragment ions were found. The asterisk (*) denotes
loss of H3O4P with a delta mass of 97.9768 from the phosphorylated fragment ion.
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chance because its mass fits one of the Expert System rules
for the peptide sequence. To calculate a proper FDR, we
therefore needed to provide a set of background peaks that
would represent false positives when they are labeled by the
Expert System. Producing realistic background peaks turned
out to be far from trivial because they need to have possible
masses that can in principle be generated from peptide se-
quences and they need to be independent of the sequence of
the peptide in question. The principle of our solution to this
problem is shown in Fig. 3A. From the large data set under-
lying this study, we collect the m/z values of all annotated
peaks, except those coming from immonium or side chain
ions. They were stored in a large peak collection of several
million entries, together with the respective peptide se-
quences and the relative intensity of the peak. For each spec-
trum in which we wanted to determine the FDR, we then
inserted a random set of 10 peaks from the collection, where
after we checked if the sequence of the selected peaks was
independent from the sequence of the current spectrum. If
one of the inserted peaks overlapped with an existing peak, it
was discarded. By definition these 10 peaks represent pos-
sible peptide fragments and, because they are chosen ran-
domly from millions of other peaks, they collectively represent
a good approximation to a true background set. This would
FIG. 4—continued
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not be the case for permutation of the sequence of the pre-
cursor in question, for instance, because many of the frag-
ment peaks in permutated sequences are identical. Whenever
the Expert System annotated one of these peaks, it was
counted as a false positive. To find the number of repeats
necessary to obtain a stable FDR for this procedure, we chose
a set of spectra and simulated a thousand times on each one.
We found that the FDR was constant after 500 iterations. For
the final FDR calculation, for each spectrum we added a
different set of 10 random peaks from the collection and
repeated this 500 times. This was then applied to each of the
more than 16,000 pure (high PIF) spectra in the large scale
data set.
Beyond providing a solid FDR estimate for each rule set,
this procedure also allowed us to identify the rules or rule
combinations that were responsible for miss-annotation, i.e.
the rules that falsely annotated the inserted peaks. These
mostly turned out to be chains of subsequent neutral losses.
In conjunction with detailed evaluation of the frequency of ion
types, we iteratively designed an optimal rule set (supplemen-
tal Table S1). For instance, neutral losses from a particular
amino acid were allowed if they occurred in more than five
percent of the fragment sequences that contained that amino
acid. Likewise, of a set of about 42 possible neutral side chain
losses, only six were sufficiently important to retain them in
the Expert System. The Figs. 3B–3D show the results of the
median FDR as a function of the peptide length based on this
final rule set. The overall FDR—indicated in red—is the same
in all plots and shows a clear growing trend in the number of
false positives with the length of the peptides. For small
peptides of 12 amino acids or less, the FDR was less than
2.1% and all peptides in the range investigated had a peak
annotation FDR of less than 5%. With these settings, the
annotations are correct in more than 97% of the cases for the
vast majority of MS/MS spectra. The Expert System could of
course be pruned to provide a lower FDR by narrowing the
mass tolerance window; however, this would come at the ex-
pense of discarding correct annotations. To explore the influ-
ence of mass accuracy on potential false positive annotations,
we repeated these calculations with required mass deviations
no larger than 5 ppm or no larger than 10 ppm. As can be seen
in Fig. 3B, this further reduced possible errors to less than
1%, or less than 0.3%, respectively. This highlights the value
of high mass accuracy in unambiguously identifying fragment
mass identity.
Furthermore, peaks with a low signal to noise are more
likely to be miss-annotated than more intense peaks. In Fig.
3C we sorted the peak intensity of the false positives into
three intensity classes (Fig. 3C). The median FDR of peaks
with high or medium abundance are only 0.1 or 0.5%. For low
abundance peaks it is higher but still with a median of no more
than 2.1%.
Next we separately investigated the FDR as a function of
peptide length for the different fragment ion types. As can be
seen in Fig. 3C, regular ions and internal fragments contribute
very little to overall false annotation (0.4 and 0.5%), whereas
neutral loss ions are wrongly annotated in 1.8% of the case or
even more.
FIG. 5. Expert System performance on a large data set. Median sequence coverage by summed fragment ion intensity is plotted as a
function of identification score. Statistics is based on more than 16,000 spectra. For every identification score, the Expert System adds a large
proportion of explainable peaks. Box plot below the graph indicates that 50% of peptides in the set have an Andromeda score between 98
and 140. Box plots on the right indicate the range of values for the intensity coverage for standard and Expert System annotation.
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Performance of the Expert System—Fig. 4 shows an illus-
trative example of an HCD fragmented peptide before and
after Expert System evaluation. The peptide was identified
with an Andromeda score of 136 and posterior error proba-
bility (PEP) of 1.1E-21 (the corresponding Mascot score was
83). The spectrum features an uninterrupted b-ion series from
b2 to b9 and an uninterrupted y-ion series from y1 to y12,
together covering the entire peptide sequence. Despite this
unambiguous identification, the peaks used by the search
engine to identify the peptide only accounted for 35% of the
summed intensity of the peaks in the fragmentation spectrum.
Coverage by number of explained peaks was even lower at
24% (allowing up to 10 peaks per 100 Th in the measured
spectrum see EXPERIMENTAL PROCEDURES). There is a
series of high abundance, high m/z fragments as well as a
large number of low abundance peaks in the low and me-
dium m/z range that are unexplained by the search engine.
After annotation by the Expert System, this situation
changes entirely. The high m/z series is revealed to be a
prominent loss of CH4SO from oxidized methionine. The low
FIG. 6. Web interface for the Expert System. A, Text field to paste the spectrum in text format (m/z value; intensity in arbitrary units). B,
Form to enter the peptide sequence, modifications and their positions. C, Detected backbone fragments and their neutral losses are indicated
in the peptide logo. Scalable spectrum annotated by the Expert System. Note that neutral loss peaks are very small compared with the major
backbone fragments. The spectrum can be downloaded with the desired resolution and in the desired graphical format.
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mass ions are neutral losses, internal fragments and com-
binations between them and they were unambiguously and
correctly assigned. Altogether, the Expert System ac-
counted for almost all prominent ions and explained a total
of 88% of the ion current. Manual annotation of this spec-
trum would have been possible but would have been very
time consuming.
Interpretation of phosphorylated peptides, especially large
ones, is more difficult than that of unmodified peptides. Fur-
thermore, accurate placement of the phosphorylation site can
be challenging. We used literature knowledge (19, 20) and the
results of a large-scale investigation into the fragmentation of
phosphorylated peptides to derive suitable fragmentation
rules for the Expert System. This led to an additional six rules,
which were easily integrated, illustrating the extensibility of
the Expert System. Fig. 4B depicts an example annotation of
the relatively complex fragmentation spectra typical of phos-
phorylated peptides. The large ion series from the low mass
range to about mass 1000 is caused by an extensive and
uninterrupted internal ion series starting from the proline in the
second position of the peptide sequence. As these internal
fragments contain several glutamines, they lead to additional
water and ammonia losses. However, there are also newly
annotated fragments resulting from neutral losses in addition
to loss of the phosphorylation site. Moreover, the neutral loss
of HPO3 is annotated.
Large-scale Evaluation of the Performance of the Expert
System—We used the population of 16,000 spectra with high
PIF—identified with a false discovery rate of 0.01% by the
search engine—and annotated them automatically using the
Expert System. For each spectrum we calculated the intensity
coverage obtained by the fragments used by the search en-
gine and the fragments explained by the Expert System.
Higher scoring fragmentation spectra would be expected to
have a larger fraction of their ion current annotatable than
lower scoring peptides. Fig. 5A shows a plot of the median of
these values for all search engine scores. A total of 95% of
these Andromeda scores are within a range of 96 to 138. Here
the median intensity coverage by standard annotation varies
from 55% at 96 to 64% at 138. The Expert System, in con-
trast, annotated between 86 and 89% of the total ion current
in the fragment spectra of the same peptides. This repre-
sents an average increase of 28%. There was only a small
percentage of peptides that were lower scoring than 96 and
for these the increased annotation percentage of the Expert
System was even larger (34%). Interestingly, even in very
high scoring HCD fragment spectra there are still many
peaks not directly annotated by the search engine. For
these, the average increase of annotated ion current be-
cause of the Expert System was still 23%.
The rule set of the Expert System was derived from HCD
data. However, HCD and CID appear to produce similar ion
types, although with different abundances. We therefore
tested if the derived rule set was also applicable to high
resolution CID data. This was indeed the case, and a total of
85% of the ion current in high resolution CID spectra ex-
plained by the Expert System, although in CID spectra a
higher percentage (79%) of the peaks are already accounted
for by standard ion types. Therefore we conclude that the
Expert System can be used equally well for high resolution
HCD and CID data although the benefits for CID are not as
large as they are for HCD.
Webserver for Expert System Annotation of Spectra—The
Expert System is now part of the Viewer component of Max-
Quant, which is freely available at www.maxquant.org. In this
environment, the Expert System can annotate arbitrarily large
data sets of identified peptides and visualize and export them
in different graphical formats such as PDF. Additionally, we
established a webserver to make the Expert System available
to any proteomics scientist, regardless of the computational
workflow that he or she is using. The webserver is located at
http://www.biochem.mpg.de/mann/tools/and its graphical in-
terface is shown in Fig. 6. The user needs to supply a mass
spectrum in the form of an m/z and peak intensity list as well
as the sequence of the identified peptide (Figs. 6A, 6B). Com-
mon modifications and their position in the sequence can also
be specified. The webserver then provides an annotation of
the spectrum within the stated mass tolerance as shown in
Fig. 6C. The graph is scalable to enable detailed study of
complex fragmentation spectra. Mass deviations in ppm (cal-
culated mass – measured mass) can also be depicted. This
annotated spectrum can be downloaded in a number of
graphical formats for use in publications.
CONCLUSION AND OUTLOOK
Here we have made use of Expert Systems—a well-known
technology in computer science—to automatically but accu-
rately interpret the fragmentation spectra of identified pep-
tides. We have shown that the Expert System performs very
well on high mass accuracy data, annotating the large major-
ity of medium to high abundance peaks. For HCD spectra it
explains on average 28% more of the peak intensities than the
search engine results alone. We derived a rigorous false pos-
itive rate, ensuing that less than 5% of peaks can be miss-
annotated—this rate is even lower for spectra with at least
median scores and fragment ion intensities of at least mod-
erate abundance. The rule set was derived by iterative inter-
pretation of large HCD data set but we show that the Expert
System is equally applicable to high resolution CID spectra.
We envision different uses for the Expert System: For be-
ginners in MS-based proteomics, it enables efficient training
in the interpretation of MS/MS spectra without requiring much
input from a specialist. For advanced users, it allows focusing
on unusual and potentially novel types of fragments. One
caveat is that the Expert System currently cannot explain
fragment peaks that belong to cofragmented precursors; a
very common occurrence that we deliberately avoided here
by selecting only pure MS/MS spectra. This limitation can be
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addressed if both precursors are identified and communi-
cated to the Expert System. Such a feature might be partic-
ularly useful for instruments that allow deliberate multiplexing
of precursors, which leads to complex MS/MS spectra (21).
The Expert System has been in routine use in our laboratory
for a number of months. During this time we have found that
it provides helpful confirmation of the identification of the
peptide and the identity of the previously unlabeled fragment
ions. This is particularly welcome in the case of complicated
spectra of important peptides, such as the ones regulated in
the biological function in question. Compared with a human
expert, the principal advantages of the Expert System are its
speed, its ability to check for all supplied rules in a consistent
manner as well as its rigorously controlled false positive rate.
Obviously, the Expert System is limited to the knowledge
supplied whereas an experienced mass spectrometrist can go
beyond these rules and discover the origin of novel fragmen-
tation mechanisms.
As we have shown here, Expert Systems can readily be
applied to problems in computational proteomics. Given their
relative ease of implementation, they may become useful in
other areas in MS-based proteomics, too.
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Prologue  
Mass spectrometry-based proteomics aims to characterize the complement of all proteins of a 
cell. However, the underlying information on expression of different proteins and their 
abundances are at least partially encoded in messenger RNAs (mRNA) that function as templates. 
Translation from mRNA to protein occurs at the ribosomes and generally is a well-understood 
process. Nevertheless, revealing details of the translation process remains challenging. 
Furthermore, mRNA levels provide only limited insight into the amount and precise nature of 
the corresponding proteins expressed in a cell. This is primarily due to the fact that not every 
mRNA is translated into a protein and sophisticated mechanisms control the actual 
abundance120,121. Therefore, systematic investigation of in vivo protein translation not only requires 
comprehensive measurement of the mRNAs present in the cell, but also benefits from RNA 
footprinting, i.e. monitoring the mRNA sequences that are covered by a ribosome for translation at 
any given time.  
Our collaborators, Jonathan Weissman’s group at the University of California in San Francisco, 
recently established a deep sequencing-based technique, referred to as ribosome profiling, to 
investigate ribosome-protected mRNA fragments with very high accuracy and through-put122. 
Briefly, eukaryotic cells are treated with a translation inhibitor such as cycloheximid to ‘freeze’ the 
state of translation prior to cell lysis. Unprotected mRNA is removed by nuclease digestion. The 
ribosome-covered mRNA fragments that consist of about 30 nucleotides are of very suitable size 
for RNA-Seq analysis, which is then used to obtain the ribosome footprints of the cell 
(Figure 11).  
Advances in deep sequencing fuel this novel method that allows answering fundamental 
biological questions in large-scale studies. Ribosome profiling experiments are ideally 
complemented by mass spectrometry-based proteomics, i.e. by investigation of the end product 
of gene expression, to cross-validate results. 
112 
 
 
Figure 11: Schematic workflow of ribosome profiling; adapted from 122. 
 
The project described in this thesis applied ribosome profiling to human fibroblast cells infected 
with human cytomegalovirus for systematic analysis of the viral transcripts. Intriguingly, our 
collaborators discovered a large number of novel open reading frames that would not be 
expected to be protein-coding genes, especially because many encode for very short proteins or 
feature non-AUG start codons. Even though the human cytomegalovirus genome was sequenced 
and annotated before, the complexity of the virus genome appears to have been vastly 
underestimated up to now123.  
 
During the collaboration, we tested several strategies to detect proteins corresponding to the 
novel open reading frames predicted by ribosome profiling. We found that the latest generation 
mass spectrometry instrumentation, Q Exactive, gave a significant boost to the number of novel 
proteins identified, partially due to its very high sequencing speed. The complete lysate of virus-
infected human cells presented a very high complexity background that we reduced by gel 
fractionation. Additionally, we tested a strategy using size exclusion filters to enrich for smaller 
proteins after cell lysis with urea, which unfortunately did not result in the expected molecular 
weight cut-off to reduce sample complexity. Besides tryptic digestion and shotgun proteomics, 
we also evaluated a top-down strategy. Especially for the very short proteins consisting of only 
10-30 amino acids, this approach should have been very advantageous compared to bottom-up 
shotgun proteomics, as the sequences often lack a tryptic cleavage site or the obtained peptides 
are too short. However, we found that all of these additional strategies were inferior to the 
conventional shotgun proteomics workflow. Remarkably, that approach allowed us to confirm 
more than 50% of the novel open reading frames that did not overlap with any previously known 
sequence and which were more than 55 amino acids in length. The detection of shorter proteins 
in complex mixtures remains object of further method development. 
In summary, this collaborative project demonstrated the scope of powerful complementary ‘omics’ 
technologies, and provides an example of setting system-wide biological studies into a broader 
context.  
  
Decoding Human Cytomegalovirus
Noam Stern-Ginossar,1 Ben Weisburd,1 Annette Michalski,2* Vu Thuy Khanh Le,3 Marco Y. Hein,2
Sheng-Xiong Huang,4 Ming Ma,4 Ben Shen,4,5,6 Shu-Bing Qian,7 Hartmut Hengel,3
Matthias Mann,2 Nicholas T. Ingolia,1† Jonathan S. Weissman1*
The human cytomegalovirus (HCMV) genome was sequenced 20 years ago. However, like those
of other complex viruses, our understanding of its protein coding potential is far from complete.
We used ribosome profiling and transcript analysis to experimentally define the HCMV translation
products and follow their temporal expression. We identified hundreds of previously unidentified
open reading frames and confirmed a fraction by means of mass spectrometry. We found
that regulated use of alternative transcript start sites plays a broad role in enabling tight temporal
control of HCMV protein expression and allowing multiple distinct polypeptides to be generated
from a single genomic locus. Our results reveal an unanticipated complexity to the HCMV coding capacity
and illustrate the role of regulated changes in transcript start sites in generating this complexity.
The herpesvirus human cytomegalovirus(HCMV) infects the majority of human-ity, leading to severe disease in newborns
and immunocompromised adults (1). The HCMV
genome is ~240 kbwith estimates of between 165
and 252 open reading frames (ORFs) (2, 3). These
annotations likely do not capture the complex-
ity of the HCMV proteome (4) because HCMV
has a complex transcriptome (5, 6), and genomic
regions studied in detail reveal noncanonical trans-
lational events, including regulatory (7) and over-
lapping ORFs (8–11). Defining the full set of
translation products—both stable and unstable,
the latter with potential regulatory/antigenic func-
tion (12)—is critical for understanding HCMV.
To identify the range of HCMV-translated
ORFs and monitor their temporal expression, we
infected human foreskin fibroblasts (HFFs) with
the clinical HCMV strain Merlin and harvested
cells at 5, 24, and 72 hours after infection using
four approaches to generate libraries of ribosome-
protectedmRNA fragments (Fig. 1A and table S1).
The first two measured the overall in vivo distri-
bution of ribosomes on a givenmessage; infected
cells were either pretreated with the translation
elongation inhibitor cycloheximide or, to exclude
drug artifacts, lysed without drug pretreatment
(no-drug). Additionally, cells were pretreated with
harringtonine or lactimidomycin (LTM), two drugs
with distinct mechanisms, which lead to strong
accumulation of ribosomes at translation initia-
tion sites and depletion of ribosomes over the
body of the message (Fig. 1A) (13–15). A modi-
fied RNA sequencing protocol allowed quanti-
fication of RNA levels as well as identification
of 5′ transcript ends by generating a strong over-
representation of fragments that start at the 5′ end
of messages (fig. S1) (16).
The ability of these approaches to provide a
comprehensive view of gene organization is il-
lustrated for the UL25 ORF: A single transcript
start site is found upstream of the ORF (Fig. 1A,
mRNA panel). Harringtonine and LTM mark a
single translation initiation site at the first AUG
downstream of the transcript start (Fig. 1A, Harr
and LTM). Ribosome density accumulates over
the ORF body ending at the first in-frame stop
codon (Fig. 1A, CHX and no-drug). In the no-
drug sample, excess ribosome density accumu-
lates at the stop codon (Fig. 1A, no-drug) (14).
Examination of the full range of HCMV
translation products, as reflected by the ribo-
some footprints, revealed many putative previ-
ously unidentified ORFs: internal ORFs lying
within existing ORFs either in-frame, resulting in
N-terminally truncated translation products (Fig.
1B), or out of frame, resulting in entirely previous-
ly unknown polypeptides (Fig. 1C); short uORFs
(upstream ORFs) lying upstream of canonical
ORFs (Fig. 2A); ORFs within transcripts anti-
sense to canonical ORFs (Fig. 2B); and previ-
ously unidentified short ORFs encoded by distinct
transcripts (Fig. 2C). For all of these categories,
we also observed ORFs starting at near-cognate
codons (codons differing from AUG by one nu-
cleotide), especially CUG (Fig. 2D).
HCMVexpresses several long RNAs lacking
canonical ORFs, including b2.7, an abundant
RNA, which inhibits apoptosis (17). In agree-
ment with b2.7’s observed polysome associa-
tion (18), multiple short ORFs are translated
from this RNA (Fig. 2E and fig. S2), and the
corresponding proteins for two of these ORFs
were detected by means of high-resolution MS
(Fig. 2E). Although the translation efficiency
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of these ORFs is low, four of them are highly
conserved across HCMV strains (table S2). We
found three similar polycistronic coding RNAs
(including RNA1.2 and RNA4.9), and two
short proteins encoded by these RNAs were
confirmed with MS (fig. S3).
To define systematically the HCMV-translated
ORFs using the ribosome profiling data, we first
annotated HCMV splice junctions, identifying
88 splice sites (table S3). We then exploited the
harringtonine-induced accumulation of ribo-
somes at translation start sites so as to identify
ORFs using a support vector machine (SVM)–
based machine learning strategy (14, 19). We
observed a strong enrichment for AUG (33-fold)
and near cognate codons in the translation initia-
tion sites identified with this analysis (Fig. 3A).
Visual inspection of the ribosome profiling data
confirmed the SVM-identified ORFs and sug-
gested an additional 53 putative ORFs (table S4).
The large majority (86%) of the SVM-identified
ORFs, and all of the manually identified ones,
were identified by means of SVM analysis of
an independent biological replicate (table S5 and
fig. S4). The observed initiation sites were not
caused by harringtonine because LTM treatment
also induced ribosome accumulation at the vast
majority (>98%) of these positions (Fig. 3B).
In total, we identified 751 translated ORFs
that were supported by both the LTM and
harringtonine data (tables S5 and S6 and file S1).
The footprint density measurements for these
ORFs were reproducible between biological rep-
licates (figs. S5 and S6). Of these ORFs, 147were
previously suggested to be coding (Fig. 3C). We
did not find strong evidence of translation for 24
previously annotated ORFs (table S7), although
these proteins may well be expressed under dif-
ferent conditions.
Many newly identified ORFs are very short
(245 ORFs ≤ 20 codons) (Fig. 3C) and are found
upstream of longer ORFs. We also identified 239
short ORFs (21 to 80 codons) (Fig. 3D). Last,
we identified 120 ORFs that are longer than 80
amino acids. These are primarily ORFs that con-
tain splice junctions or alternative 5′ ends of
previous annotations.
Several lines of evidence support the valid-
ity of the ORFs we identified. First, as seen for
the previously annotated ORFs, newly iden-
tified ORFs showed a significant [P < 10−70;
Kolmogorov-Smirnov (K-S) test] excess of ri-
bosome footprints at the predicted stop codon
(Fig. 1A and fig. S7). Because our ORF predictions
Fig. 1. Ribosome profiling of HCMV-infected cells. (A) Ribosome occupancies
after various treatments (illustrated to left); cycloheximide (CHX), no-drug,
harringtonine (Harr), and LTM together with mRNA profiles of the UL25 gene
at 72 hours after infection. An arrow marks the mRNA start. (B and C) Ribo-
some occupancy profiles for (B) UL38 and (C) UL10 genes that contain internal
initiations. The gray area symbolizes a low-complexity region.
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were based on translation initiation sites found
in the harringtonine and LTM samples, the ob-
servation that these accurately predicted down-
stream stop codons in an untreated sample
provides independent support for our approach.
Second, ribosome-protected footprints displayed
a 3-nucleotide (nt) periodicity that was in phase
with the predicted start site both globally (Fig.
3E) and in specific ORFs that contain internal
Fig. 2. Many ribosome footprints do not correspond to previously annotated
ORFs. (A) Ribosome occupancy profiles for the leader region of UL139 gene.
(B) Ribosome occupancy profiles of plus and minus strands (red and blue,
respectively) for the UL91 gene. (C) mRNA and ribosome occupancy profiles
for a previously unidentified short ORF. (D) Ribosome occupancies around a
short ORF that initiates at a CUG codon. (E) Ribosome occupancy profiles for
RNA b2.7. (Top) The annotated MS/MS spectra of two distinct peptides orig-
inating from ORFL6C and ORFL7C.
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out-of-frame ORFs (fig. S8). Third, brief inhi-
bition of translation initiation using an eIF4A
inhibitor Pateamine A (20) led to depletion of ri-
bosome density from the body of the large ma-
jority of the predicted ORFs (fig. S9), indicating
that the ribosomes were engaged in active elon-
gation. The newly identified ORFs also exhibited
a distribution of expression levels similar to that
of previously annotated canonical ORFs (fig. S10).
Last, many of the newly identified ORFs are
conserved in other HCMV strains (table S2).
High-resolution tandem mass spectrometric
measurements on virally infected cells by using
stringent criteria and manual validation (files S2
and S3) (16, 21) unambiguously detected 53 pre-
viously unidentified proteins out of the 96 ge-
nomic loci that are not overlapping with annotated
ORFs and contain at least one specific previously
unidentified protein that is longer than 55 amino
acids (table S8). For classes of new ORFs that
were difficult to monitor withMS (truncated forms
of longer proteins or short proteins), we used a
tagging approach. For two N-terminally trun-
cated proteins (derived fromUL16 andUL38), we
confirmed the appearance of alternative shorter
transcripts and detected the expected full length
and truncated tagged protein products (fig. S11).
The truncated protein derived from UL16 was
also observed in the context of the native virus
(fig. S12), and we confirmed a splice variant of
UL138 by using an antibody (fig. S12). For five
short ORFs (including two initiated at near cog-
nate start sites), we fused the ORFs in frame to a
green fluorescent protein (GFP)–coding region
in their otherwise native transcript context. We
identified protein products of the expected sizes
and confirmed that we correctly identified the
translation start sites (fig. S13). We also showed
that one of these short proteins (US33A-57aa),
which was not identified with MS but was re-
cently predicted by means of transcript analysis
to be coding (6), is expressed in the context of
the native virus (Fig. 3F and fig. S12). Addition-
ally, we focused on the very short, near cognate
driven uORFs that lie directly upstream of UL119
and US9, whose inclusion changes during infec-
tion as a result of changes in the 5′ end of the
transcripts. We found that these uORFs modu-
lated the translation efficiency of a downstream
reporter gene (fig. S14).
Last, we examined the subcellular localiza-
tion for 18 newly identified ORFs (11 of which
were detected by means of mass spectrometry)
(table S9) using transient expression of GFP-
tagged proteins. We detected 15 proteins, 10 of
which showed specific subcellular localization
patterns: six in mitochondria, three in the endo-
plasmic reticulum (ER), and one in the nucleus
(Fig. 3G and fig. S15). Immunoprecipation and
MS experiments on two of these GFP-tagged
proteins, ORF359W (ER localized) and US33A
(mitochondrially localized), identified a few spe-
cific interacting proteins. Western blot analysis
confirmed the interactions with TAP1 (ORF359W)
and the mitochondrial inner membrane transport
TIM machinery (US33A) (fig. S16).
HCMV genes are expressed in a temporally
regulated cascade. Our data provides an oppor-
tunity to monitor viral protein translation through-
out infection. Most of the viral genes, including
newly identified ORFs, showed tight temporal
regulation of protein synthesis levels; 82% of
ORFs varied by at least fivefold. Hierarchical
clustering of viral coding regions by their foot-
print densities during infection (a measure of
the relative translation rates) revealed several dis-
tinct temporal expression patterns (fig. S17).
As was seen previously for a limited number
of genomic loci (8–11, 22), examination of viral
transcripts during infection revealed a pervasive
use of alternative 5′ ends that is critical to the
Fig. 3. Annotating the HCMV-translated ORFs. (A) Fold
enrichment of AUG and near-cognate codons at pre-
dicted sites of translation initiation compared with their
genomic distribution. (B) The ribosome footprints occu-
pancy after LTM treatment at each start codon (relative
to the median density across the gene) is depicted for
the previously annotated ORFs (blue) and newly iden-
tified ORFs (red; empty red for ORFs that were removed).
The occupancy at a codon five positions downstream of
the start codon is depicted as a control (green). (C) Venn
diagram summarizing the HCMV-translated ORFs. Fifty-
three ORFs were initially identified through manual in-
spection. (D) The lengths distribution of newly identified
ORFs (red) and previously annotated ORFs (blue). (E) Po-
sition of 30-nt ribosome footprints relative to the reading
frame in the newly identified ORFs (red) and previous-
ly annotated ORFs (blue). (F) MRC-5 cells were mock-
treated or infected with TB40-US33A-hemagglutinin
(HA), and protein lysates were analyzed with Western
blotting with indicated antibodies. (G) HeLa cells were
transfected with GFP fusion proteins together with an ER marker (KDEL-mCherry) or stained with MitoTracker Red (Invitrogen, Grand Island) and
imaged by means of confocal microscopy.
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tight temporal regulation of viral genes expres-
sion and production of alternate protein products
during infection. For example, at the US18-US20
locus, 5 hours after infection there is one main
transcript starting just upstream ofUS20 enabling
US20 translation. At 24 hours after infection, a
shorter version of the transcript is detected starting
immediately upstream of US18, enabling its trans-
lation. A third previously unknown transcript
isoform starting within the US18 coding sequence
emerges at 72 hours after infection, resulting
in translation of a truncated version of US18
(ORFS346C.1) at this time point (Fig. 4, A and B).
Another example is detailed in fig. S18, and we
identified reproducible temporal regulation of
5′ ends in 61 viral loci (encompassing ~350 ORFs)
(figs. S19 and S20 and table S10), six of which
we confirmedwithNorthern blot analysis (Fig. 4B
and figs. S11 and S21). Thus, our studies reveal a
pervasive mode of viral gene regulation in which
dynamic changes in 5′ ends of transcripts con-
trol protein expression from overlapping coding
regions. Just as alternative splicing (a process in
which a single gene codes for multiple proteins)
expands protein diversity, alternative transcript
start sites may provide a broadly usedmechanism
for generating complex proteomes.
The genomic era began with the sequencing
of the bacterial DNAvirus, phi X, in 1977 (23)
and the mammalian DNAvirus, Simian virus 40
(24), the following year. Since then, extraordinary
advances in sequencing technology have enabled
the determination of a vast array of viral genomes.
Deciphering their protein coding potential, how-
ever, remains challenging. Here, we present an
experimentally based analysis of translation of
a complex DNA virus, HCMV, by using both
next-generation sequencing and high-resolution
proteomics. It is possible that many of the short
ORFs we have identified are rapidly degraded
and do not act as functional polypeptides. None-
theless, these could still have regulatory function
or be an important part of the immunological
repertoire of the virus as major histocompatibility
complex (MHC) class I bound peptides are
Fig. 4. A major source of ORFs’ diversity during infection originates from
alternative transcripts starts. (A) The mRNA and ribosome occupancy profiles
around US18 to US20 loci at different infection times (marked left). Small
arrows denote the different mRNA starts, and (top) the corresponding mRNAs
are illustrated. (Bottom) An expanded view of the US18 locus at 72 hours after
infection and includes the harringtonine and LTM profiles (asterisks indicate
the internal initiation). (B) Total RNA extracted at different time points during
infection was subjected to Northern blotting for ORFS346C.1.
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generated at higher efficiency from rapidly de-
graded polypeptides (25). Our work yields a
framework for studying HCMV by establishing
the viral proteome and its temporal regulation,
providing a context for mutational studies and
revealing the full range of HCMV functional
and antigenic potential.
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7   Summary & Concluding Remarks 
In this thesis, the fundamental principles of shotgun proteomics were investigated from a global 
analytical perspective. The discipline of MS-based proteomics deals with various challenges at 
different levels, starting from optimal sample preparation methods and prominently including 
mass spectrometry technology with its associated data analysis tools. It has become clear in our 
and other laboratories that a strong integration and good balance between these topics is of 
pivotal importance for overall success. With the ultimate goal of high data quality for 
comprehensive proteome analysis in mind, we focused on (1) the instrumental capabilities 
including improvements to sensitivity, sequencing speed and resolution and (2) development of 
data analysis tools that translate these technological advances into the most comprehensive and 
confident peptide and protein identifications possible. The cumulative benefit of these 
contributions was demonstrated in the collaborative project Decoding human cyclomegalovirus in 
which we applied the latest technologies of mass spectrometry-based proteomics to confirm the 
existence of a large proportion of novel proteins predicted by ribosome profiling.  
Figure 12 illustrates three levels that need to be carefully linked for a successful shotgun 
proteomics experiment, and it illustrates the areas in which the efforts of this thesis have made a 
contribution.  
 
 
Figure 12: Different levels of shotgun proteomics research. Focus and contribution of the projects of this thesis are 
marked in red; numbers (1-8) indicate the corresponding articles. 
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Initially we performed a baseline study that outlines the requirements needed in mass 
spectrometric instrumentation to efficiently analyze highly complex shotgun proteomics samples. 
This effort provided detailed insight into the influence of the three major instrument parameters 
sequencing speed, sensitivity and purity of precursor isolation, and allowed judging the potential 
of the most commonly applied data-dependent acquisition strategy with regard to the accessibility 
of the peptidome resulting from digestion of all proteins in the sample. Due to the high complexity 
of shotgun proteomics samples, mere improvement of sequencing speed and sensitivity is not 
sufficient although highly beneficial. The purity of precursor isolation remains an inherent 
limitation of the data dependent peptide sequencing approach. However, the vast majority of 
proteomics studies do not always require complete sequence coverage of all proteins and the 
desired aim of complete proteome analysis as a complementing technology to next-generation 
sequencing is not necessarily affected.   
The latest generation Orbitrap instrumentation was optimized and evaluated in terms of hardware 
and software as a major effort of this thesis. Especially the high sequencing speed of the 
quadrupole Orbitrap combination (Q Exactive) proved to be of tremendous importance for 
increased proteome coverage; the duty cycle of the quadrupole Orbitrap instrument is increased 
by a factor 2-3 over its predecessor (Article 2). This substantial advancement does not come at 
the expense of lower quality mass spectra as it appears to do in quadrupole TOF type 
instruments, but is largely facilitated by parallel ion accumulation and scanning capability of the 
instrument and by an enhanced Fourier transformation algorithm, which effectively doubles the 
resolution or decreases the transient times by half. Perhaps most importantly for the future, this 
platform makes targeted proteomics feasible in various applications. Already, we have 
demonstrated that multiplexed SIM scans can increase the sensitivity up to 50-fold. Targeted 
approaches are complementary to data-dependent methods that primarily aim at high duty cycles 
in peptide sequencing. In the future, however, both strategies may be combined to ensure the 
measurement of specific peptides and comprehensive proteome analysis in shotgun approaches.  
We found that the best use of the ultra-high resolution featured by the compact high-field 
Orbitrap analyzer incorporated into the Orbitrap Elite instrument was to translate resolution into 
a speed advantage for shotgun proteomics. This is done by selecting shorter transient lengths or 
by using the high resolution Orbitrap analyzer in parallel with the linear ion trap for tandem mass 
spectra acquisition. Beyond shotgun proteomics, ultra-high resolution proved to be extremely 
beneficial for top-down proteomics where it achieved baseline resolution of the isotope patterns 
of purified proteins of medium to even large size and improved the sequence coverage in their 
121 
 
tandem mass spectra. Furthermore, it became possible to investigate intact proteins by MS and 
MS/MS on a chromatography time-scale (Article 3).  
While high resolution is a system-inherent parameter to the mass spectrometer, high mass 
accuracy is enabled by high resolution, but also depends on the calibration procedure. We 
performed a comparison between the mass accuracy achieved by internal calibration with the so-
called lock mass procedure and with a non-linear recalibration algorithm applied to the data during 
post-processing. The software lock mass matched the maximum hardware capabilities of the 
instrument in terms of mass accuracy, which clearly demonstrated that addressing the problem of 
calibration at a later point in the shotgun proteomics pipeline is highly practical and beneficial 
(Article 5).  
The high mass accuracy MS/MS data obtained with HCD fragmentation from the dual linear ion 
trap Orbitrap platform introduced in 2009 was a clear example of superior data quality compared 
to previous technological platforms. Visual inspection of the tandem mass spectra immediately 
convinced the trained expert, however, the commonly used commercial peptide database search 
tools such as Mascot were not able to access the full potential of this data. A novel search engine, 
Andromeda, developed by Jürgen Cox as an addition to the MaxQuant software package, features 
similar performance as Mascot, but is capable of searching fragment ion spectra with arbitrarily 
high mass accuracy. In this context, we also implemented a novel algorithm for a second database 
search that attempts to identify a second peptide in the fragmentation window and thereby takes 
maximum advantage of the high mass accuracy. We found that Andromeda retrieved about 10% 
additional identifications of unique peptides. This does not fully solve the inherent problem of 
co-fragmenting precursor ions (Article 1), but it often turns the apparent disadvantage into a 
benefit, i.e. a second peptide identification (Article 4).  
Independent of high mass accuracy and regardless of successful search engine identification, 
many tandem mass spectra contain highly abundant peaks that lack an assignment. This situation 
can be confusing when visually inspecting results. The advent of the high-high strategy now makes 
it possible to unambiguously explain most of such unassigned peaks. The basic chemistry of 
peptide fragmentation in the gas-phase has been studied in great detail for decades. However, 
mass spectrometrists usually had to rely on very low numbers of peptides investigated with older 
mass spectrometer types or somewhat larger numbers of low resolution MS/MS spectra acquired 
in ion traps. In this thesis, we have critically reviewed, brought together, checked and partially 
extended the knowledge on peptide fragmentation mechanisms and ion types using our large 
collections of high resolution collision induced fragmentation spectra. To make this information 
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easily accessible and enable comprehensive annotation of large-scale datasets, we have established 
a computer-assisted Expert System that provides annotations of tandem mass spectra in 
publication quality (Article 7). An in-depth statistical investigation of the ion types found in 
higher energy collisional dissociation spectra was iteratively carried out between Expert System 
development and human expert annotation. We also used the automated annotation to compare 
the nature of HCD and ion trap fragmentation spectra of tryptic peptides (Article 6).  
The technological improvements outlined in this thesis then culminated in the successful 
identification of novel proteins of human cytomegalovirus despite the highly complex 
background from a human cell line. High sequencing speed in conjunction with high MS/MS 
data quality and comprehensive automated annotation were the key-features in this success. The 
mass spectrometry-based proteomics data convincingly complement the ribosome profiling 
findings of the same cellular system, which not only supports the biological evidence of the 
results on new open reading frames, but also underlines the maturity and potential of both 
technologies (Article 8).  
 
Taken together, shotgun proteomics technology continues to present interesting challenges 
inherent to the nature of proteomics samples and to the data-dependent analysis, which despite 
alternative developments is still by far the most successful strategy. Remaining areas for 
development are clearly related to the accessibility of the peptidome, because the proteome can 
often be covered in sufficiently high depth already. Other fundamental challenges include the 
electrospray ionization process that is still very poorly understood. For instance, ion suppression 
is known to have negative effects on instrument sensitivity and signal-to-noise ratios. 
Improvements in these basic issues therefore may translate into extended mass and fragment 
mass measurements with a remarkable potential for better data quality and thus for the depth of 
biological conclusions based on proteomics studies. Furthermore, it became clear during this 
thesis that there are more than enough peptide precursor ions available (Article 1). Due to the 
high complexity of overlapping elution profiles, however, it is not trivial to decide on the fly 
which precursor ions to target for fragmentation. It would be desirable to select each precursor 
ion only once at optimal quality, in the case of SILAC pairs just the more abundant partner, and 
to schedule the fragmentation event at the apex of the chromatographic peak. These and even 
more sophisticated approaches may in the future be enabled by intelligent data acquisition software. 
This was recently principally demonstrated124 and would allow to optimally benefit from the 
enhanced instrument capabilities. Finally, in order to successfully complement next-generation 
DNA and RNA sequencing, it is of primary importance to focus on the robustness of proteomics 
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technology and to establish fast, inexpensive and user-friendly workflows and instrumentation. 
The more and more streamlined proteomics pipeline, including the latest benchtop format and 
largely automated data analysis tools, provides a promising perspective for moving mass 
spectrometry-based proteomics technology into biological laboratories and into the clinic where it 
can be used by an increasing number of scientists.  
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